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ABSTRACT OF THE DISSERTATION 
Development and Application of Mass Spectrometry Based-Approaches for Protein Higher 
Order Structure Analysis and Protein-Protein Interaction Characterization  
by 
Mengru Zhang 
Doctor of Philosophy in Chemistry 
Washington University in St. Louis, 2020 
Professor Timothy Wencewicz, Chair 
Professor Michael L. Gross, Co-chair 
 
Proteins, one of the most fundamental biomolecules, adopt unique higher order structures (HOS) 
to enable diverse biological functions. Deciphering protein HOS is crucial to gain deeper insights 
of their working mechanisms and to develop biotherapeutics. Mass spectrometry (MS)-based 
approaches evolved rapidly in the past 30 years and are now playing critical roles in protein HOS 
characterization. One of those approaches is MS-based footprinting whose principle is to map the 
solvent accessible surface area (SASA) to deliver structural information. Protein footprinting can 
be achieved by reversible labeling, e.g., hydrogen-deuterium exchange (HDX), and by 
irreversible labeling using radical-based reagents or other targeted labeling reagents. Irreversible 
labeling such as fast photochemical oxidation of protein (FPOP) and cross-linking (XL) delivers 
the information of the reactive amino acid side chains, whereas HDX allows the analysis of the 
backbone amides. Information from the two aspects are different yet complementing to each 
other. In Chapter 1, the two MS-based footprinting methodologies are reviewed and discussed in 
detail including the fundamental, history, and recent applications.  
xvi 
 
In the second section, development of the irreversible radical footprinting is the primary focus, 
specifically the elaboration of FPOP platform. Chapter 2 describes the generation and evaluation 
of a new radical reagent, the carbonate radical anion, on the FPOP platform; a radical that can 
selectively label methionine and aromatic residues, complementing others radical reagents in the 
footprinter “toolbox”. Chapter 3 demonstrates a novel way of elaborating FPOP platform that is 
to follow protein unfolding by coupling two lasers together: one to induce protein 
conformational changes by pH jump and the other to label protein with radical reagents. A time 
delay between the two lasers enables the characterization of the dominant protein conformations 
at different stages of unfolding. 
The third section emphasizes the integration of several footprinting approaches as well as 
computational methods for comprehensive analysis of protein HOS. In Chapter 4 and 5, HDX, 
XL-MS and molecular docking are combined to determine protein-protein binding interfaces and 
to map epitope/paratope of an antigen-antibody complex, respectively. In particular, Chapter 4 
discusses the potential of using HDX to adjudicate candidate docking models for quaternary 
structure elucidation. Besides molecular docking, homology modeling in combination with XL-
MS is also a successful marriage to decipher protein structures, an example is demonstrated in 
Chapter 6. Restraints derived from cross-links help modify and validate a predicted structure of 
phycolisome, contributing to the first proposed architecture of the protein complex in 
cyanobacteria.  
The six chapters combine to demonstrate the development and application of MS-based 
footprinting in protein HOS characterization. Given the effectiveness and powerfulness of these 
methods, significant contributions by MS-related approaches are well to be expected in the field 
of structural proteomics.  
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Chapter 1: Introduction to Mass Spectrometry-Based 

























* This chapter is based on the following publication: Liu, X. R.; Zhang, M. M.; Gross, M. L. 
Mass Spectrometry-Based Protein Footprinting for Higher Order Structure Analysis: 




Proteins exhibit diverse higher order structures (HOS) that contribute to their distinctive 
functionalities. Characterization of protein HOS is crucial to allow deeper understanding of their 
interactions and enable better designs of biotherapeutics. There are many biophysical approaches 
to probe protein HOS: traditional optical methods that provide fast but low-resolution 
information and high-resolution techniques (X-ray crystallography and nuclear magnetic 
resonance) that deliver atomic-level information. Mass spectrometry-based (MS) approaches 
offer middle-to-high resolution data and complement the others while providing significant 
advantages (e.g., fast throughput, sensitive detection, in-solution characterization). One of the 
essential components of the MS-based approaches is protein footprinting, which utilizes different 
labeling reagents to map the solvent-accessible area (SASA) of proteins to describe HOS. 
Reversible footprinting utilizes H-D exchange for a relatively unbiased labeling on the backbone 
amide hydrogens; however, reagents employed in irreversible footprinting react, often with high 
specificity, with the side chains of accessible residues. In addition, the labeling time scale, 
sample preparation and experimental set-up are all different for the two footprinting methods, 
contributing to different applications. This chapter summarizes and compares these differences in 
detail including the historical and fundamental aspects, providing a comprehensive background 
for the thesis.  
1.2 Introduction 
Proteins are one of the fundamental biomolecules, regulating complex yet delicate bioactivity 
networks. The diverse functionalities1 of proteins include (i) providing mechanical support as the 
cell skeleton; (ii) transporting other biomolecules to the targeted locations; (iii) transmitting 
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signals to coordinate different types of biological process; (iv) catalyzing cellular reactions to 
assist new molecules formation; (v) binding to pathogens to provide immune protection. To 
afford distinctive biological functions, protein three-dimensional (3D) structures are highly 
diverse, which in turn leads to several mechanisms that are taken to execute their various roles. 
Therefore, it is crucial to characterize protein higher order structure (HOS), and that insight can 
not only deepen our understanding of their functions mechanistically but will also aid the design 
of biotherapeutics along the way.  
There are four orders of protein structures, namely (i) primary structure that consists of the 
amino acids sequence encoded genetically in nucleic acids; (ii) secondary structure that arises by 
folding of the primary structure to give, for example, α-helices, β-sheets, and β-turns; (iii) 
tertiary structure resulting from assembly of all local structures into an overall 3D architecture; 
(iv) quaternary structure that forms when one protein interacts with another to give a protein 
complex. Characterization of protein HOS typically refers the secondary structure and beyond, 
and this class of structure can be addressed by many biophysical approaches.  
To probe globally the secondary structure content or the conformational changes near a label, 
CD, FT-IR, FRET and UV can be good candidates. Although these optical techniques provide 
relatively low resolution, they deliver the results efficiently and rapidly. On the other hand, the 
approaches that have the highest resolution, X-ray crystallography,2 nuclear magnetic resonance 
(NMR)3-5 and cryo EM6-7, give atomic-level information but also show some disadvantages. X-
ray crystallography relies on the diffraction pattern of a crystalized protein sample, which can be 
challenging to obtain. In addition, the information derived from a solid-state structure may not be 
relevant in solution. NMR does probe the protein structures in solution,8-9 but the required 
sample amount is large, typically milligrams. Furthermore, the long signal-averaging time and 
4 
 
complicated data analysis also limit its applications. Recently developed cryo-EM also enables 
the characterization of non-crystalline samples10-11 with low sample amount and straightforward 
sample preparation. The approach, however, favors high-molecular-proteins, typically larger 
than 100 kDa.12 
Over the past three decades, mass spectrometry-based methods have evolved from a few 
scattered studies in specific amino acid labeling and HDX to many applications that give middle-
to-high resolution. The sensitive detection, fast throughput, low amount of protein sample 
(nanogram to microgram level) in solution, rapidly developed instrumentation, and advanced 
data analyzing software greatly promote its adoption to various biological questions and protein 
systems.  
One critical aspect to characterize protein HOS is MS-based footprinting13, which maps solvent-
accessible surface area (SASA) on protein or protein complexes. MS-based footprinting can be 
further subdivided into two classifications, namely reversible and irreversible footprinting. The 
most common example of reversible footprinting is based on the H-D exchange on the backbone 
amide hydrogens; this approach is also known as the hydrogen-deuterium exchange MS (HDX-
MS). Irreversible footprinting makes use of targeted-labeling reagents with slower chemistry 
(mins to hours) and radical-labeling reagents that can react with residue side chains on the micro 
to millisec time scale. When combined with bottom-up MS analysis, these approaches resolve 
the structural information from peptide level to residue level.  
In this chapter, we review the history, fundamentals, experimental designs, and key applications 
of both the reversible and irreversible footprinting. The review serves to introduce the 
development and application of the MS-footprinting approaches as a theme of this thesis. 
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1.3 Reversible Protein Footprinting: Hydrogen-Deuterium 
Exchange 
1.3.1 History and Fundamentals 
Hydrogen deuterium exchange (HDX), a rapid emerging technique in recent years, has been 
adopted widely to study protein conformations and dynamics. In 1954, Hvidt and Linderstrøm-
Lang carried out the first HDX on protein with pork insulin, establishing the connection between 
the H/D exchange rate and protein dynamics.14 Later, HDX was coupled with other analytical 
techniques (e.g., NMR15-17 and Fourier transform infrared (FTIR) spectroscopy) to achieve better 
spatial resolution. The marriage of HDX and NMR not only enables residue-level information 
for small proteins18 but also allows the determination of exchange rates for individual amide 
protons3, 19. The broad application of HDX-NMR has been largely limited, however, by the 
complications of handling large proteins. Instead, the integration with mass spectrometry brought 
forth a more sensitive and broadly applicable approach. Given the sensitive detection of MS and 
the apparent mass shift when exchanged into deuterium, HDX-MS enabled advances to larger 
proteins at lower concentration. The first study of HDX-ESI-MS was carried out by Katta and 
Chait20 in 1991. After deuterium exchange, they observed a shift of the centroid mass on the 
isotopic envelope of the global protein. Later, Zhang and Smith21 coupled a proteolytic approach 
with HDX to locate the structural changes at regional resolution, a pioneer study setting up the 
paradigm for the HDX analysis today.  
HDX delivers the structural information of proteins by describing the local solvent accessibility 
and hydrogen bonding networks on amide backbone. The backbone amide hydrogens that are 
exposed to solvent on a protein surface and involved weakly in hydrogen bonding are more 
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labile, and they exchange more rapidly than the ones that are buried inside the protein structure 
and stabilized by H-bonds. The hydrogens on the sidechains, however, are even faster 
exchangers that are difficult for most experiments to measure. The negligible exchange on side 
chain hydrogens makes the information from HDX an “unbiased” readout that reports all amino 
acids containing an N-H hydrogen on backbone. The rate constant of N-H to N-D, kch, is 
determined by pD, temperature, and the local environment of the residues. HDX is both acid and 
base-catalyzed, giving a minimal kch at pH around 2.5. 22-23 Practically, the apparent HDX 
exchange rate, kHDX, is much smaller than kch, mainly affected by the accessibility to the amide 
sites and the intramolecular interaction of N-H···O=C among peptide bonds.24 The breathing 
motion of the H-bonds comes with an opening and a closing transition (expressed as kop and kcl, 
respectively), which can compete with kch, contributing to different HDX regimes, EX1 and EX2 
(eq 1.1). In EXI where kch >> kcl, the apparent kHDX = kop, indicting an immediate exchange to 
deuterium after the initial opening event. In EX2 where kcl >> kch, the apparent HDX exchange 
rate is characterized as kHDX = Kopkch, in which Kop = kop/kcl. Generally, the EX2 regime is more 
prevalent than EX125-26, whereas the combination of the two is also common to see27-28.⇌ 
 N-Hclosed  N-Hopen  N-Dopen  N-Dclosed   (1.1) 
1.3.2 Experimental Setup and Applications 
Most HDX experiments are conducted differentially between two states, for example a bound 
and an unbound protein or a wildtype and a protein mutant. The changes in SASA that result 
from the binding interactions or conformational alterations are represented by the deuterium 
uptake extent. In practice, HDX is often coupled with bottom-up analysis to get regional or even 
residue-level information. Prior to a differential HDX experiment, peptide mapping is an 
essential step to create a list of peptides that can be monitored to afford spatial resolution. The 
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main components in peptide mapping is to optimize the quenching condition for a maximal 
denaturation of the targeted protein and, at the same time, minimal back exchange of the 
incorporated D to H. Concentration of the denaturant and the reducing regent as well as the 
incubation time and temperature all require careful consideration. The optimized quenching, 
digestion protocol, and MS method are then applied in the HDX experiment (workflow is shown 
in Figure 1.1).  
The HDX data obtained are typically analyzed by commercial software (e.g., HDExaminer,29 
HDX Workbench,30), where a built-in algorism fits the isotopic distribution of each peptide, 
giving the centroid of the pattern and the average deuterium uptake compared no exchange.  
 
Figure 1.1 Schematic representation of HDX-MS workflow.  
HDX-MS being a valuable asset in the characterization toolbox for protein HOS analysis has 
many advantages. The use of deuterium as a footprinting reagents introduces minimal 
perturbation on protein structure and provides a “unbiased” labeling on nearly all residues 
(except Proline), comparing to other protein labeling techniques. In addition, the interface with 
mass spectrometry enables a fast throughput of data acquisition. Recent developments of HDX 
data processing software further contribute to more efficient data analysis, promoting wide 
applications in both academic and industrial research laboratories. Up to now, HDX-MS has 
been successfully applied to map epitope/paratope of biotherapeutics (an example is discussed in 
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detail in Chapter 5),31-34 to characterize protein binding interface with other biomolecules (an 
example is discussed in detail in Chapter 4),35-38 to follow protein folding/unfolding dynamics,39-
40 and to address the allosteric regions of protein or protein complexes.41  
There are challenges for further advancing the approach. To increase the spatial resolution, even 
to individual amino acid level, researchers have made considerable effort including multi-
enzyme digestion to increase overlapping peptides,42-43 high-pressure digestion for enhanced 
digestion efficiency,44-45 and employment of ETD or ECD for orthogonal fragmentations with 
minimal HD scrambling46-48. Furthermore, the demanding adaptability of HDX-MS to membrane 
proteins is also a concern, wherein the on-line removal of lipids can be troublesome. Although 
the recent development of using zirconium (IV) oxide to remove detergent and lipids49 represents 
a promising solution, a robust methodology is still on the way.   
1.4 Irreversible Protein Footprinting: Chemical Cross-
linking 
The 20 amino acids have different kinds of functional groups on their side chains; most have 
functional groups (COOH, SH, NH2, OH, CONH2, aromatic ring) that can be labeled with 
chemical reagents that react specifically, usually with one or two amino acids. These modifying 
reactions can be used for footprinting provided the reactivity of these groups depends on SASA 
of the protein, and the modifications in the early stages do not affect the protein structure, 
minimizing the biased report during the footprinting itself. Reagents react directly and usually 
slowly with specific solvent-accessible side chains in contrast to free radicals, which react 
rapidly. The product contains a characteristic mass tag that can be detected by MS analysis. 
Although numerous reagents have been developed to react with the amino acid side chains, a 
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qualified protein footprinting reagent needs to label the protein under physiological conditions 
with reasonable efficiency and speed. The size and hydrophilicity of the reagent should be close 
to that of water to ensure its reactivity is an indicator of SASA. Most of these reagents developed 
to date are highly specific, targeting one or two side chains or functional groups although some 
can react with more than two.  
Residue-specific reagents have a long history of development for various purposes, while their 
applications in protein footprinting generally started from 1990s. This field is well reviewed in 
two articles50-51, hence is not covered in this section. Chemical crosslinkers, which can be viewed 
as bifunctional footprinters, are discussed in detail.  
1.4.1 Assessing Topology and Stoichiometry through Chemical Cross-linking 
Chemical cross-linking has developed as a complementary area of research owing to its 
capability to probe HOS and to locate and define protein/protein interfaces. Our intention, 
however, is not to review this topic comprehensively, but to describe the workflow, show how 
XL can be viewed as a means of footprinting (i.e., “double footprinting”), discuss its role in 
integrated approaches, and highlight some recent developments to unify the methodology 
described in this work.  
Cross-linking mass spectrometry (XL-MS) is effective at assessing protein complex topologies 
and elucidating protein structures besides capturing protein-protein interactions. Conceptually, 
XL utilizes bifunctional labeling reagents to cross-link (footprint) the constituent proteins 
forming an interface, thus providing information on the interacting species and their interfaces. 




Figure 1.2 Workflow of bottom-up cross-linking mass spectrometry 
To date, most of the MS-based XL studies have been by a bottom-up approach, whose workflow 
is presented in Figure 1.2. Briefly, proteins are first incubated with chosen cross-linkers under 
the optimized conditions that are established usually by monitoring with techniques simpler than 
MS (e.g., gel electrophoresis). The tethered proteins are then submitted to enzymatic digestion, 
enrichment of informative peptides, and LC-MS/MS for separation and detection. The MS data 
are further analyzed by using search engines to identify cross-linked peptides with an uncertainty 
specified by mass tolerance and false discovery rate (FDR). Significant advances since 2008 in 
data analysis have facilitated this approach; new software includes but is not limited to pLink,52 
xQuest,53 XlinkX,54 and StavroX55. Generated cross-link maps not only identify the connectivity 
of the adjacent protein subunits but also provide distance restraints as given roughly by the 
molecular separation between the two reactive functional groups of the cross-linker.  
XL-MS alone is a middle-to-low spatial resolution approach because usually there are limited 
number of reactive residues at or near an interface of two proteins, and few crosslinks form. 
Young et al.56 in 2000 showed that by combining XL distance restraints and computational 
modeling is a compelling way to improve the resolution for elucidating protein structures. The 
workflows can be adapted for integrative modeling57-58 and de novo structure prediction59-60. The 
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major challenges of computational studies are the sampling and scoring of the generated 
models61. Larger data sets derived from XL-MS effectively decrease the size of the sampling 
space and benefit the scoring function, thus promoting efforts to find high-confidence models. 
Given there can be various reactive groups and spacer lengths on cross-linkers, a strategy 
involving multiple reagents should be taken to insure comprehensive information.  
In 2014, Chait and coworkers58 demonstrated the use of disuccinimidyl suberate (DSS) and a 
zero-length EDC in characterization of the nuclear pore sub complex of Nup84. Two data sets 
generated from the use of two reagents delivered different but complementary structural 
information that significantly benefited the subsequent model construction. Many other studies 
adopted similar ideas by combining amine-targeting reagents and carboxyl-targeting reagents 
(e.g., dihydrazides62-63) or nonselective cross-linkers64-65. In addition, the use of reagent 
combinations with different spacer lengths is recommended because short cross-linkers yield 
fewer cross-links but with narrower distance restraints, whereas long cross-linkers afford more 
cross-links but less structural definition because the distance assignments are over a broader 
range.61  
New sample preparation methods also have developed rapidly (e.g., on-bead cross-linking60), 
improving the cross-linking chemistry and providing better analysis sensitivity. Many examples 
are discussed in recent reviews.66-68   
By way of contrast, footprinting by targeted and free-radical reagents and/or by HDX maps 
solvent accessible regions and reflects differences in protein dynamics or binding events. This 
information provides deeper understanding of the entire protein structure, not just interfaces, and 
can adjudicate constructed 3D models from XL for in-solution proten.69-71 
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XL is not limited to structural characterization of a single protein complex, but rather it can 
promote protein-protein interactions (PPIs) studies in proteome-wide investigations.52, 72-74 To 
meet the need for understanding the roles, functionalities, and mechanistic behavior of many 
protein complexes through their PPIs maps, cleavable XL reagents have been developed,75 
simplifying and increasing the accuracy for identification of cross-linked peptides. Incorporation 
of affinity groups and sophisticated enrichment procedure have led to success; examples are 
studies performed on E. coli73 and Caenorhabditis elegans (C. elegans).74 For example, the Heck 
group54 reported a XL-MS study of whole human cell lysates in which they identified 2179 
unique cross-links. These protein complexes (e.g., 80S ribosomal core complex) reveal novel 
interactions and provide new structural insights. 
To summarize, the increasing number of publications based on XL-MS continue to demonstrate 
its utility in MS-based biophysics, particularly in combination of other techniques. Integrating 
XL with other methods enables characterization of dynamic biological systems even of 
heterogeneous systems. The continuing development of cross-linkers will increase applications. 
Reagents that react more rapidly and target more and more amino acids, instrumentation 
advances that provide new fragmentation methods in MS/MS (e.g., CID, ETD, EThCD and 
UVPD), and software are expected for the future. Furthermore, improved separation and 
enrichment procedures will accommodate the increasing mixture complexity following XL and 
digestion and allow detection of low abundant yet informative cross-linked species.  
1.4.2 Chemical Cross-linkers 
Chemical cross-linking occurs via the formation of covalent bonds between interacting proteins 
and within a protein on adjoining regions.76-78 This structural proteomics tool often uses a 
bifunctional chemical reagent and can be viewed as bifunctional footprinting. Many reagents 
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have been developed, promoting more and more applications of chemical cross-linking. The 
character of a cross-linking reagent is determined by the nature of chemistry, spacer length, and 
built-in functional groups. Cross-linking can be an effective complement to monofunctional 
reagents that serve as footprinters, and therefore the subject is briefly covered in this review 
particularly to make that point. The emphasis is on the commonly used reagents, which fits the 
theme of footprinting. Indeed, the location of monolinks can be viewed as a footprint. Our 
discussion is organized around the cross-linking reagents as follows.  
1.4.2.1 Amine-reactive Cross-linkers: NHS-Ester and Imidoester 
N-hydroxysuccinimide Ester 
NHS-esters are the most widely used cross-linkers in field. The ester group undergoes attack by 
nearby nucleophilic sites (e.g., primary amines on Lys side chains or at the N-terminus of a 
protein/peptides, hydroxyl groups on Ser or Thr, and even sulfhydryl groups on Met) to form C-
X bonds (X = N, O, S). The differing reactivities with various nucleophilic groups, however, 
depends on reaction conditions and can introduce bias. Primary amines possess the highest 
reactivity at physiological pH, and their reactivity can be further enhanced when the pH is > 7.79-
80 Hydrolysis of NHS-esters has a half-life of 4-5 hours at pH 7 and 0 °C81; the hydrolysis, 
however, is accelerated under alkaline conditions and at higher temperature.82-83 Other possible 
products (i.e., esters and thioesters formed with Ser/Thr or Met) are less stable and undergo more 
rapid hydrolysis.83 Although the reaction is favored under acidic conditions (pH = 6.0), cross-
linking at pH = 7 still occurs. The current consensus is to consider all possible residues as sites 
for reactions in simple protein systems, whereas only Lys residues and the N-termini are 
recommended for cross-linking a large complex or in a whole proteome study to minimize 
dispersion of cross links and maximize probability for detecting the cross-links.84  
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Scheme 1.1 Common NHS-ester cross-linkers 
 
The first NHS-ester originated in late 1970s as a homo-bifunctional cross-linker.85 Since then, 
many NHS-esters possessing useful physical and chemical properties have become suitable for 
answering a range of biological questions. Designs include cross-linkers with high 
hydrophobicity and zero charge, being lipophilic and membrane-permeable and ideal for 
intramembrane cross-linking (e.g., DSS) and disuccinimidyl glutarate (DSG), Scheme 1.1). 
Other cross-linkers incorporate a sulfonate group, which imparts water-solubility and avoids 
steps of pre-dissolution in organic solvents that could perturb aqueous conditions and cause some 
protein denaturation.  
Currently, sulfo-NHS esters have become the dominant cross-linkers in characterizing soluble 
proteins and their interactions. bis(Sulfosuccinimidyl)suberate (BS3, Scheme 1.1), the most 
extensively used sulfo-NHS cross-linker, can be encoded with deuterium to facilitate better 
cross-link assignment. The spacer length is 11.4 Å, allowing cross-linking for residues separated 
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by 27 Å measured between two α carbons in an amino acid residues that are linked (termed 
Cα).86  
New developments in NHS-esters resonate well with the rapid growth in proteomics research 
enabled by advanced MS. More complicated systems with larger-scale protein candidates require 
better sequencing in MS/MS for a confident cross-linking identification. The disadvantage of 
using conventional cross-linkers is that the user must sequence species made up of two cross-
linked peptides and the cross-linker, introducing complexity into fragmentation and challenging 
the acquisition of high-quality, readily interpretable MS/MS data. Cleavable cross-linkers are, 
therefore, designed to address that problem.68 NHS-esters have incorporated chemical-cleavable 
motifs (e.g., S-S bond in 3,3'-dithiobis(sulfosuccinimidylpropionate) (DTSSP)79) and CID-
cleavable functional groups that include C-S bonds (e.g., disuccinimidyl sulfoxide (DSSO)87 and 
cyanurbiotindimercaptopropionyl succinimide (CBDPS)88) and C-N bonds (e.g., disuccinimidyl 
dibutyric urea (DSBU)89 and N-hydroxyphthalamide ester of biotin aspartate proline (BDP-
NHP)90). Chemical structures of these cross-linkers are shown in Scheme 1.1. In addition, some 
NHS-crosslinkers contain biotin tags (e.g., CBDPS and BDP-NHP), to provide a means of 
enriching the crosslinked species by affinity purification. 
Imidoester 
Scheme 1.2 Common imidoester cross-linkers 
 
Imidoesters, introduced in 1966 as one of the oldest reagents for protein cross-linking, are water-
soluble reagents that react specifically with primary amines (see Lys footprinting section 
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above).91 The functional imidate group reacts to form an amide bond via intermediates at an 
optimized pH range of 8-10.82 One major advantages of using imidoester cross-linkers is that the 
reaction product, an amidine, carries one positive charge. Charge removal that occurs with most 
lysine-targeting cross-linkers may disrupt intramolecular and intermolecular interactions and 
distort protein conformation, giving a biased result. The lifetime of imidoesters, however, is 
limited by rapid hydrolysis, being less than 30 min.92-93 The most commonly used cross-linkers 
in this class are dimethyl pimelimidate (DMP), dimethyl suberimidate (DMS) and a cleavable 
analog, dimethyl 3,3′-dithiobispropionimidate (DTBP), as depicted in Scheme 1.2. 
1.4.2.2 Carboxylic Acid-reactive Cross-linkers: Carbodiimide and Dihydrazides 
Scheme 1.3 Common carbodiimide and dihydrazide cross-linkers 
 
The most widely used carbomiimide is EDC (Scheme 1.3), also known as a “zero-length” cross-
linker.94-95 When this reagent facilitates cross-linking of carboxylate groups and primary amines, 
there is no spacer chain inserted between the targeted proteins, but rather an amide bond (~ 3 Å) 
between COOH and NH2-containing sidechains.
94-95 One critical reaction intermediate, O-
acylisourea, is not stable in aqueous condition (Scheme 1.6), and it continues to degrade back to 
the carboxyl group. Therefore, sulfo-NHS is often incorporated in the cross-linking protocol to 
transform the O-acylisourea into a stabilized NHS-ester for more efficient conjugation. EDC 
cross-linking shows the highest reactivity at pH 4.5 and still a moderate reaction efficiency at 
neutral pH.76 2-(N-Morpholino) ethanesulfonic acid (MES) and phosphate buffer are compatible 
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with carbodiimide reagents; however, more concentrated reagents should be used in the latter 
buffer owing to the reduced reactivity.  
Other commonly used cross-linker for Asp and Glu are dihydrazides. In 2008, Kruppa and 
Novak96 first reported its use in combination with EDC activation. The reaction was carried out 
in acidic conditions (pH = 5.5), which is not physiologically friendly, to give a low cross-linking 
yield. Later in 2014, Aebersold and coworkers63 reported a new coupling reagent (other than 
EDC), 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride (DMTMM), and 
achieved significantly increased reaction yields and better biocompatibility at neutral pH. 
Recently, Lei and coworkers97 developed a coupling, reagent-free crosslinker, 
bis(trimethylsilyldiazomethyl)dioxaoctane (Scheme 1.3), that offers selectivity and efficiency 
under physiological conditions. Isotopic encoded dihydrazides are now commercially available 
with different spacer lengths (e.g., adipic acid dihydrazide (ADH) and pimelic acid dihydrazide 
(PDH), Scheme 1.3). 
1.4.2.3 Sulfhydryl-reactive Cross-linkers: Maleimide 
Maleimide cross-linkers react specifically with sulfhydryl groups at pH 6.5-7.5 to form stable 
thioethers.98-99 Under alkaline conditions (pH > 8.5), primary amines are also possible targets but 
not Tyr and His.100 One major concern in maleimide cross-linking is to conjugate free sulfhydryl 
groups, requiring prior reduction of existing disulfide bonds; breaking the -S-S- bond has high 
potential to distort protein native structure. A more common way of employing maleimide 
chemistry is in combination with NHS-esters, where both functional groups are coupled onto a 
heterobifunctional cross-linker. These cross-linkers can be incubated with a protein sample in a 
stepwise manner, reducing disulfide bonds after reaction with primary amines.82 In addition, to 
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ensure the best cross-linking performance, many thiol-containing compounds (e.g., DTT and 
BME) should be eliminated in the reaction buffer. 
1.4.2.4 Carbonyl-reactive Cross-linkers: Hydrazide 
Hydrazides are carbonyl-reactive reagents that exhibit highest reactivity at pH 5-7. Aldehydes 
and ketones are major targets that can be found in glycoproteins introduced by oxidation of the 
polysaccharide.82 The hydrazone bonds thus formed are moderately stable in aqueous solution 
and can be further secured by reducing the double bond to a secondary amine.  
1.4.2.5. Photoreactive Cross-linkers: Aryl Azide and Diazirine 
Photoreactive cross-linkers are generally nonspecific owing to the high reactivity of the 
intermediate species, a nitrene, carbene, or free radical. The most adopted chemistry utilizes 
nitrenes and carbenes, whose precursors are azides or diazirines, respectively. Among the three 
major categories, phenyl azides play a dominant role in current applications. Different 
substituents on the aromatic rings shift their UV absorption dramatically; therefore, they are 
selected with a biological question in mind.82 Nitrophenyl azides, which can be activated at 300-
460 nm, are compatible with most studies because this long wavelength causes minimal damage 
to protein molecules. Upon UV activation, the nitrene diradical can insert into most chemical 
bonds but with a preference for active C-H and N-H sites.101 Diazirines are a relatively new 
class, first reported in the 1990s, and they have better photostability than phenyl azides.102  





Carbene diradicals are usually generated photochemically at ~ 355 nm, and they show reactivity 
with both single and double bonds. Like the nitrene diradical, heteroatom-H bonds undergo 
easier insertion. Some diazirine reagents are designed as analogs of amino acids (e.g., photo-Leu 
and photo-Met103) that can be incorporated into the protein sequence during translation for in-situ 
radical generation. High reactivity of carbenes and nitrenes can also cause problems in cross-link 
identification. The use of homo-bifunctional photoreactive cross-linkers tends to make product 
analysis complex; therefore, one radical precursor is usually combined with an amine- or 
sulfhydryl-reactive motif. The commonly used cross-linkers are N-5-azido-2-
nitrobenzoyloxysuccinimide (ANB-NOS)104 and sulfosuccinimidyl 4,4'-azipentanoate (sulfo-
NHS-diazirine, sulfo-SDA), as seen in Scheme 1.4. 
1.4.3 Conclusion and Perspective 
Protein footprinting takes advantage of early research that provided many effective chemical 
reactions for protein labeling. These reagents can now serve as probes to characterize protein 
SASA and as a basis to reason about protein HOS. The sites of modification can now be 
efficiently measured by MS, owing to the rapid development of LC separations and hybrid mass 
spectrometers with MS/MS capabilities. The chemical cross-linker, which is viewed as a 
bifunctional protein footprinter, when connected to two proteins offers valuable distance 
restraints between the proteins. These targeted footprinting reagents coupled with MS detection 
now are utilized to answer several biological questions and are becoming increasingly significant 
in structural biology. 
A limitation of targeted footprinting is that reagents primarily react with one or a few residues 
that contain functional groups including bases, acids, nucleophiles and aromatic rings, leaving a 
sizable fraction of the amino acid residues to be “silent”. Bulky reagents may be unable to 
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penetrate an interface, suggesting that the lack of reaction may not signal the lack of an interface. 
Moreover, the footprinting reactions are relatively slow, making most targeted footprinters 
unable to characterize fast protein dynamics (e.g., protein folding and protein aggregation). To 
overcome these drawbacks requires a new approach that has broader residue coverage and higher 
reaction rate. Fast footprinting reagents represented by reactive radical species meet these 
requirements as discussed in section 1.5.  
1.5 Fast Labeling Reagents: Reactive Radical Species 
1.5.1 Hydroxyl Radical  
Hydroxyl radical (HO●), a reactive oxygen species (ROS), forms naturally in the cellular 
environment through partial reduction of oxygen. The ROS levels determine cellular oxidative 
stress, which mediates the modification of nucleic acids, proteins, and lipids, regulating signaling 
pathways and contributing to multiple diseases105-107. The hydroxyl radical as a footprinting 
reagent was initiated nucleic acid research108 and promoted later for protein HOS analysis. 
Currently, HO● is the most widely used radical-based footprinter given its many advantages. 
First of all, the size and hydrophobicity of HO● are comparable with the water molecular, 
making it readily accessible to the exposed protein surface. Secondly, its natural presence in 
biological fluids demonstrates the comparability of HO● with most of the protein systems. In 
addition, being a relatively strong oxidant (E0 = 2.30 V), HO
● can react with most of amino 
acids, providing broad residue coverage and comprehensive SASA information. The reaction 
rate with different amino acids, however, range over a few orders of magnitude as seen in earlier 





Table 1.1 Rate constants for reactions between amino acids and HO●109-110 
Free Amino Acid Rate Constant (M-1s-1) pHa 
Cys 3.5 × 1010 7.0 
Trp 1.3 × 1010 6.5 – 8.5 
Tyr 1.3 × 1010 7.0 
Met 8.5 × 109 6 – 7 
Phe 6.9 × 109 7 – 8 
His 4.8 × 109 7.5 
Arg 3.5 × 109 6.5 – 7.5 
cystine 2.1 × 109 6.5 
Ile 1.8 × 109 6.6 
Leu 1.7 × 109 ~6 
Val 8.5 × 108 6.9 
Pro 6.5 × 108 6.8 
Gln 5.4 × 108 6.0 
Thr 5.1 × 108 6.6 
Lys 3.5 × 108 6.6 
Ser 3.2 × 108 ~6 
Glu 2.3 × 108 6.5 
Ala 7.7 × 107 5.8 
Asp 7.5 × 107 6.9 
Asn 4.9 × 107 6.6 
Gly 1.7 × 107 5.9 
1.5.1.1 Fenton Chemistry 
In 1890s, H.J.H Fenton discovered the first oxidation of tartaric acid by hydrogen peroxide under 
ferrous iron (II) catalysis. 112 The “Fenton-like” reactions were further promoted by other 
transition metals, for example, Fe(II), Cu(I). 113-116 The well-recognized mechanism of Fenton’s 
reaction is the listed “classical Fenton pathways” (eq 1.2-1.8), proposed initially by Haber and 
Weiss 117-118 and later revised by Barb and co-workers119-120. The chain reactions start from Fe(II) 
and Fe(III) catalysis (eq 1.2 and 1.3) and terminate by oxidation of Fe (II) to Fe (III) (eq 1.8). 
The reduction and oxidation of ferrous and ferric ions, together with their reactions with H2O2, 
contribute to the propagating generation of HO● (eq 1.4 – 1.7).  
Fe2+ + H2O2 → Fe
3+ + HO● + OH- (1.2) 
Fe3+ + H2O2 → Fe
2+ + HO2
● + H+ (1.3) 
H2O2 + HO
● → HO2





-● + H+ (1.5) 
Fe3+ + HO2
● → Fe2+ + O2 + H
+ (1.6) 
Fe3+ + O2
-● → Fe2+ + O2 (1.7) 
Fe2+ + HO● + H+ → Fe3+ + H2O (1.8) 
Hydroxyl radicals generated from Fenton chemistry were first used for footprinting in 1985, 
when Tullius and Dombroski 121-123 mapped protein binding sites on DNA. The well-designed 
Fenton system contains H2O2, Fe(II)-EDTA complex, which can increase the metal ion 
concentration and allow favorable formation of Fe(III)-EDTA during propagation, and ascorbate, 
which reduces Fe(III) back to Fe(II) to complete a catalytic cycle. Such design established a 
benchmark approach for nucleic acid footprinting and was further expanded with other transition 
metals124-129 including Cu(II), Mn(II), Co(II), and Cd(II). 
In 1990, the Fenton system was improved by employing a synthetic metal-chelate complex, Fe-
(S)-1-(p-bromoacetimidobenzyl)-EDTA (Fe-BABE) 130-132. The Fe-BABE tethers the metal and 
catalyzes HO● formation at specific sites of a protein, for example, the location where cysteine 
residues reside. In addition, the spacer component in the chelating complex delivers spatial 
information of the interacting biomolecules, opening a possibility to capture conformational 
changes. The Fe-BABE system has many advantages compared to the traditional Fenton 
systems, including higher HO● productivity at neutral pH and the capability of site-directed 
oxidation. Its limitations, however, are those of all “Fenton-like” reactions: long timescale for the 
radical chemistry (usually minutes), the possibility that conformational changes occur during 
labeling, and the large amount of H2O2 (30%) 133 that can be detrimental to targeted 




1.5.1.2 Synchrotron Radiolysis of Water 
Synchrotron X-ray is a powerful source to generate HO● through radiolysis of water. The 
generated photons transfer energy to electrons, giving hydrated electrons (eaq
-). Then, the ionized 
water reacts with another to produce HO● (eq 1.9 - 1.11).110 The generated HO● undergoes self-
quenching (eq 1.12) or accepts a hydrated electron to form a hydroxyl anion (eq 1.13).134 
2H2O + e
- (ionizing irradiation) → H2O
+● + H2O* + eaq
- (1.9) 
H2O




● + H● (1.12) 
HO● + eaq
- → OH- (1.12) 
2 HO● → H2O2 (1.13) 
Chance and coworkers first put the National Synchrotron Light Source at Brookhaven National 
Laboratory to use for footprinting in both nucleic acids and protein systems. 135-137 In a radiolysis 
experiment, HO● dosimetry, the effect of beam current, the effect of different buffers and 
additives need to be carefully considered. A detailed discussion is available in a review article.110 
Hydroxyl radical footprinting enabled by synchrotron radiolysis of water has significant 
advantages. Water, as the radical precursor, is physiological-related and compatible with almost 
all bio-systems. In addition, the amount of water (~55 M) is in large excess with respect to the 
targeted biomolecules, maximizing labeling probability. What’s more, the radical dosage can be 
easily controlled by a shutter electronically138, enabling the millisecond formation of HO●. The 
disadvantage, however, is the limited access to a synchrotron sources, which can be overcome in 





1.5.1.3 Laser Photolysis 
Upon UV irradiation, homolytic cleavage of H2O2 into HO
● will occur at the quantum yield of 
0.4-0.5. The subsequent chain reactions follow the Haber-Weiss cycle (Table 1.2) and terminate 
by self-quenching.  
Table 1.2 Reaction scheme and rate constant of hydroxyl radical generation from hydrogen 
peroxide upon laser photolysis 
 Reaction Rate Constant (M-1s-1) 
1 H2O2 + hv →2 HO
● Φ248 = 0.4-0.5
[139-140] 
2 HO● + H2O2 → H2O + HO2
●  2.7 × 107 [140] 
3 HO2
● + H2O2 → H2O + O2 + HO
● 3.06 × 105 [140] 
5 HO● + HO● → H2O2 7.0 × 10
9 [141] 
Although UV photolysis of H2O2 had been accepted in some industrial process (e.g., water 
treatment) the first attempt for protein footpriting was reported in 2004 by Sharp and his co-
workers142. They utilized a UV lamp to photolyze 15% H2O2 in protein solutions for 5 mins. The 
mapped SASA of lysozyme and β-lactoglobulin are consistent with literature structures, 
demonstrating the success as a footprinter. However, the high H2O2 concentration and long 
exposure time are of concern for broader applications.  
To overcome the aforementioned limitations, Aye and Sze143 employed a pulsed Nd:YAG laser 
at 266 nm and photolyzed H2O2 in a static system. Only 0.3% H2O2 was added just before the 
laser photolysis to minimize prior oxidation from the radical precursor. At the same time, 
Hambly and Gross141 reported a KrF excimer-laser-based method (248 nm) that can generate 
HO● and give subsequent labeling in a flow system. In addition, they incorporated a scavenger 
reagent such as Glu141 and His144 to control the primary radical lifetime at micro-seconds level. 
An experimental setup (Figure 2.1) and detailed discussion are in Chapter 2. In brief, the 
combination of a flow system and the utilization of a radical scavenger enables the protein of 
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interest to be irradiated and submitted to radical reactions only once per pulse of the laser, 
minimizing repetitive labeling on the protein that may be altered in conformation upon the initial 
oxidation. The oxidized protein samples will then be collected in a quenching buffer that 
contains Met and catalase to scavenge the H2O2 and avoid post oxidation.  
The H2O2 photolysis has an obvious advantage comparing to synchrotron radiolysis, which is the 
portable laser source that is more accessible to any laboratory. The limitation, however, mainly 
relates to the oxidative nature of the H2O2 precursor, raising concerns for proteins that are prone 
to oxidation. Over the years, the fast photochemical oxidation of protein (FPOP) approach has 
successfully addressed many biological questions such as binding interfaces in a protein/protein 
or protein/ligand complex145-146, protein aggregation147, binding affinity 148-150, and protein 
dynamics151-152. The widespread adoption to industrial research, however, can be limited by 
associated safety concerns. Efforts are now undergoing to replace the laser source with 
alternative sources, for example a discharge lamp.  
1.5.2 Carbenes 
Diazirines, common precursor of carbene diradicals, were synthesized in 1960153 and emerged as 
a versatile photoaffinity labeling (PAL) agents in the late 1970s.154 PAL reagents usually are 
comprised of a binding motif and a reactive motif. Practically, the binding motif of PAL reagent 
reversibly binds to the active site of the target protein. Upon photoactivation, reactive motif is 
activated thus react with adjacent site, after which the PAL reagent is covalently attached to the 
target protein, serving as a footprint.155-157 Investigators typically activate diazirines with a UV 
laser at approximately 350 nm to cause release of N2 molecules and give an equimolar amount of 
carbene diradicals. Highly reactive carbenes form irreversible covalent bonds with proteins, 
allowing stringent downstream affinity purification and target identification.  
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The use of diazirine-based PAL is an effective strategy to understand protein-drug or other small 
molecule interactions and identify new drug binding sites. To address specific questions, 
investigators have designed and synthesized several diazirine analogs to adapt the affinity agent 
to the protein sample environment. For example, adamantylidene, a lipophilic reagent and an 
analog of adamantane, was used to obtain topological information of Na/K ATPase158 and Ca-
ATPase159 in membranes as early as 1983. In addition, H-diaziflurane, an analog of halothane, 
allowed the examination of binding sites of inhaled anesthetics and their action mechanism.160  
More recently, reagents containing diazirines were adopted as a new class in photo-activatable 
cross-linkers, and several were described.76, 161 The ability to react with many bond types or 
amino acid residues makes carbenes powerful reagents to capture protein dynamics and 
intermolecular interactions. Obtaining multiple cross-links magnifies the information by 
providing more distance restraints on an interacting protein system, and thereby furnishing vital 
data for molecular simulation or docking to give a more complete description of the system.  
Residue Specificity and Proposed Reaction Pathways 




Richards et al.162 first described the carbene diradical as a footprinting reagent in 2000. 
Methylene was generated from diazirine gas (CH2N2) upon UV irradiation and allowed to 
footprint α-lactalbumin. The labeling yield, however, was low, owing to the limited solubility of 
gaseous CH2N2 in aqueous media. Furthermore, the explosive gas requires conscientious 
preparation, storage, and safe handling, limiting wide application.  
 
Figure 1.3 Photoleucine-derived carbene footprinting on hMyoglobin. (a) Deconvoluted mass 
spectra of myoglobin after footprinting with carbenes. (b) Deconvoluted mass spectra of labeled 
and unlabeled holo-CaM. (c) Ca2+-binding induces conformational change on calmodulin where 
apo-calmodulin (closed circles) and holo-calmodulin (open circles) were labeled with 100 mM 
photoleucine in phosphate buffer and monitored as function of time. (d) Free holo-calmodulin 
(filled circles) is referenced to M13-bound holo-calmodulin (open circles). Reprinted with 
permission from Ref. 163. Copyright 2011 American Chemical Society. 
Later in 2011, Schriemer and coworkers163 reported a new diazirine-based reagent, photoleucine 
(Reagent 1 in Scheme 1.5) that has higher water solubility and stability than CH2N2. The reaction 
platform incorporates a Nd:YAG pulsed laser (355 nm, 1000 Hz) for radical initiation and a 96-
well plate cover with lids containing slits, allowing the laser beam to enter the protein solution. 
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With this experimental setup, the investigators obtained a maximum conversion of the diazirine 
to the carbene diradical by using an irradiation time of 2 min in the absence of other competitive 
chromophores. Furthermore, they found that photoleucine does not react with targeted proteins 
without laser activation. Upon photolysis, irreversibly labeled products exhibit a characteristic 
+115.03 Da mass shift (Figure 1.3a and 1.5b).  
       (1.14) 
To examine the labeling sensitivity of carbene diradicals for different accessible surfaces of 
proteins, two calmodulin systems (i.e., with/without Ca+ and bound/unbound to the peptide M13) 
were investigated. The average number of labels on each protein molecule can be estimated by 
determining the difference in the centroid masses between the labeled and unlabeled proteins as 
seen in a deconvolved mass spectrum of the intact protein (eq. 1.14 and Figure 1.3c, d), where mi 
and Ii represent mass and signal intensity, respectively. A reduction in protein surface area 
resulting from Ca+ binding or M13 binding is reflected clearly as the measured labeling extent 
over 2-10 min of irradiation; namely holo-CaM is 45 ± 7% less labeled and M13-CaM is 39 ± 




Figure 1.4 Carbene footprinting derived from multiple diazirine reagents. (a) Fractional 
distributions of carbene label derived from reagent 1 as determined by ETD (z-ions, filled 
circles) and HCD (y-ions, open circles) for peptide LTDEEVDEMIR (117−127) in CaM. (b) 
Residue-level reagent incorporation for select residues, based on ETD fragmentation of 
MKDTDSEEEIR (77−87), VFDKDGNGYISAAELR (92−107) and LTDEEVDEMIR 
(117−127) with Reagent 1 (gray bars) and Reagent 2 (black bars). Error bars are ± 1 standard 
deviation. Reprinted with permission from Ref.164 Copyright 2012 American Chemical Society. 
(c) Average frequency of carbene insertion at each residue generated from the photolysis of 
reagent 2, 3, and 4 in the presence of protein digests (777 peptides). Site of the label insertion 
was located with MS/MS with a Fusion Lumos with EThcD fragmentation and analyzed with 
Mass Spec Studio software. Reprinted with permission from Ref.165.  Copyright 2017 Springer 
Nature.  
Residue-level quantification of carbene-induced modification needed attention, and that was 
discussed in a sequel study.164 Theoretically, carbene diradicals can insert into X-H bonds and 
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C=C bonds.166 Insertion into carboxylic acid functional groups will form labile esters that can be 
lost in CID fragmentation, thus complicating data interpretation and even losing information. 
The Shriemer group164 chose ETD fragmentation as an alternative to CID and compared the two 
fragmentation methods by reporting the fraction modified for each y/z ion. Although most 
fragments shared the same trend, the y10 ion gave poor precision because it undergoes a neutral 
loss of the modifying group (Figure 1.4a). Notably, reducing the collision energy reduces the 
loss, but the abundance of the peptide fragments (product ion in MS/MS) is also reduced. ETD is 
a superior fragmentation method for retaining labile modifications to afford more comprehensive 
information than CID. ETD, however, performs poorly when peptides are low in charge and 
small in size. The best approach might be to use a combination of the two modes of MS/MS.  
Another issue is the electrostatic interaction between the carbene precursor and various amino 
acid side chains; the interaction may concentrate the precursor molecule around the site, 
promoting more modification and a biased residue preference. Switching to another carbene 
precursor reagent, 4,4-azipentanoic acid (2 in Scheme 1.5), that contains no positively charged 
amine group, shows the effect. Although both reagents give similar results for Tyr, Lys, Glu, and 
Asp, positive-charged photoleucine shows higher reactivity with the negatively charged aspartic 
acid (Figure 1.4b). In addition, the ionic strength of the buffer and solution temperature also 
affect the electrostatic interaction, where increasing ionic strength decreases electrostatic 
interactions167 and higher temperatures will lower the dielectric constant168. 
A related approach was also reported by the Gross group169 in 2015, when they adapted carbene 
generation in solution on the FPOP flow system. Careful control over the exclusion volume 
guarantees that photoleucine and the protein CaM are mainly irradiated once, thus diminishing 
concerns of perturbing the solution equilibrium by the generated nitrogen gas and causing 
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conformational change with excess labeling. The outcome is less modification for holo-CaM, 
consistent with its more compact conformation and significant labeling on Try, Asp and Glu, 
possibly owing to interactions of the protein with photoleucine, concentrating the reagent on the 
protein surface. 
In 2017, Schriemer and coworkers165 refined the carbene platform to employ a single-shot laser 
with higher energy (i.e., 150 mJ) to avoid nitrogen perturbation and protein conformational 
change at the induced air-water interface. Prior to irradiation, the sample solution was snap-
frozen by liquid nitrogen before laser irradiation to restrict radical diffusion, to maintain protein 
HOS, and to minimize quenching of carbene radical and increase modification. To establish 
residue specificity with carbene chemistry, the investigators, in a Herculean study, footprinted 
777 peptides by using three different precursors, a negatively charged precursor 2 (Scheme 1.5), 
a neutral reagent 3 (3,3'-azibutan-1-ol, Scheme 1.5), and a positively charged reagent 4 (3,3'-
azibutyl-1-ammonium, Scheme 1.5). The labeling trends are similar for the three reagents, and 
the bond insertion propensities generally are a function of side-chain polarity and size. Reagents 
2 and 3 both favor Arg, Glu and Asp, whereas, the neutral reagent 4 shows higher reactivity with 
His (aromatic and neutral) in addition to the three residues, Arg, Glu, and Asp. Remarkably, 
many hydrophobic amino acids show noticeable modification (Figure 1.4c), supporting the high 
reactivity of carbenes, even with aliphatic groups. The nature of the carbene precursor also 
impacts the residue selectivity by participating in complex molecular interactions to increase the 




Figure 1.5 Carbene footprinting on FPOP platform. (a) Extent of labelling of a range of proteins 
with reagent 1 (100 mM, 16 s irradiation), and reagent 5 (10 mM, 4 s irradiation (*1 s in the case 
of CaM)). (b) Fractional modification by reagent 5 of USP5 peptides in the presence (black bars) 
and absence (white bars) of di-ubiquitin. Error bars are ± standard deviations (n = 3) and 
significant differences (Student’s t-test, p < 0.05) are highlighted with a red dot. (c) Model of 
USP5 (based on PDB 3IHP) showing the locations of the five peptides (red) that are masked 
from labelling by di-ubiquitin binding and their relative locations to the ZnFUBP and catalytic 
domains. Reprinted with permission from Ref.170 Copyright 2016 Springer Nature. 
Manzi et al.170 tested a carbene from the precursor, 4-(3-(trifluoromethyl)-3H-diazirin-3-
yl)benzoate (reagent 5, Scheme 1.5) that is more reactive than those from reagents 1 – 4. The 
investigators’ design involved installing an adjoining trifluoromethyl group (Figure 1.5a), 
leading to the use of less reagent and less irradiation time (i.e., 10 mM for 4 s irradiation). 
Further, the labeling efficiency improved in comparison to that with photoleucine at 100 mM and 
16 s irradiation. The improved reactivity is due to increased stabilization of the carbene radical 
by the added trifluoromethyl group and the increased hydrophobicity but little change in 
zwitterionic character. They tested the new reagent on an unknown protein complex (i.e., the 
deubiquitinating enzyme ubiquitin specific protease 5 (USP5) upon binding with di-ubiquitin (di-
Ub)). USP5 is a multi-domain cysteine protease including two ubiquitin associated domains 
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(UBA) and a Zn-finger ubiquitin-binding domain (ZnF-UBP). Previous studies showed the 
binding stoichiometry between USP5 and di-Ub to be 1:1, suggesting additional binding sites 
than those in Znf-UBP. These sites were not identified. The investigators footprinted the C335A 
mutant of USP5 with carbenes in the presence and absence of one equivalent di-Ub and observed 
distinct binding regions (Figure 1.5b), which were mapped onto the X-ray structure of USP5 
(Figure 1.5c). The catalytic domain was shown to be the other binding site and, additionally, a 
remote conformational change for the region represented by peptide G606-K630 was found. The 
design of new, successful radical precursors indicates that there are more opportunities for 
improvement and application, emphasizing the potential of carbene footprinting as an effective 
and accurate structural probe for HOS of proteins.  
The pathways for carbene chemistry may involve several radical intermediates whose structures 
and reactivities can be tailored by using different precursors. For example, it is possible to 
generate by photolysis not only singlet171 and triplet carbenes172 but also diazo isomers that 
further decompose into carbocations.173,174 Although a singlet carbene preferentially inserts into 
O-H, N-H and S-H bonds,173 it is challenging to pinpoint the dominant pathway just from the 
nature of the modified products. Insertion into Thr can be done by singlet carbene through O-H 
bond insertion or by triplet insertion into the methylene group located on the amino acid side 
chain. In addition, the small energy difference (i.e., ~ 2 kcal/mol175) between the two states add 
complications because mixtures of products can form. Because heteroatom-containing residues 
are usually the favored sites of reaction (e.g., Glu, Asp, Tyr and Arg), the singlet state may be 
favored; however, blended pathways are more likely. A general route is shown in Scheme 1.6 




Carbene footprinting has high potential in structural biology. The labeling time is shorter than 10 
ns,176 faster than most protein folding. Irradiation on a flow-system or excitation after snap 
freezing eliminates deceptive modifications originating from carbene insertions in a protein that 
has undergone a protein conformational change. Compared to the hydroxyl radical, the short 
survival time of carbenes owing to reaction with solvent water obviates the need for a scavenger. 
Carbene generation by diazirines is at a less damaging wavelength to proteins (i.e., ~ 350 nm). In 
addition, most carbene precursors do not react with proteins prior to laser irradiation (unlike 
H2O2 for HO
●), and this lack of reactivity minimizes background interference. Once a carbene 
inserts, there are no reactive biproducts as there are when a radical reacts. Furthermore, the 
resultant mass shift for carbene modification can be adjusted to be bio-orthogonal by tailoring 
the precursor design. The physical properties of reagents, however, can favor preconcentration 
on the surface of the protein, possibly delivering biased residue preference or even information 
loss. Those properties can also be chosen advantageously to promote binding in lipid 
membranes, permitting footprinting of transmembrane proteins. As this field develops and more 
diverse carbene reagents are implemented, a better understanding of interactions will emerge to 
permit rational design of new carbenes. New footprinting reagents that can target specific 




1.5.3 Other Radical Reagents 
1.5.3.1 Sulfate radical anion 
Sulfate radical anion, SO4¯
●, is a potent oxidant with a standard reduction potential of 2.43 V at 
neutral pH.177 Its strong oxidation capability can cause considerable damage to different cellular 
components including lipids, carbohydrates, proteins and DNA/RNA.178  
Bridgewater and Vachet 179-181 in 2005-2006 first used sulfate radical anion to determine binding 
and map the SASA of proteins. In 2010, the Gross group182 generated sulfate radical anion on the 
FPOP platform by photolysis of -OSO2-O-O-O2SO
- at a quantum yield of 0.55. The reactivity 
and specificity of SO4¯
● is similar to those of HO● for residues Met, Trp Glu and Ser; the 
reactant radical favors His and Tyr . The overall reactivity ranking of SO4¯
● is:  
Met > Tyr = Trp > Phe = Glu = His > Ser > Pro > Asp = Thr > Lys = Gln > Leu = Val = Ile 
1.5.3.2 Trifluoromethyl Radical 
Fluorine-containing compounds are extremely rare in biology; only five entities containing F 
have ever been identified.183 The most common molecule is fluoroacetate, which is found in 
many tropical plants as a toxin. Footprinting reactions that insert either fluorine or fluorine-
containing substrates may be advantageous because fluorine is the most electronegative184 
(Pauling Electronegativity = 4.0) common substance and has a small radius (1.33 Å), not so 
dissimilar to that of H,185 allowing F to be a surrogate for H. 
Trifluoromethyl radical as a footprinting reagent, was implemented by Cheng et al.186 in 2017 to 
be used on the FPOP platform. The radical precursor is the water-soluble salt, NaSO2CF3 
(Langlois reagent). The ●CF3
 formation is initiated by the HO●, from photolysis of hydrogen 
peroxide. A likely mechanism is the HO● displaces ●CF3 by attack on the S=O bond to form 
HOSO2
-, the conjugate base of sulfurous acid. The ●CF3 can react with 18 out of 20 different 
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amino-acids residues, except Met and Cys, showing its complementary nature with HO●, which 
reacts rapidly with Met and Cys. Combination of ●CF3 and HO
● in tandem allows more 
comprehensive characterization of the residues on a targeted protein than does either radical 
alone, providing a better opportunity to capture subtle structural changes.  
1.5.3.3 Iodine Radical 
In physiology, iodine plays essential roles in metabolic regulation of thyroid function, especially 
hormone production.187-188 The iodine radical has potential to be an effective fooprinting reagent 
given its specific reactivity towards tyrosine and histidine. This chemistry was initiated on an 
FPOP platform, as shown by Chen et al.144 using 4-iodobenzoic acid as the precursor. The I● is 
formed presumably in concert with a ●C6H4COOH by photolysis of I-C6H4-COOH at 248 nm. 
The carboxylphenyl radical likely abstracts an H● from the OH of Tyr or from the NH of the 
imidazole ring to give a stabilized radical that is subsequently “capped” by reaction with I● to 
give an iodinated protein, although there may be other mechanisms.  
Compared to HO● footprinting, the unique and larger mass shift of iodination increases the 
confidence of assigning the modification sites. Although the coverage afforded by the iodide 
radical is limited, footprinting two targeted residues can answer specific questions with easier 
data analysis. In addition, the precursor of the iodine radical doesn’t react with proteins, which 
minimizes the background modification and allows simplified post-label sample handling. 
Unlike specific amino acid labeling, the modifications on the FPOP platform are fast, alleviating 
concerns about labeling-induced conformational changes. 
1.5.4 Conclusion and Perspective 
Radical footprinting is an effective means to acquire HOS information for proteins. Radical 
reactions are much faster (nano to milliseconds) than reactions of a conventional chemical 
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reagent that modifies one or a few amino acid residues. Therefore, free radical footprinting will 
deliver fast, broad, and less biased information by largely avoiding questions of labeling-induced 
perturbation of protein structure. In addition, the short timescale can allow a sensitive report of 
subtle structural and even dynamical changes. An advantage of the labeling speed is the 
successful temperature jump, two-laser experiment on the FPOP platform where HO● 
footprinting can successfully track the folding of barstar at times as short as a few tenths of 
millisecond.189 An example of versatility is the tracking of multiple intermediate oligomeric 
states during amyloid beta aggregation.190  
Different radicals (e.g., ●CF3, I
●, SO4¯
●, HO●) allow irreversible covalent modifications to occur 
on the side chain of an amino acid with various residue specificity. To address a particular 
biological question, a radical reagent with preferred residue selectivity can be an appropriate 
choice over one with larger residue coverage. For example, using carbene footprinting in the 
protein systems that are rich in Glu and Asp (e.g., as for calcium-binding proteins) will enable 
quick and simple data analysis and high throughput. Thus, a footprinting “toolbox” with diverse 
radical-based reagents is of great interest to our group.  
1.6 Conclusion 
During the past two decades, we have seen extensive development of the targeted reagents, 
including chemical cross-linkers, and fast radical labeling reagents, enabled by improved-design. 
experimental set-ups, well-tailored chemistry, evolving MS instrumentation, and new data 
processing software.  
Chemical cross-linkers are bifunctional protein footprinters, which are governed by similar 
principles as protein footprinting by targeted reagents. The bi-functional nature of the reagent 
allows generating distance restraints between two cross-linked residues, and such restraints can 
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be further utilized to locate protein/protein binding interfaces, to assess protein topologies, to 
characterize a protein’s interactome in a large complex, and to facilitate protein docking 
(applications in binding interface determination are demonstrated in Chapter 4 and 5) and 
modeling (an application in structure prediction is shown in Chapter 6). 
Fast radical labeling, an approach that not only allows irreversible modification on side chains of 
amino acid but also permits rapid labeling chemistry, is another essential means to assess protein 
HOS. Establishing a footprinting “toolbox” with diverse reagents can provide ready availability 
to researchers to address various biological questions (development of a novel radial reagent is 
discussed in Chapter 2). In addition, the elaboration of the FPOP platform that integrates two 
radical footprinters is also an intriguing subject for future research. Taking advantages of the 
rapid generation and reactions of a radical species, one radical can trigger protein conformational 
changes, for example by inducing a pH change, and the other can footprint the protein. When 
changing the time gap between the generation of the two radicals, the folding/unfolding process, 
therefore, can be captured in time (some method development is discussed in Chapter 3), 
providing an opportunity to study protein dynamics with even residue-level spatial resolution.  
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Fast Photochemical Oxidation of Protein (FPOP), based on a pulsed KrF laser (248 nm) for free-
radical generation, is a protein footprinting method that utilizes hydroxyl radicals to footprint 
proteins in solution. FPOP has been recognized as a biophysical technique in structural 
proteomics interrogation, including epitope mapping, protein-aggregation characterization, 
protein-folding monitoring, and binding-affinity determination. The distinct merits of the 
platform are: i) the use of a scavenger to control radical lifetime and allow fast (“snapshot”) 
footprinting of solvent-accessible residues in protein; ii) the employment of a flow system to 
enable single-shot irradiation of small plugs of the targeted sample; iii) the incorporation of 
methionine and catalase after radical oxidation chemistry to prevent post-oxidation with residual 
oxidizing species; and v) the utilization of mature mass spectrometry-based proteomic methods 
to afford analysis. In addition to HO●, other reactive reagents (e.g., carbenes, iodide, sulfate 
radical anion, and trifluoromethyl radical) can be implemented on this platform to increase the 
versatility and scope. In this study, we further elaborate the use of FPOP platform to generate 
secondary radicals and establish a workflow to answer fundamental questions regarding the 
intrinsic selectivity and reactivity of radicals that are important in biology. Carbonate radical 
anion is the example we chose owing to its oxidative character and important putative pathogenic 
roles in inflammation. This systematic study with model proteins/peptides gives consistent 
results with a previous study that evaluated reactivity with free amino acids and shows that 
methionine and tryptophan are the most reactive residues with CO3
-●. Other aromatic amino 
acids (i.e., tyrosine, histidine, and phenylalanine) exhibit moderate reactivity, whereas aliphatic 
amino acids are inert, unlike with HO●. The outcome demonstrates this approach to be 
appropriate for studying the fast reactions of radicals with proteins.       
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2.2 Introduction  
Fast Photochemical Oxidation of Protein (FPOP), an alternative to radiolysis of water with 
synchrotron radiation to give HO● 1-2, was initially invented by Hambly and Gross3. Hydroxyl 
radicals, formed by a pulsed KrF laser irradiation of hydrogen peroxide, oxidize protein side 
chain in situ and footprint the exposed residues depending on their intrinsic reactivity and solvent 
accessibility. With employment of a scavenging reagent, radical lifetime can be tuned in the 
microsecond time frame to enable protein structural characterization faster than most 
conformational changes. In addition, the irreversible modification by HO● allows comprehensive 
downstream proteomics sample handling, digestion, and mass spectrometry analysis. The FPOP 
approach, as a valuable biophysical tool in protein structure elucidation, has been recognized for: 
1) mapping binding interface in protein-ligand interaction, including small molecules binding 
events4 and antigen-antibody interaction5-6; 2) revealing multistage protein aggregation7; 3) 
determining binding affinity; 4) identifying hidden conformational changes8, 5) characterizing 
overall protein dynamics9-10. In addition to HO●, other reactive reagents (e.g., sulfate radical 
anion11, carbene diradical12, iodide, and trifluoromethyl radical13, have been implemented on the 
FPOP platform to afford broader labeling opportunities, giving more comprehensive coverage of 
amino acid residues. Now, we wish to elaborate further the utility of the FPOP platform and to 
demonstrate its capacity to answer more fundamental questions in biological free-radical 
chemistry. To do this, we address the adaption of the FPOP platform to ascertain the selectivity 
and reactivity of the carbonate radical anion with model proteins.  
In biological fluids, the bicarbonate anion exists at of 24 mM in serum and 14 mM in 
intracellular media equilibrated with approximately 1.3 mM carbon dioxide14.  The radical anion 
can be formed from the abundant bicarbonate-carbon dioxide pair by superoxide dismutase 
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(SOD)15, xanthine oxidase (XO)16, and other enzymes that can play pathogenic roles in many 
physiological conditions. As a key mediator, carbonate radical anion may cause oxidative 
damage that eventually leads to vascular disease and neurodegeneration14. Its best-known 
metabolic function is to modulate peroxynitrite activity, a strong oxidant generated from nitric 
oxide and superoxide anion. The CO3¯
●/ NO2 couple, dissociated from nitrosuperoxycarbonate 
(ONOOCO2
-), promotes protein nitration17. In this process, CO3¯
● is believed to abstract H from 
amino acids, typically tyrosine, followed by NO2 addition to give a nitro-substituted residue.  
Carbonate radical anion, a potent one electron oxidant (E0 = 1.59 V, pH = 7.0), can favorably 
oxidize electron-rich donors by electron transfer18.  CO3¯
● is also a site-selective oxidant of 
guanine over other DNA bases as a damaging reagent19. The biological consequences of 
reactions of the carbonate radical anion on proteins are also of concern.  Many investigations 
show, for example, that CO3¯
● can oxidize tryptophan-rich lysozyme to afford a ditryptophan 
form20, CO3¯
● can affect redox signaling pathways by oxidizing tyrosine-containing protein21 
and CO3¯
● can also cause activity loss of horseradish peroxidase22. Most of the research on 
CO3¯
● relies on a previous radiolysis study23 carried out in 1973 with free amino acids; this work 
shows tryptophan and tyrosine to be the preferred amino acids. The reactivity of amino acid 
residues, however, in peptides and protein is likely different, depending on context and solvent 
accessibility.  
To provide more fundamental information and provide a method for determining the fast 
reactions of radicals with proteins, we describe a systematic study of the selectivity and 
specificity of CO3¯
● with proteins/peptides as targets. To accomplish this, we extended the FPOP 
platform for generating secondary radicals. Incorporating hydrogen peroxide into sample 





-) to generate secondary radicals. The flow system we used 
overcomes the steric effect of static laser irradiation, ensuring the homogeneity of each labeling 
event. Specifically, for proteins and peptides dissolved in sodium bicarbonate/bicarbonate buffer, 
we can successfully generate the carbonate radical anion and monitor the oxidation of selected 
residues on proteins and peptides, taking advantage of mass-spectrometry-based analysis. For the 
first time, we successfully demonstrate the reactivity and selectivity of carbonate radical anion 
towards side chains of amino acid residues in proteins to significantly advance the previous 
studies of reactions with free amino acids. Moreover, the method and platform reported here can 
be generalized for other bio-relevant studies of free radicals, providing new possibilities for 
radical generation and subsequent fundamental investigations of protein/radical reactivity. 
2.3 Principles 
2.3.1 FPOP Platform 
 
Figure 2.1 FPOP platform. A sample syringe, driven by a syringe pump, is connected to silica 
tubing, where part of the polyimide coating is removed to afford a transparent window. The other 
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end of the capillary is inserted into a collection tube containing reagents to deactivate left-over 
oxidizing agents. A 248 nm KrF excimer laser is placed such that its beam is perpendicular to the 
flow system and has lenses to focus on the flow tube. Sample proteins will react with the radicals 
within the laser window. The flow rate is determined such that between every two solution plugs 
exists an unexposed portion, termed an “exclusion volume”, that minimizes “double hits” on the 
protein solution. 
An FPOP platform (Figure 2.1) implements a 248 nm KrF excimer to photolyze cleavable 
reagents (e.g., hydrogen peroxide). A silica capillary connects both a syringe pump and a 
collection tube that terminates the flow. The polyimide coating is removed along the tube to give 
a transparent window for the laser beam. The laser, typically generated at 7.4 Hz by an external 
pulse generator, is restricted by an iris and focused by two convex lenses to pass through the 
transparent window. Within the laser window, hydrogen peroxide is photolyzed into hydroxide 
radicals. These radicals under usual concentration conditions oxidize the protein sample, but 
under the conditions of this study react with carbonate/bicarbonate anion to generate secondary 
carbonate radical anions. This approach should be adaptable to formation of other radicals that 
are important in biology. 
To avoid over oxidation on the same solution plug, the flow rate on the syringe pump is carefully 
tuned. A small volume of solution portion is intentionally excluded to create a barrier between 
two exposed plugs, termed an exclusion volume. The flow-rate calculation is by equation 2.1, 
where the exclusion volume is typically ~ 20%. After the oxidation chemistry, the protein sample 
is collected in the tube containing methionine and catalase to prevent post-oxidation by excess 
hydrogen peroxide and any remaining oxidative species.  




2.3.2 Numerical Simulation of CO3¯● Oxidation Chemistry 
Generation of the carbonate radical anion in the laboratory can be by pulse radiolysis of N2O-
saturated aqueous solution containing sodium bicarbonate at alkaline pH22, 24 or UV photolysis of 
suitable metal complexes (e.g., [Co(NH3)4CO3]ClO4 
20). It can also be formed from human 
superoxide dismutase (hSOD) 25 in phosphate buffer with EPR spin-trapping detection or 
oxidation of bicarbonate with a sulfate radical anion generated by photolysis of persulfate anion 
and detected with UV spectroscopy19, 26. In the current study, we considered generating the 
carbonate radical anion as the secondary radical through a cascade process starting with sulfate 
radical anion, formed by photolysis of sodium persulfate. The persulfate anion, however, reacts 
moderately with amino acid residues (e.g., tryptophan and methionine) even in the absence of 
laser irradiation. In addition, the rate constant for carbonate radical anion production from the 
sulfate radical anion is at least 1000 times smaller than that of protein oxidation by the sulfate 
radical anion. Furthermore, the carbonate radical anion is a considerably weaker oxidizing agent 
(E0 = 1.59 V) than the sulfate radical anion (E0 = 2.43 V), rendering it difficult to make CO3¯
● 
the predominate oxidative species in the reaction regime. We anticipated these difficulties and 
chose instead to employ a weaker oxidant, hydroxyl radical (E0 = 2.30 V), from hydrogen 
peroxide photodissociation. To select appropriate conditions, we conducted numerical simulation 









Table 2.1 Reaction scheme and rate constants for generation of the carbonate radical anion by 
reactions of hydroxyl radicals from H2O2 with carbonate/bicarbonate in a buffer.  
 Reaction Rate Constant (M-1s-1) 
1 H2O2 + hv →2 HO
● Φ248 = 0.4-0.5 
2 HO● + CO3
2- → OH- + CO3
●- 3.0 × 108 [27] 
3 CO3
2- + H2O → HCO3
- + OH- 3.06 × 105 [28] 
4 HO● + HCO3
- → H2O + CO3
●- 8.5 × 106 [27] 






2- + CO2 
5× 107 [18] 
In a carbonate/bicarbonate aqueous buffer, hydroxyl radicals from photolysis of hydrogen 
peroxide upon pulsed laser irradiation (Table 2.1, Reaction 1) react with the carbonate (Table 
2.1, Reaction 2) or bicarbonate anions (Table 2.1, Reaction 4) to form the carbonate radical 
anion. Both reactive radicals will decay through recombination (Table 2.1, Reactions 5,6). Using 
these rate constants, we carried out a numerical simulation using Mathcad 14.0 to predict the 
outcome from second-order kinetics, as shown in Figure 2.2. We adopted the “Rkadapt” function 
in MathCad to solve the system of ordinary differential equations that arise from the network of 
second order reactions. The time interval from 0 to 10 ms was divided into 10 decades, each 




Figure 2.2 Numerical simulation of CO3¯
●. Numerical simulation of (a) CO3
2- concentration as a 
function of the ratio of [CO3¯
●] and [HO●] oxidized tryptophan concentration, where the amino 
acid tryptophan is taken as a model for reactions of amino acids on a target protein; (b) CO3¯
● 
and other related species as a function of time with 700 mM CO3
2-. Different curves, as denoted 
by different colors, are plotted on a log scale to represent time-dependent concentrations of each 
components. The products produced by oxidation of CO3¯
● and HO● are colored in orange and 
dark blue, respectively. The dashed line represents the time at which the chemistry is optimized 
(i.e., largely complete in 10 µs).  
In the simulation, the initial concentration of hydrogen peroxide is 15 mM and the starting 
concentration of HO● after laser irradiation is approximately 1 mM, which is the typical yield as 
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measured previously29. In addition, we used the reaction with tryptophan as a model for the 
reaction of CO3¯
● with a target protein. Under the cascade chemistry regime (Figure 2.2a), the 
ratios of CO3¯
● and HO● oxidized tryptophan concentrations show corresponding increases when 
[CO3 
2-] increases at pH = 10. With 1.2 M CO3 
2- as buffer, CO3¯
● gives almost 26-fold more 
oxidized product than that by HO●, showing the best result. Taking the practical solubility of 
CO3
2- and HCO3 
- into consideration, however, we chose 700 mM carbonate anion as the 
condition for the detailed simulation shown in Figure 2.2b. As denoted by the green curve, the 
hydroxyl radical reacts with carbonate and bicarbonate anion, yielding nearly complete 
conversion to CO3¯
● in less than 1 µs. The concentration of carbonate radical anion reaches a 
maximum at ~ 0.01 µs and then remains roughly constant until near 100 µs. Ultimately, CO3¯
● 
self quenches, showing a decrease as shown by the red curve. The vertical grey dash line 
represents approximately the timescale for oxidation chemistry (~ 10 µs). At and beyond this 
time, the CO3¯
● is already the predominant oxidative species as can be seen by comparing with 
its underlying area with that of HO●, which has largely disappeared. The concentrations for 
CO3¯
● and HO● oxidized tryptophan after 10 µs is 0.93 µM and 0.06 µM, respectively. Although 
there are remaining hydroxyl radicals, the CO3¯
● oxidation contributes almost 15-fold more than 
HO●, allowing us to determine the reactivity and selectivity of CO3¯
● towards different amino 
acids contained in a protein.     
2.4 Materials 
• Bombesin acetate salt hydrate, α-melanocyte stimulating hormone, angiotensin I bovine, 
leucine enkephalin, bradykinin, glycine, catalase, urea, L-histidine, L-methionine, 30% 
hydrogen peroxide, triethylammonium bicarbonate buffer (TEAB), HPLC-grade solvents, 
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apo-myoglobin from equine skeletal muscle, ubiquitin from bovine erythrocytes 
(Millipore Sigma Co., St. Louis, MO, USA)  
• Sequencing grade trypsin (Promega Co., Madison, WI, USA)  
• Silica capillary (150 µm i.d., Polymicro Technologies, Pheonix, AZ, USA) 
• C18 reversed-phase desalting column (nanoViper, 100 µm x 2 cm, 5 µm,100 Å; Thermo 
Fisher Scientific, Waltham, MA, USA) 
• Analytical column with C18 reversed-phase material (Magic, 100 µm, 180 mm, 5 µm, 
120 Å; Michrom Bioresources, Inc., Auburn, CA) 
• Solvent A (water with 0.1% formic acid by volume) and solvent B (80% acetonitrile with 
0.1% formic acid by volume). 
• C18 NuTip (Glygen Co.) 
2.5 Instrumentation 
• 248nm KrF excimer laser (GAM Laser Inc., Orlando, FL, USA) 
• Syringe pump (Harvard Apparatus, Holliston, MA, USA) 
• External pulse generator (B&K Precision, Yorbal Linda, CA, USA) 
• Ultimate 3000 Rapid Separation system (Dionex, Thermo Fisher Scientific, Waltham, 
MA, USA) 
• Bruker MaXis 4G quadrupole time-of-flight mass spectrometer (Bruker, Co., Billerica, 
MA) 






2.6.1 Preparation of Buffer Solution and Stock Solution 
(1) Dissolve 0.7819 g sodium carbonate and 0.5361 g sodium bicarbonate in 10 mL distilled 
water to constitute 700 mM carbonate/bicarbonate buffer to achieve a pH value of 10.0 ± 0.2.  
(2) Dissolve 0.376 g glycine, 0.12 g sodium hydroxide in 10 mL distilled water, then add 0.584 g 
sodium chloride and 0.745 g potassium chloride to constitute 700 mM glycine-NaOH buffer with 
the same ionic strength at pH = 10 ± 0.2.  
(3) Prepare histidine solution by dissolving 0.0233 g histidine in 1 mL glycine-NaOH buffer, 
then dilute into 50 mM histidine stock solution. 
(4) Make 70 mM methionine stock solution in both 1 mL carbonate/bicarbonate buffer and 
glycine-NaOH buffer with 0.0105 g methionine as scavenger.  
(5) Prepare 5 µM catalase solution in 1 mL distilled water by dissolving 0.0012 g catalase and 
diluting to 500 nM. 
(6) Dissolve 0.0050 g ubiquitin and 0.0085 g apo-myoglobin in two different buffers to afford 
500 µM protein solutions. Dilute further to 50 µM stock solution. In addition, prepare 0.0010 g 
bombesin acetate salt hydrate, 0.0010 g α-melanocyte stimulating hormone, 0.0010 g angiotensin 
I bovine, 0.0010 g leucine enkephalin and 0.0010 g bradykinin solution in two different buffers 
with concentrations in the range 600 – 780 µM depending on its molecular weight. Dilute all 
solutions to ~ 500 µM and mix those in the same buffer to give 50 µM a ‘Peptide Cocktail’ stock 
solution.  
(7) Prepare 300 mM hydrogen peroxide solution immediately before the FPOP laser irradiation 
by mixing 30 µL 30% (v/v) hydrogen peroxide solution with 970 µL of two different buffers 
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individually. Keep the hydrogen peroxide solution on ice throughout the experimental procedure 
to avoid decomposition. 
2.6.2 Protein Oxidation on FPOP  
Oxidation achieved by carbonate radical anion 
(1) Warm the 248nm KrF laser and measure the laser energy with a sensor meter. Adjust the 
laser energy to 24 mJ/pulse at a frequency of 7.4 Hz. The laser width is measured by placing 
colored tape right behind the transparent silica tubing (width = 2.73 mm) and observing a burn 
mark. Choose a 20% exclusion volume, giving a flow rate of 26.8 µL/min, which can be 
calculated based on the equation 1.  
(2) Inject 10 µL of 70 mM methionine stock solution in carbonate/bicarbonate buffer and 1 µL 
500 nM catalase solution to a low-bind Eppendorf tube to be used as the collection tube. Place 
the collection tube at the end of the silica tubing. 
(3) Mix 5 µL of 50 µM protein solution or ‘Peptide cocktail’ with 42 L carbonate/bicarbonate 
buffer; then add 3 µL of 300 mM hydrogen peroxide solution. Transfer the sample solution to a 
syringe and insert it in the syringe pump (Figure 1). Start the pump and trigger the laser 
irradiation. The time window between the addition of hydrogen peroxide and laser irradiation is 
controlled as 20 s.  
(4) After laser irradiation, digest the protein sample with trypsin according to manufacturer’s 
protocol. Desalt the digested peptides and ‘peptide cocktail’ by using C18 NuTip to eliminate 
excess salts and remaining reagents.  
Oxidation by hydroxyl radicals 
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Adopt the same experimental procedure as in the above description with the reagents in glycine-
NaOH buffer, except add 1 µL of 50 mM histidine stock solution into 46 µL protein  before the 
final addition of hydrogen peroxide solution.    
LC-MS/MS analysis 
Dilute 5 µL digested protein sample into 45 µL water with 0.1% formic acid and centrifuge for 3 
min. Then load the sample solution onto a C18 reversed-phase desalting column at 4 µL/min for 
10 min.  Use a custom-packed analytical column for sample separation on Ultimate 3000 Rapid 
Separation with C18 reversed-phase material in silica tubing. Use gradient solvents A (water 
with 0.1% formic acid by volume) and B (80% acetonitrile with 0.1% formic acid by volume). 
Control the flowrate at 400 nL/min with the following gradient: 2% B to 60% B in 60 min, 
increase to 90% in 2 min, maintain at 90% for 5 min, return to 2% B in 1 min and equilibrate at 
2% B for 7 min.  Use a Thermo Q Exactive Plus orbitrap mass spectrometer (or other suitable 
proteomics instrument) coupled with a Nanospray Flex source for downstream detection with 2.5 
kV spray voltage at 250 °C. Acquire the data in the data-dependent mode, where the 10 most 
abundant ions are selected for “higher energy” collisional dissociation (HCD). 
2.7 Results and Discussion  
2.7.1 Generation of Carbonate Radical Anion on FPOP Platform 
To demonstrate the oxidative modification by carbonate radical anion, we chose apo-
myoglobin(aMb) as the model protein. We conducted the experiments with 15 mM hydrogen 
peroxide, as the radical precursor, at pH = 10 in 700 mM CO3
2-/HCO3
- buffer to maximize 
CO3¯
● formation and in 700 mM glycine-NaOH buffer to give only HO● as a parallel control. In 
the negative control experiments, the solution composition, including ion strength of the buffer, 
is maintained as the same. With no laser irradiation (Figure 2.3a), the unmodified protein signal 
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(at charge state of +20) is the most intense one followed by a small signal for the oxidized 
species seen with a +15.9949 Da mass shift, showing a basal oxidation. Irradiation by the KrF 
laser under the same conditions generates CO3¯
● and oxidizes aMb to give a more intense signals 
for singly oxidized species (+15.9949 Da), doubly oxidized species (+31.9898 Da) and triply 
oxidized species (+47.9847 Da), etc. (Figure 2.3b). As compared to the hydroxyl-radical 
oxidation in the glycine-NaOH buffer (Figure 2.3c), the two oxidation profiles showed good 
similarity, demonstrating that CO3¯
● oxidation also results in the addition of ‘an oxygen’ to the 
target protein. This is consistent with an oxidation mechanism of CO3¯
● whereby the formation 
of protein radical occurs by hydrogen atom abstraction, followed by an addition of dioxygen 





Figure 2.3 Oxidation profiles of apo-myoglobin (aMb). The quadrupole time-of-flight (QTOF) 
mass spectra of the +20 charge state of aMb with labeling conditions of (a) in CO3
2-/HCO3
- 
buffer without laser irradiation (negative control); (b) in CO3
2-/HCO3
- buffer with laser 
irradiation; (c) in glycine-NaOH buffer with laser irradiation, oxidized by hydroxide radical at 
global level. 
2.7.2 Selectivity and Reactivity of CO3¯● with Model Peptides 
Utilizing the conditions that favor formation of CO3¯
● initiation, we employed model peptides 
with little or no higher order structure for a comprehensive study of its intrinsic residue-level 
specificity. Along with CO3¯
● chemistry, hydroxyl radical oxidation was also performed for 
batch control and for comparison purposes, as previously described. To examine peptides, we 
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prepared a “peptide cocktail” containing bombesin acetate salt hydrate, α-melanocyte stimulating 
hormone (α-Mel), angiotensin I bovine, leucine enkephalin (Leu-enkephalin) and bradykinin and 
mixed the solutions with hydrogen peroxide in two different buffers at pH = 10. Oxidation 
percentages of the modified amino acids (Figure 2.4) is shown in the decreasing order upon the 
reactivity of CO3¯
● and has been corrected by subtracting basal oxidation from negative control 
as shown in Figure 2.3a.  Methionine and tryptophan are the most reactive amino acids for both 
radicals, where nearly 90% becomes oxidized by CO3¯
● and 60% by HO●. A similar 
phenomenon occurred for tyrosine where modification by CO3¯
● is almost 8-times higher than 
that by HO●. One possible reason is the weaker oxidative character leads to considerably longer 
lifetime for CO3¯
●. The more specific reactivity towards selected amino acids for CO3¯
● will 
likely give more oxidation of those reactive residues. Phenylalanine and histidine can also react 
with CO3¯
● with similar reactivity as for HO●. Oxidation of other aliphatic amino acids (e.g., 
proline on bradykinin) occurs with HO● treatment. For the CO3¯
● condition, however, only 
phenylalanine oxidation occurred. From all of the evidence, we conclude that CO3¯
● is a more 
selective oxidant than HO●, and the order of inherent reactivity of CO3¯
● is: 





Figure 2.4 Comparison of the residue-level fraction modified (in percentage) of a ‘Peptide 
Cocktail’ by CO3¯
● and HO●. Different color represents different peptides and the sequence are 
shown correspondingly. Solid bars denote the HO● oxidation extent and the patterned bars 
denote the CO3¯
● oxidation. Presented data has been corrected for negative control. Error bars 
are the standard deviations of three independent runs. The inset is an enlarged portion of the 
figure. For bradykinin, only F undergoes oxidation with CO3¯
●, whereas F and P oxidation are 
both oxidized but not distinguishable because the chromatograms of the two modified peptides 
overlap.   
The results are consistent with those of a previous investigation18 where the reactivity of free 
amino acids in solution was measured, and in which methionine, tryptophan and tyrosine were 
found to be the most reactive amino acids towards CO3¯
● with rate constants of 1.2×108 M-1s-1, 
4.4×108 M-1s-1 and 2.9×108 M-1s-1, respectively. Although the reported rate constant for histidine 
is almost 100-fold larger than that for phenylalanine (i.e., rate constants of 7.0×106 M-1s-1 and 
5.0×104 M-1s1), the reactivities of the two residues are similar when they are part of proteins and 
peptides. It is worth noting that the electrostatic interaction between negatively charged 
carbonate radical anion and the positive charged imidazole group at lower pH may contribute to 
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an increased reactivity. Therefore, in real biological systems, the reaction rate with histidine may 
vary depending on the local pH.  
2.7.3 Residue-Resolved Modification Measurement by LC-MS/MS  
We quantified the oxidation extent at the residue level from the peak areas of the 
chromatograms. Extracted ion chromatograms (EICs) for each modified and unmodified species 
were exported from raw files with Qual Browser (Thermo Xcalibur 2.2 software) (Figure 2.5). 
The (+16 Da) angiotensin I oxidized by the carbonate radical anion (Figure 2.5b) and by the 
hydroxyl radical (Figure 2.5c) are listed below the unmodified peptides. Different colors 
represent different residues that are modified. The modification fraction for a residue is 
calculated with equation 2.2, where Aox is the peak area for the oxidized-species signal and Aun is 
the peak area for the unmodified. Chromatographic peaks are fitted by Gaussian Function and 
the averaged R2 is 0.97. For complex with overlapping signals of oxidized residues (Figure 2.5c), 
the peak representing tyrosine oxidation (purple in Figure 2.5b) is scaled into the lower panel, 
and the oxidation extent of valine is represented by the grey gaussian peak. In addition, each 
product-ion (MS/MS) spectrum (e.g., for Figure 2.6) was manually validated to assure an 
accurate oxidizing residue assignment. Comparing the signals for the fragment ions, we see a 
clear +16 Da mass shift for b4 and subsequent b ions for the modified peptide as compared with 
the unmodified peptide, indicating that oxidation took place on the Y4 residue. 




Figure 2.5 Extracted ion chromatogram (EICs) of angiotensin I. Specifically, the wildtype (a), 
and the oxidized angiotensin I by CO3¯
● (b) and HO●. (c). Different colors (coded with the 
chromatogram colors) indicate different oxidized residues as determined by product-ion 
(MS/MS) spectra. Each peak is fitted by Gaussian Function and the overall fitting curve is 
presented as blue dotted line. The averaged R2 for the fitting is 0.97. 
From the shown chromatogram (Figure 2.5), it clearly shows that the number of oxidized 
isomeric peptides by the CO3¯
● is significantly less than that by the HO●. In the CO3¯
● oxidation 
condition, we resolved at least 4 isomeric peptides, two of which undergo oxidation on Tyr, and 
two other minor ones involve oxidation on His and Phe. For HO●. oxidation, however, a more 
complex pattern of oxidation occurs presenting at least 6 isomeric products, including oxidations 




Figure 2.6 Product-ion (MS/MS) spectra of oxidized and wildtype angiotensin I. 
2.7.4 Selectivity and Reactivity of CO3¯● with Model Proteins 
In addition to peptides mixture, we further investigate the selectivity and specificity of CO3¯
● 
with proteins, where apo-myoglobin and ubiquitin were chosen as the model systems. 
Experiments were carried out with CO3¯
● dominant condition and HO● governing condition 
individually followed by “bottom-up” proteomics. After integrating the signals obtained through 
LC-MS/MS, we can list the modified amino acids for each protein (Figure 2.7). From the 
ubiquitin data set (Figure 2.7a), CO3¯
● gives the most oxidation on methionine (M), as does 
HO●, underscoring their oxidation preference towards methionine. Other reactive residues 
include the aromatic amino acids phenylalanine (F) 4 and 45, tyrosine (Y) 59 and histidine (H) 
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68 undergo moderate oxidation by CO3¯
● as compared to HO●. Most other amino acids that are 




Figure 2.7 Comparison of residue-level fraction modified (in percentage) of (a) ubiquitin and (b) 
apo-myoglobin modified by carbonate radical (CO3¯
●) and hydroxyl radical (HO●). Solid bars 
denote the hydroxyl radical oxidation and the patterned bars denote the carbonate radical anion 
oxidation. Presented data has been corrected for negative control. Error bars are standard 
deviations of three independent runs. 
For apo-myoglobin (Figure 2.7b), tryptophan W7 exhibits the highest oxidation extent on by 
CO3¯
● showing a doubled fraction modified value as compared to that for HO●. Histidine also 
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gives nearly doubled modification fraction by CO3¯
● oxidation, for example H36 and H81, 
indicating its considerable reactivity. The oxidation behavior towards methionine is consistent 
with the results for ubiquitin, where CO3¯
● oxidation slightly favors that of HO●, shown as 
M131. Other potentially reactive residues like H113, H116 and F106 undergo an oxidation 
extent of less than 0.5%, just as with HO●. The reason is likely to be the small solvent accessible 
area (SASA) for these sidechains on protein surface. In addition, the size difference in CO3¯
● 
and HO● may contribute to the reaction extent on a given amino acid. For example, the oxidation 
percentage of W14 is 3%, which is nearly 5-times lower than that of W7 (14.8 %). The SASA of 
W7 and W14 is 15.3 Å2 and 6.8 Å2, respectively by calculation11. Thus, for the smaller HO●, the 
oxidation extent is greater than that for the larger CO3¯
●, which has difficulty penetrating the 
surface to react with W14. Other residues like V13/67/68, L11/86, I21 and Q8/Q9 are relatively 
inert to CO3¯
● with no shown oxidation. 
Compared to the results for the model peptides, the CO3¯
● oxidative preference towards Met and 
Trp over HO● is consistent and so does the negligible reactivity towards aliphatic amino acids. 
However, for tyrosine, oxidation extent by CO3¯
● in ubiquitin (Y59 in Figure 2.7a) is much less 
than that with model peptides, shown as 1.6% vs 30-50%. The difference arises from the location 
of the Y59 in the 3D structure and its limited SASA, emphasizing the importance of 
incorporating peptides with minimal higher order structure to eliminate conformational effect in 
the discussion of residue-level specificity.  
2.8 Advantages and Caveats 
We optimized the production of carbonate radical anion on a FPOP platform by using a reaction 
cascade scheme starting with the hydroxyl radical. This approach enables the study of peptides 
and proteins to determine the relative reactivities of various amino acid sites in those species. 
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Although the results for the protein/peptides systems are largely consistent with those of an early 
study carried out with free amino acids, this new approach provides direct evidence for the 
radical reactions of proteins (and other biomolecules) with radicals, here the carbonate radical 
anion, demonstrating clearly those residues or regions of the biomolecule that are reactive.  
The approach suggests that a general approach can be achieved by implementing the FPOP 
platform to generate either primary or secondary biologically relevant radicals (by cascade 
reactions) and to determine their fundamental reactivities with biomolecules. Primary HO● and 
SO4¯
● radicals can be formed from peroxy-compounds. Generation of secondary radicals (e.g., 
CO3¯
●, NO2
●, halides) may be optimized by varying buffer contents, pH, and radical precursor 
and by involving a radical scavenger. In the current study, this was done by using kinetic 
simulations. For other radicals for which kinetic data do not exist, the conditions must be 
optimized by using mass spectrometry analysis. Other spectroscopy techniques (e.g., 
fluorescence microscopy) can also be incorporated in the post-modified identification. 
Although we used no scavenging reagents in the current study for the generation of carbonate 
radical anion, incorporating such reagents can be done in future studies. The use of histidine as a 
scavenger in the hydroxyl-radical generation not only controls radical lifetime but also intercepts 
radicals and minimizes protein modification, a point that may be important for physiologically 
relevant studies. For example, biological systems respond to different oxidative stress, and the 
oxidizing potential can be varied on the FPOP platform. In addition, the FPOP flow design 
effectively avoids over-modification of a target and improves labeling homogeneity by 
controlling flow rate, exclusion volume, and radical lifetime. We suggest that this repurposed 
FPOP platform coupled with mass spectrometry-based analysis is a new option for studies of 
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Chapter 3: Free Radical Footprinting to Probe 
Unfolding of Holo-Myoglobin Triggered by Laser-





























Understanding protein folding/unfolding is crucial to gain deeper insights of related biological 
processes. Commonly adopted characterization methods to follow protein conformational 
changes are circular dichroism, fluorescence, FT-IT and NMR. Among them, the spectroscopic 
approaches are the most extensively used, given the fast detection timescale at femtoseconds to 
microseconds. However, their spatial resolution is low. Mass spectrometry-based approaches 
enable residue-level resolution, and they may become an asset to probe protein conformational 
changes. Whereas the major limitation is the time resolution that typically is milliseconds, too 
long for protein folding/unfolding happening at microseconds. We designed and established a 
platform by integrating fast photochemical oxidation of protein (FPOP) and a laser-induced pH 
jump to allow the fast characterization at the microseconds to low milliseconds timescale. Using 
holo-myoglobin as a model system, we considered different footprinting methods (e.g., hydroxyl 
radical and carbene diradical footprinting), establishing a foundation for future research. 
3.2 Introduction  
Protein folding/unfolding is essential for understanding biological processes, reaction 
mechanisms, and basic interactions that are important in therapeutics 1-3. To study protein 
conformational changes in kinetics experiments, investigators commonly use spectroscopic 
methods such as fluorescence spectroscopy. The basic principle is to measure the fluorescence of 
some amino acid residues (e.g., tryptophan) that fluoresce differently when buried inside a 
protein or exposed on its surface. The approach provides usually global information to probe 




Mass spectrometry-based characterization of protein folding/unfolding started in the early 1990s 
with the development of pulsed H/D amide exchange and covalent labeling by chemical reagents 
of equilibrium states. 4-5 The most pronounced advantages of the MS-based approaches is the 
ability to pinpoint the amino acid residues involved in the protein conformational changes, 
thereby increasing the spatial resolution achievable by optical approaches. The limitation, 
however, is time resolution, typically milliseconds, a time scale that is longer than most folding 
events occurring at microsecond. 6 
One representative study was carried out by Konermann and coworkers7 who took advantages of 
the fast photochemical oxidation of protein (FPOP)8, a platform that can generate hydroxyl 
radical (HO●) through photolysis of hydrogen peroxide on a flow system and label the solvent 
accessible surface area (SASA) of different protein conformations at low microseconds. In 
combination with a continuous-flow rapid mixing apparatus, the protein can be denatured from 
50 ms to 5 min prior to HO● footprinting. Later, Gross and Chen9 published a breakthrough 
study at 2010. They integrated a laser-induced temperature jump and the FPOP platform to probe 
the folding process of barstar protein at microseconds to low milliseconds timescale. The two 
lasers, one to perturb protein conformations, and another to form HO● radicals are aligned 
carefully intersecting at the same transparent window, and the needed time delay between the 
two lasers is enabled by a signal generator with a delay circuit. By controlling the delay time 
from 0.2 to 1.0 ms, they traced the structural changes of barstar by analyzing oxidative 
modifications. The shift of mass centroid was further fitted as a function of delay time by using 
single-exponential function, providing the rate constant for the transition from the unfolded to 
the first intermediate state. After bottom-up proteolysis, the key residues associated with barstar 
folding during the first stage of folding were also resolved, demonstrating the capability of this 
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approach to achieve enhanced spatial resolution to study protein folding/unfolding at sub-
millisecond time scale.10   
Besides adding a denaturant or introducing a temperature jump, other perturbations can induce 
protein folding/unfolding. One of many is a laser-initiated pH jump, which was demonstrated 
frequently by using holo-myoglobin (hMyo) 11-13 with spectroscopic detection. It is known that 
conformational change of hMyo is determined by the solubility of the heme.14 The heme group is 
less soluble in acidic conditions, therefore having a tendency to remain inside the protein’s 
hydrophobic binding pocket. In addition, the heme-protein interaction is thermodynamically 
more favorable, promoting the persistence of a native-like conformation (closed state). Basic pH, 
on the other hand, facilitates heme release, pushing the equilibrium towards a relative unfolded 
conformation (open state). In a detailed study published at 2006, Corrie and coworkers11 
observed the two-state transition from pH 3.5 to 4.5. The pH jump is induced by the irradiation 
on a widely used photoacid, 2-nitrobenzaldehyde (NBA). The kinetics of hMyo unfolding could 
be described with a triple exponential function, giving the lifetimes of three dominant 
intermediates that are 18 ± 1 ms, 0.53 ± 0.01 s and 0.94 ±0.01 s.  
In chapter 2, we demonstrated one way to elaborate the FPOP platform, that is to develop new 
radical footprinting reagents. In this study, we aim to develop the FPOP platform from another 
aspect. We are interested in advancing the two-laser platform for broader applications, 
specifically for pH-sensitive proteins. hMyo is a good model system for this purpose. We 
designed an integrated platform wherein, by tuning the laser frequency, exclusion volume, and 
flow rate of the sample solution, the delay time between the two lasers can be controlled to 
capture different unfolded states. In addition to HO● footprinting, we also evaluated carbene 
labeling as a probe for protein folding/unfolding, establishing the foundation for further research.  
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3.3 Material and Method 
3.3.1 Material 
Sodium chloride, tris-buffer, citric acid, 2-nitrobenzaldehyde, methionine, catalase, holo-
myoglobin, and apo-myoglobin were purchased from Millipore Sigma (Saint Louis, MO).  1-(2-
Nitrophenyl)ethyl sulfate was purchased from ApexBio Technology (Houston, TX). 3-(3-
Methyl-3H-diazirin-3-yl) propan-1-ol was purchased from Ambeed (Arlington, IL).  
3.3.2 Hydroxyl Radical Footprinting 
For the equilibrium conditions, hMyo (4 µM) was dissolved in citrate-phosphate to achieve pHs 
less than 7, and in tris-buffer for pHs greater than 7. Incubation took about 30 mins prior to 
constitution of the sample solution which contains 5 mM H2O2 and 1 mM histidine. The 
collection tube includes 10 µL of 70 mM methionine and 1 µL of 500 nM catalase for post-
oxidation quenching.  
For the pH-jump experiments, deionized water was boiled overnight in a three-neck round 
bottom flask under nitrogen protection. A syringe of 50 mL with a long needle was used to 
transfer the degassed water into an Erlenmeyer flask under a continuous flow of nitrogen. A self-
built Schlenk line connects a nitrogen tank with the flask and with three others to protect the 
reagents such as saturated NBA/NaCl solution and protein solution, from absorbing CO2 
throughout the experiments. The NBA reagent and hMyo (or aMyo) powder were kept and 
dissolved under nitrogen protection to avoid further introduction of CO2. Specific H2O2 and 
histidine concentration are indicated correspondingly in the discussion. Measurements of pH 
were performed on a SevenEasy pH meter (Columbus, OH). The experimental for the laser 
parameters are: ~ 25.00 mJ, 16 kV for KrF laser; ~ 10 mJ for YAG laser with maximized 
amplification; ~ 1.95 mm focal size; frequency (repetition rate) of 5 Hz; ~ 12.5 µL/min flow rate. 
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Mass spectrometry characterization was conducted on Bruker MaXis 4G on the global level to 
measure modification extent at the intact protein level.  
3.3.3 Carbene Footprinting 
Carbene footprinting was performed similarly as the description above except no methionine and 
catalase were in the collection tube. The concentration of MDPO in stock solution was 200 mM 
in NaCl, and the final concentration was 10 mM.  
3.4 Experimental Design 
 
Figure 3.1 Two-laser platform that induces a pH jump at 355 nm followed by hydroxyl radical 
generation at 248 nm for protein footprinting.  
To probe protein conformational changes in-time, we coupled two lasers, namely the KrF 
excimer laser with a wavelength at 248 nm and the Nd:YAG laser at 355 nm, into an integrated 
platform (Figure 3.1). Upon irradiation at 355 nm, the photoacid contained in the sample solution 
is excited and dissociates protons to lower the pH and further induce the folding/unfolding 
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process of a pH-sensitive protein. The second laser at 248 nm then photolyzes the constituent 
H2O2, generating HO
● to map the changing SASA of the protein. A delay counter is configured 
between the two lasers, allowing HO● footprinting to be executed at several delays 
(microseconds to milliseconds) after the initial conformational change. The upper limit of the 
monitoring time is determined by the exclusion volume, a design that avoids double labeling of 
the targeted protein, and the laser frequency. In this study, the two lasers were both operated at 
every 200 ms (f = 5 Hz) with an exclusion volume of 20 % at the flow rate of 12 µL/min. The 
upper limit of the time delay is therefore 40 ms (200×20%). Other settings, including the focus 
lenses for both lasers, the syringe pump, and the quenching solution in the collection tube, are 
the same with a typical FPOP experimental setup.  
3.5 Results and Discussion 
3.5.1. Conformational Changes of Holo-Myoglobin at Equilibrium  
Although investigators followed the unfolding of hMyo with spectroscopic methods, the 
unfolding process, which we seek to characterize by HO● footprinting, is unknown. To 
understand the conformational changes in the context of SASA changes, we incubated hMyo 
individually at different pHs from 3.2 to 8.0. All protein solutions, with 19 pH conditions, were 
equilibrated in buffers for 30 mins prior to the HO● labeling, initiated by 248 nm laser. Each 
experiment was performed in duplicate. Representative oxidation profiles are shown in Figure 
3.2. The first peak represents the unmodified protein (m/z = 848.6 at charge +20), followed by a 
series of higher-molecular species giving consecutive +16 oxidation. The number of the oxidized 
proteins are different at various pHs, indicating different extents of oxidation that reflect 
different protein conformations. For better comparison, we further calculated the modification 
percentage (eq 3.1) based on the intensity of all the peaks, e.g., +16, +32, +48, etc. We observed 
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higher oxidation percentages when the conditions are acidic. At pH = 3.6, the fractional 
oxidation is about 50 %, indicating a relatively open conformation comparing to that in 
conditions with larger pH values. 
 (eq 3.1) 
 
Figure 3.2 Oxidation profiles of hMyo by hydroxyl radical footprinting at several pHs under 
equilibrium conditions. The peak series represent the protein of charge +20.  
We further plotted the oxidation percentages as a function of pH and observed a two-state 
transition starting from a pH around 3.5 (Figure 3.3). When the pH increased to 5.5, the 
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oxidation extent dropped significantly by about 25% and then decreased gradually at pH values 
larger than 5.5. The observed pH range accountable for the conformational transition is similar to 
that in a previous study as monitored by UV spectroscopy 11.  
The successful HO● footprinting of hMyo for equilibrium states laid the foundation for the 
following investigation, where the laser at 355 nm is incorporated to induce pH changes in 
advance.  
 
Figure 3.3 Modification percentage of hMyo as a function of pH. The blue dash lines indicate 
the estimated pH range for the two-state transition. The patterned data points correspond to the 
representative MS spectrum in Figure 3.2. The fitting is based on a logistic function in Origin, 
and the correlation coefficient is R2 = 0.996. 
3.5.2 Control Experiments at 248 nm 
To enable a pH-jump upon irradiation on photoacids, the protein solution should contain no 
buffers (only NaCl solution). We further screened the concentration of H2O2 and histidine that 
determines the dosage of HO● to achieve comparable oxidation extents with the ones at 
equilibrium states. In addition, NaCl solution dissolves atmospheric CO2, giving an acidic pH 
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around 6.2 at room temperature. Over-night degassing of the stock NaCl solution is needed in the 
experimental preparation, and the fresh NaCl solution requires nitrogen protection throughout the 
footprinting experiments. These procedures help maintain the NaCl solution at around neutral pH 
even after addition of the protein solution and the photoacid. The conditions we adopted are: 1.5 
mM H2O2, 0.5 mM of His, and 4 uM of hMyo in NaCl, giving a pH of 6.8. In the presence of the 
saturated NBA solution (~ 8 mM), the pH further dropped to 6.3, but the hMyo is still retained in 
a native-like conformation (pH > 5.5).  
To start with, we examined the oxidation profiles for the open and closed states of hMyo without 
incorporation of NBA. We prepared two protein solutions, one at pH 6.3 and the other at 3.2. 
The pHs of the two samples were adjusted with HCl solution to mimic the pH of initial and final 
situation, respectively, if using NBA for pH jump. The framed oxidation percentages at the 
closed state of hMyo is 23% (Figure 3.4a) and 48% for the open state (Figure 3.4b), similarly to 




Figure 3.4 Oxidation profiles of hMyo upon only 248 nm laser irradiation under different 
conditions: a) hMyo (4 µM) with His (0.5 mM) and H2O2 (1.5 mM) at pH 6.3 in NaCl; b) hMyo 
(4 µM) with His (0.5 mM) and H2O2 (1.5 mM) at pH 3.2 in NaCl; c) hMyo (4 µM) with His (0.5 
mM), H2O2 (1.5 mM) and NBA (~ 8 mM) at an initial pH of 6.3 in NaCl; d) hMyo (4 µM) with 
His (0.5 mM), H2O2 (1.5 mM) and NBA (~ 8 mM) at an initial pH of 3.2 in NaCl; e) hMyo (4 
µM) with His (0.5 mM), H2O2 (7.5 mM) and NBA (~ 8 mM) at the initial pH of 3.2 in NaCl.  
Then, we included saturated NBA (~ 8 mM) in the sample solution and evaluated the 
footprinting upon laser irradiation at 248 nm. Based on our design, the photoacid will be 
activated for proton release only at 355 nm and will desirably stay inert when HO● is generated 
under 248 nm, the wavelength used for footprinting. We observed, however, a decrease in pH 
from 6.8 to 3.2 upon 248 nm irradiation, consistent with the UV absorption profile of NBA that 
absorbs light from 200 to 400 nm. Although the NBA being activated at 248 nm is not preferred, 
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the use of NBA in our experimental design may still work. The reason is that in an actual pH-
jump experiment, if most of the NBA is exhausted by the first laser irradiation at 355 nm, the pH 
change caused by the remaining NBA at the second laser can be negligible. To test this, we 
measured the pH of the protein solution after 355 nm irradiation, obtaining a value of 3.2. The 
same solution was then recycled and submitted for the second laser at 248 nm. The final pH 
value is 3.0 ± 0.1, very similar to the value after the treatment at 355 nm, indicating a near-
complete consumption of NBA before irradiation by the KrF laser.  
We are now in position to test the labeling profiles by HO● footprinting initiated at 248 nm. The 
closed conformation of hMyo (initial pH at 6.3, Figure 3.4c) gives an oxidation percentage of 
30% whereas that of the open conformation (pH 3.2, Figure 3.4d) is only 38%, which is a much 
smaller modification level than the condition without NBA (Figure 3.4b). NBA appears to be a 
HO● quencher, and its incorporation requires higher dosage of HO● to produce a convincing 
difference in the oxidation extents to distinguish the conformational transitions. We further 
screened the H2O2 concentration and determined that we could increase it to 7.5 mM for the 
following experiments (Figure 3.4e).  
3.5.3 Control Experiments at 355 nm 
Besides evaluating the system with only 248 nm, we decided to conduct control experiments 
with only 355 nm. Ideally, only the photoacid NBA will be photolyzed under YAG laser (355 
nm) for pH change while the H2O2 will stay unreactive only with a burst from the KrF laser. We 
incorporated either H2O2 (without NBA but with hMyo and histidine, Figure 3.5a) or NBA 
(without H2O2 but with hMyo and histidine, Figure 3.5b) in protein solutions and observed only 
the peaks corresponding to unmodified species, showing the results as per the design. When 
H2O2 and NBA were included together, however, hMyo became oxidized (Figure 3.5c), 
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indicating that there are reactions occurring between NBA and H2O2 and the generated reactive 
species are likely accountable for the oxidation.  
To rule out that this is a protein-dependent chemistry, we performed similar experiments on two 
other proteins, calmodulin (Figure 3.5d-f) and β-lactoglobulin (Figure 3.5 h-g). Although the 
relative oxidation extents vary for different proteins, which may be accountable by the number of 
reactive residues exposed on the surface, all three proteins are clearly oxidized. On the other 
hand, we did notice that the oxidation percentage on hMyo is only 36% (Figure 3.5c), less than 
50% that was observed previously (Figure 3.4e) with same H2O2 concentration. The difference 
between the two values may still provide us the chance to probe conformational changes of 
hMyo. It is likely that the unknown reactive species label hMyo almost instantaneously upon the 
proton releases. The labeling process can further induce perturbations in the protein 
conformations and potentially bias the unfolding and subsequent footprinting readout. 
Nevertheless, if the oxidized hMyo can still undergo conformational changes, this study may 
serve as the foundation for setting up a characterization platform to follow protein 




Figure 3.5 Oxidation profiles of hMyo upon only 355 nm  laser irradiation under different 
conditions: a) hMyo (4 µM) with His (0.5 mM) and H2O2 (7.5 mM) at pH 6.3 in NaCl; b) hMyo 
(4 µM) with His (0.5 mM) and NBA (~ 8 mM) at pH 6.3 in NaCl; c) hMyo (4 µM) with His (0.5 
mM), H2O2 (7.5 mM) and NBA (~ 8 mM) at pH of 6.3 in NaCl. Oxidation profiles of calmodulin 
are under similar conditions listed from d) to f) and of β-lactoglobulin are listed corresponding 
from h) to g).  
3.5.4 pH Jump with Different Delay Times 
To establish whether the oxidized hMyo undergoes further conformational changes, we 
attempted to footprint the most unfolded protein conformation through a “recycled” experiment. 
After being labeled with the 355 nm laser, we collected the hMyo solution and let it sit for 3 
mins to allow the unfolding to maximize. The protein solution was then recycled for 248 nm 
irradiation for the upper-limiting oxidation extent (Figure 3.6e). Compared to the oxidation 
percentage with only 355 nm laser irradiation (Figure 3.6b), the increase in the extent of labeling 
confirms that a conformational change of hMyo occurs after the initial oxidation, promoting us 
to probe the conformational transitions during unfolding.  
We set the time delays between the two lasers as 0 ms, 1 ms, 5 ms, 20 ms and 40 ms in parallel 
runs to capture the dominant conformation at different time points. When labeling hMyo 
simultaneously with two lasers (355 nm - 0 ms - 248 nm), we observed that the second laser 
irradiation contributed approximately 8% more oxidation (Figure 3.6c) compared to the 
condition of 355 nm irradiation only (Figure 3.6b). The total oxidation percentage with no time 
delay is 46%, a value that characterizes the starting conformation during the transition. If we use 
40 ms as the time delay (355 nm - 40 ms - 248 ms), the overall oxidation percentage increased to 
51% (Figure 3.6d), similar to the value of a completely unfolded conformation (Figure 3.6e). 
Although the extent of oxidation increased with longer time delays, the absolute difference 
between the two delay times is only 5%, making it hard to distinguish different conformations 
95 
 
when using a series of smaller delay times. In addition, the reproducibility of this experiment 
throughout the process was not high. We suggest that the main reason is still the unknown 
chemistry between NBA and H2O2 to yield unspecified reactive radical species. The undefined 
system leads to uncontrollable oxidations. To overcome this problem, only one of the two 
chemicals can exist in the pH jump solution. 
 
Figure 3.6 Oxidation profiles of hMyo with different time delays between 355 nm and 248 nm 
laser. Specific conditions are: a) no laser control; b) control with only 355 nm irradiation; c) 0 ms 




3.5.5 pH Jump with Carbene Radicals 
To avoid the simultaneous presence of NBA and H2O2, we substituted H2O2 with diazirine for 
carbene footprinting, which is usually initiated with the YAG laser at 355 nm. Given that NBA 
can also be activated at 248 nm, we can trigger the proton release first with this laser and then 
fooprint the protein with 355 nm irradiation; therefore, the order of implementing the two lasers 
needs to be switched (Figure 3.7) compared to the previous design. In addition, we screened 
several diazirine reagents (Scheme 3.1) for carbene footprinting and succeeded with 3-(3-methyl-
3H-diazirin-3-yl) propan-1-ol (MDPO).  
 
Figure 3.7 Enlarged labeling window using carbene footprinting. 
 
Scheme 3.1 Diazirine reagents for carbene footprinting. 
The labeling profiles of hMyo upon 355 nm irradiation of MDPO are shown in Figure 3.8. We 
first incubated hMyo with MDPO in NaCl solution and observed consecutive + 86.07 Da peaks 
after the peak for the unmodified protein. The carbene labeling for the closed and open state of 
hMyo were conducted with initial pHs of 6.8 (Figure 3.8b) and 3.2 (Figure 3.8c), respectively. 
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More carbene additions were observed under the acidic conditions, consistent with larger SASA 
in the open conformation. Then, we evaluated the labeling performance of MDPO at 248 nm and 
observed no + 86 Da peaks (Figure 3.8d), consistent with the experimental design.  
 
Figure 3.8 Carbene labeling profiles of hMyo under different conditions that are listed in each 
panel. 
In the presence of MDPO and hMyo, the photoacid NBA was also included in the sample 
solution for YAG laser at 355 nm. The carbene labeling, however, didn’t occur, and only a low 
intensity peak corresponding to oxidation appeared (Figure 3.9a) instead, indicating chemistry 
between MDPO and NBA. To establish whether it is the NBA or the transformed NBA-acid can 
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react with MDPO, we performed a similar “recycled” experiment as before. Specifically, we 
mixed hMyo with only NBA and submitted the solution to 248 nm irradiation, trying to exhaust 
NBA into the acid form. Then, we added MDPO to the collected solution for carbene 
footprinting at 355 nm. We observed a similar pattern of showing predominantly oxidation 
species (Figure 3.9b). In addition to the +16 Da peaks, we noticed two small peaks that represent 
carbene addition. Therefore, we screened different conditions, trying to promote this carbene 
chemistry. Even when the concentration of MDPO was tripled, we only observed significant 
increase in peak intensity for oxidation (Figure 3.9c). Furthermore, by using apo myoglobin 
(aMyo) as a control, we also excluded the possibility of the heme group being the initiator of this 





Figure 3.9 Carbene labeling profiles of hMyo and aMyo under different conditions that are listed 
in each panel. 
3.6 Conclusion 
The two-laser platform based on HO● footprinting shows preliminary results to probe 
conformational changes of hMyo. Unknown reactive species that result from chemical reactions 
between the photoacid NBA and H2O2 prohibit control of the system. Unfortunately, replacement 
of H2O2 and HO
● footprinting with carbene footprinting was not successful. We also tried to 
substitute NBA with another widely used photoacid, 1-(2-nitrophenyl)ethyl sulfate (NPE) 13. 
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However, NPE itself can label protein upon 248 nm or 355 nm irradiation even in the absence of 
other footprinting reagents.  
One of the many reasons of why the chemistry is complex is due to the complication of the 
proton releasing mechanisms. Other investigators offer several mechanisms, some of which 
include easily oxidizable intermediates. For example, one proposed mechanism15 (Scheme 3.2) 
of NBA rearrangement upon laser activation involves two single nitrogen-oxidation bonds that 
are susceptible for a strong oxidant like H2O2. Therefore, a nitroso-group can be troublesome 
being part of the photoacid. For further investigations, other types of photoacids such as benzyl 
ester16-17 may be a good choice. 
 
Scheme 3.2 One proposed proton release mechanism of NBA. 
For carbene footprinting, it is known that it preferentially reacts with polar motifs such as 
carbonyl groups. The presence of a carbonyl in a photoacid is usually necessary, given that the 
pH jump involves transformations into an acidic form. Thus, carbene footprinting may not be a 
good candidate for this purpose. Other types of radical-based footprinting may be worth to try 
(e.g., iodine radical and trifluoromethyl radical footprinting). 
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Chapter 4: An Integrated Approach for Determining a 
Protein-Protein Binding Interface in Solution and an 
Evaluation of HDX Kinetics for Adjudicating 






















* This chapter is based on the following publication: Zhang, M. M.; Beno, B. R.; Huang, R. Y-
C.; Adhikari, J.; Deyanova, E. G.; Li, J.; Chen, G.; Gross, M. L. An Integrated Approach for 
Determining a Protein-Protein Binding Interface in Solution and an Evaluation of HDX Kinetics 




We describe an integrated approach of using hydrogen−deuterium exchange mass spectrometry 
(HDXMS), chemical crosslinking mass spectrometry (XL-MS), and molecular docking to 
characterize the binding interface and to predict the three-dimensional quaternary structure of a 
protein−protein complex in solution. Interleukin 7 (IL-7) and its α-receptor, IL-7Rα, serving as 
essential mediators in the immune system, are the model system. HDX kinetics reports 
widespread protection on IL-7Rα but shows no differential evidence of binding-induced 
protection or remote conformational change. Crosslinking with reagents that differ in spacer 
lengths and targeting residues increases the spatial resolution. Using five cross-links as distance 
restraints for protein−protein docking, we generated a high-confidence model of the IL-7/IL-7Rα 
complex. Both the predicted binding interface and regions with direct contacts agree well with 
those in the solid-state structure, as confirmed by previous X-ray crystallography. An additional 
binding region was revealed to be the C-terminus of helix B of IL-7, highlighting the value of 
solution-based characterization. To generalize the integrated approach, protein−protein docking 
was executed with a different number of cross-links. Combining cluster analysis and HDX 
kinetics adjudication, we found that two intermolecular cross-link-derived restraints are 
sufficient to generate a high-confidence model with root-mean-square distance (rmsd) value of 
all alpha carbons below 2.0 Å relative to the crystal structure. The remarkable results of binding-
interface determination and quaternary structure prediction highlight the effectiveness and 
capability of the integrated approach, which will allow more efficient and comprehensive 
analysis of interprotein interactions with broad applications in the multiple stages of design, 




4.2 Introduction  
Precisely regulated but complex protein-protein interactions are paramount to safeguard 
homeostasis in the immune system1. Protein-binding events initiate vast arrays of signal 
transduction, communicating critical information to orchestrate multiple health-related immune 
responses2. Comprehensive characterization and impartial understanding of the binding 
interfaces at high spatial resolution are imperative for both academic and pharmaceutical 
research. A traditional approach to obtain binding information is X-ray crystallography3. The 
need for fastidious crystallization and long growth times can limit its application. In addition, the 
delivered solid-state information can raise questions about its relevance to the physiological 
environment.  Nuclear magnetic resonance (NMR), on the other hand, provides a liquid-phase 
characterization but at the expense of large amounts of isotopically-labelled sample, demanding 
signal averaging, and complicated data interpretation4. Mass spectrometry (MS)-based methods 
are exceptionally appealing in this context given their low detection limit, fast throughput, and 
compelling use of native proteins. 
Hydrogen deuterium exchange mass spectrometry (HDX-MS)5,6 is a robust analytical technique 
for characterizing protein-protein interactions,7 protein-ligand binding, higher-order structure8, 
and conformational dynamics.9-11 Conformational changes induced by protein-protein binding 
lead to changes in deuterium uptake kinetics, enabling comparisons between different states 
(e.g., bound and unbound), thus permitting the determination of binding interfaces and changes 
in dynamics. Spatial resolution exceeding the peptide-level can be achieved by multi-protease 
digestion for overlapping peptides, by electron transfer dissociation (ETD)/electron capture 
dissociation (ECD) fragmentation12-14, or by combining HDX results with other characterization 
approaches (e.g., chemical crosslinking and docking, as in this study).  
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Chemical crosslinking with subsequent MS analysis (XL-MS) has considerable value in the 
structural biology toolbox.15-16 It can deliver topological information of protein complexes by 
bridging the neighboring domains in close proximity, defined by characteristic spacer lengths on 
cross-linkers. Advanced analysis software17-19, new crosslinking reagents and protocols20 have 
greatly escalated its applications. The obtained information is even more propitious to uncover 
higher-order quaternary structure when coupled with other methods (e.g., macromolecular 
docking).  
Complementing X-ray crystallography and NMR, protein-protein docking is a computational 
methodology that also yields complete three-dimensional structural information for protein 
complexes. Despite rapid and regular increases in computer speed, parallel processing, 
acceleration of computation through the use of GPUs and the development of improved 
algorithms and scoring functions, accurate modeling of protein complexes remains challenging, 
even starting with high-quality structural models (e.g., X-ray crystal structures) of the binding 
partners21. This is due in part to the large number of potential complex structures that must be 
evaluated in the absence of additional information (sampling problem)22 and to limitations in the 
ability to score accurately the models generated (scoring problem)23-24. An integrated platform25-
28 that utilizes experiment-derived information (i.e., HDX-MS and XL-MS data) to define 
restraints that guide the sampling stage of protein-protein docking has the potential to provide 
models with high accuracy and resolution.  
In this study, we chose interleukin 7 (IL-7) as a test case to demonstrate the integrated 
characterization platform. IL-7 is a representative member of the cytokine family, modulating 
immune cell physiology through receptor recognition2, 29. IL-7 sequentially binds to IL-7R, its 
-receptor, and c through its extracellular domain to form a ternary-complex that activates the 
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Janus kinase (JAK) and enables phosphorylation of the signal transducer and activator of 
transcription (STAT).30 Downstream signal transduction switches on transcription of the anti-
apoptotic genes, promotes cell survival, and causes proliferation of both naïve and memory T 
cells.31 Many investigators consider recombinant human IL-7 an ideal treatment agent in cancer 
immunotherapy. 32 It can promote immune reconstitution33-34 through peripheral T cell 
expansion, increase the efficacy of tumor regression,35 and antagonize the immunosuppressive 
network.36 Understanding the critical role of regulating immune functions requires 
characterization of the involved binding interface, further motivating the investigation of IL-
7/IL-7R as a model system. The approach, once established, will doubtlessly benefit other 
protein systems (e.g., other cytokine complexes, antigen/antibody complexes). Deeper 
understanding will aid biomedical design37 of protein interface engineering2 and epitope-based 
preventive vaccines38 that are crucial to maintain homeostasis and physiological well-being.  
Our goal is to implement and test an analytical approach that is comprised of HDX, chemical 
crosslinking and protein-protein docking to characterize the binding interface of IL-7/IL-7R. 
With the integrated methods, we generated an accurate three-dimensional model that allows 
detailed description on the direct inter-protein contacts in the binding region. Furthermore, we 
investigated how HDX kinetics can adjudicate candidate docking models en route to an ultimate 
high-confidence complex structure. A previous X-ray crystallographic study39 of IL-7/IL-7R is 
available for final comparison purposes.  
The binding regions assigned by using the approach are in good accord with the published 
crystal structure and, moreover, indicate another involvement (i.e., C-terminus of helix B in IL-
7). Docking results generated with different numbers of cross-links further demonstrate that, with 
HDX kinetics adjudication, a high-confidence model can be delivered by using only two 
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intermolecular cross-links. Although HDX-MS has been employed for complementary 
information in some biological studies40-44 along with XL-MS, the two methods are usually 
treated individually. Other studies27-28 that incorporated XL-based docking have shown that 
HDX kinetics can be utilized to examine the constructed 3D model; however, none has assessed 
the process in a systematic way. The integration and evaluation of the three approaches 
convincingly shows the combination can yield higher-order structural information and provide 
basic and practical insights for further applications. 
4.3 Experimental 
4.3.1 Material 
BS3-h12/d12 (bis(sulfosuccinimidyl) suberate) was purchased from Creative Molecules. BS2G-
d4 (bis(sulfosuccinimidyl) 2,2,4,4-glutarate-d4), BS2G (bis(sulfosuccinimidyl) 2,2,4,4-glutarate), 
EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride), Zeba column and 
colloidal blue staining kit were purchased from Thermo Fisher Scientific (Waltham, MA). Sulfo-
NHS (N-hydroxysulfosuccinimide sodium salt), MES buffer, dithiothreitol and iodoacetamide 
were purchased from Millipore Sigma (Saint Louis, MO). Recombinant human IL-7Rα protein 
was purchased from Sino Biological (Wayne, PA). Recombinant human IL-7 protein was 
purchased from R&D System (Minneapolis, MN). RapiGest SF Surfactant was from Waters 
(Milford, MA). Sequencing grade modified trypsin and chymotrypsin were from Promega Co. 
(Madison, WI). C18 NuTip was purchased from Glygen (Columbia, MD). PNGase(glycerol-
free) F was purchased from BioLabs (Hitchin, UK). 4-20% bis-tris precast gels (ExpressPlusTM 
PAGE) were purchased from GenScript®. 
4.3.2 Hydrogen-Deuterium Exchange 
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The HDX experiments were performed with three states: IL-7 unbound state, IL-7Rα unbound 
state, and IL-7/IL-7Rα bound state. For the bound state, two proteins were incubated at a 1:1 
ratio in the equilibrium buffer (10 mM PBS buffer, pH = 7.4) for at least 45 min at 25 °C. HDX 
was initiated by diluting 5 µL of the protein solution (20 µM) 5-fold with labeling buffer (10 
mM PBS in 90% D2O, pD = 7), which was substituted into the H2O buffer for control 
experiments. Quenching buffer (25 µL, 4 M GdnHCl, 700 mM TCEP, pH = 2.5) was added at 
different exchange times (i.e., 10, 30, 60, 900, 7200 s and incubated for 3 min). The experiments 
were in triplicate. The protein mixture was injected immediately into a custom-built HDX 
platform for digestion by passing through an immobilized pepsin column (2 mm × 20 mm) with 
200 µL/min flow rate. A ZORBAX Eclipse XDB C8 column (2.1 mm × 15 mm, Agilent 
Technologies, Santa Clara, CA) was used for desalting with 0.1% trifluoracetic acid for 3 min. 
After switching the platform into the analysis mode, the peptide mixture was separated on a 
Xselect CSH C18 column (2.1 mm × 50 mm, Waters Corporation, Milford, MA) with a 9.5-min-
linear gradient (4–40% acetonitrile with 0.1% formic acid) at 200 µL/min flow rate. Peptides 
were then submitted to a LTQ-FT mass spectrometer (Thermo Fisher, Waltham, MA) for data 
acquisition at a mass resolving power of 100,000 at m/z 400. An electrospray ionization source 
was operated with the following parameters: spray voltage: 5kV; capillary temperature: 250 C; 
capillary voltage: 38 V; tube lens: 185 V. The HDX platform, including columns and valves, 
were submerged in an ice slush bath to minimize back exchange.  
After data acquisition, HDX kinetics was analyzed by HDExaminer® (Sierra Analytics, Inc). Per 
residue deuterium uptake difference for each time point was calculated and exported from the 
software based on available overlapping peptides using “heavy” smoothing fuction. The 
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cumulative uptake differences and the associated propagation error was calculated manually. 
Three times propagation error was chosen to give 99.7% certainty. 
4.3.3 BS3 and BS2G Crosslinking 
Prior to any experiments, IL-7 and IL-7Rα were incubated as 1:1 ratio for 1 h in 10 mM PBS 
buffer (2.7 mM KCl, 137 mM NaCl, pH = 7.4). The BS3-h12/d12 crosslinker (1 mg) was 
dissolved in PBS buffer to make a 25 mM stock solution. The IL-7/ IL-7Rα complex was then 
mixed with the fresh BS3-h12/d12 solution at 1:25, 1:50 and 1:100 ratio, where the concentration 
of IL-7/ IL-7Rα was 10 µM. The reaction mixture was kept at 25 °C for 45 min. Tris-HCl 
solution (1 M, pH = 7.4) was added at a final concentration of 50 mM and incubated for 15 mins 
to stop the crosslinking chemistry. For the BS2G crosslinking, the experimental procedure was 
identical except that BS2G-d4 and BS2G-h4 stock solutions were prepared separately at 25 mM 
and manually mixed later at 1:1 ratio prior to the XL reactions. Crosslinking experiments were in 
triplicates for each condition. 
4.3.4 EDC Crosslinking 
IL-7 and IL-7Rα were incubated in 35 mM MES buffer (15 mM KCl, pH = 6.5) with 1:1 ratio 
for 1 h. A freshly made EDC/sulfo-NHS stock solution (400 mM EDC/sulfo-NHS in MES 
buffer, pH = 6.5) was added to the IL-7/IL-7Rα solution for 1 h at 25 °C to allow the XL 
reactions; the protein concentration was 17 µM and EDC/sulfo-NHS was 5-20 mM in different 
trials. To quench the reaction, Tris-HCl (2M, pH = 7.4) was added to a final concentration of 200 
mM, followed by 15 mins incubation. Crosslinking experiments were in triplicates for each 
condition. 
4.3.5 Enzymatic in-solution Digestion 
111 
 
The protein mixture was desalted with a Zeba column and denatured by adding 0.75% (w/v) 
RapiGest stock solution in Tris-HCl (100 mM, pH = 7.4) at 80 °C for 30 min, with a final 
concentration of 0.25% (w/v) RapiGest. After cooling to room temperature, reduction and 
alkylation of disulfide bonds was achieved by incubating sequentially with 7.5 mM DTT at 55 
°C for 30 min and 14 mM IAM at dark for 30 min. The protein mixture was then digested and 
deglycosylated by adding trypsin and PNGase F. After 1 h incubation at 37 °C, chymotrypsin 
was added for overnight digestion to achieve better coverage. Digestion was stopped under 3% 
formic acid and incubated at 37 °C for 30 min. The peptide mixture was treated with C18 NuTip 
for desalting according to the manufacturer’s protocol. The eluents were vacuum dried and 
resuspended in 0.1% formic acid in distilled water, ready for LC-MS/MS analysis. 
4.3.6 LC-MS/MS Analysis 
A solution of 5 µM peptide digest was loaded onto a C18 reversed-phase desalting column 
(Acclaim PepMap C18, 100 µm x 2 cm, 5 µm, 100 Å; Thermo Fisher Scientific) at 4 µL/min for 
10 min. A custom-packed analytical column with C18 reversed-phase material (Magic, 100 µm x 
180 mm, 5 µm, 120 Å; Michrom Bioresources, Inc., Auburn, CA) in silica tubing was used for 
sample separation on Ultimate 3000 Rapid Separation system (Dionex, Co.). The eluent 
consisted of solvent A (water with 0.1% formic acid by volume) and solvent B (80% acetonitrile 
with 0.1% formic acid by volume). The flowrate was controlled as 400 nL/min with a 120 min 
gradient: 2.5% B to 12% B in 30 min, increased to 60% B for 65 min, ramped to 85% B in 5 
min, kept at 85% B for 5 min, returned to 2.5% B in 5 min, and equilibrated at 2.5% B for 10 
min.  A Nanospray Flex source was mounted on a Thermo Q Exactive Plus orbitrap mass 
spectrometer for downstream detection. The associated parameters were: spray voltage, 2.5 kV; 
capillary temperature, 250 °C; full MS maximum injection time, 200 ms; tandem MS maximum 
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injection time, 100 ms; and charge exclusion, 1, 6, 7, 8. In the BS3-h12/d12 and BS2G-h4/d4 
crosslinked samples, acquisition was performed with user-defined MS-Tag in the data-
independent mode. In the EDC crosslinked samples, acquisition was carried out under data-
dependent mode, selecting the 20 most-abundant ions for higher energy dissociation (HCD).  
4.3.7 Identification of Crosslinked Products 
The raw LC-MS/MS files were analyzed by pLink19, 45 (ver. 2.3.1, Institute of Computing 
Technology, Chinese Academy of Sciences, Beijing, China) and Protein Prospector (ver. 5.22.1, 
UCSF Mass Spectrometry Facility). IL-7 and IL-7Rα sequences were added manually to the 
search database. XL information, including monoisotopic linker mass of light and heavy form of 
BS3 (156.079 Da and 168.154 Da) and BS2G (118.057 Da and 114.032 Da), linked sites and 
composition were all required in pConfig. Trypsin/chymotrypsin digestion was manually defined 
and added to the library. Search parameters in pLink were: enzyme: trypsin/chymotrypsin; 
missed cleavage: 3; precursor tolerance: 10 ppm; fragment tolerance: 30 ppm; variable 
modification: oxidation of M, deamidation of N, Q and N-terminus; fixed modification: 
carbamidomethyl of C; minimal peptide length: 6 aa; maximal peptide length: 60 aa; minimal 
peptide mass: 600 Da; maximal peptide mass: 6000 Da. The crosslinked peptides were examined 
in pLabel to give corresponding summary reports. The identified XL peptides were equal or 
smaller than a 5% false discovery rate at spectral level with a 10 ppm MS1 filter tolerance. 
Isotopic doublets were manually confirmed in the raw file, and product-ion (MS/MS) spectra 
were further validated and compared with the calculated masses of product ions. 
4.3.8 Protein-Protein Docking 
IL-7/IL-7Rα protein-protein docking analyses were performed with the Rosetta (v. 3.846-48) 
docking_protocol (RosettaDock) code49-50 on a cluster of multi-processor Linux servers. For the 
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docking analyses, the A chain from the X-ray crystal structure of unbound IL-7R extracellular 
domain (PDB ID: 3UP1) was used as the protein model for IL-7R51. Unfortunately, no crystal 
structure of unbound IL-7 was available either in-house or in the public domain. Thus, the A 
chain from the IL-7/IL-7R complex crystal structure (PDB ID: 3DI2) provided the model for IL-
739. The protein models were prepared for docking in a two-stage process starting with the 
Rosetta score_jd2 program, which added residue atoms that were not present in the PDB files, 
added hydrogen atoms, and removed non-protein residues. The second preparation step utilized 
the Rosetta relax program to perform energy minimization of the structures output by score_jd2 
within the context of the Rosetta energy model.  With the relax application, 10 models were 
generated for each structure by using the “constrain_relax_to_start_coords” and 
“coord_constrain_sidechains” options to limit structural changes, and the model of each protein 
with the lowest Rosetta total energy score was selected.  
The IL-7 and IL-7R models were imported into Maestro (Schrödinger Release 2019-1: Maestro, 
Schrödinger, LLC, New York, NY, 2019.) and manually displaced relative to each other to 
arbitrary extents and then merged into a single two-chain model that was written to a PDB 
format file as input for the subsequent protein-protein docking analyses. Docking exercises 
utilizing all possible unique combinations of 1-5 distance constraints based on the IL-7/IL-7R 
cross-links identified for residue pairs (IL-7:IL-7R) were performed using the RosettaDock 
program. The set of five experimental-identified intermolecular cross-links from which the 
combinations of distance constraints were derived includes only those for which atomic 
coordinates for Cα atoms for both residues are present in the X-ray structures of IL7 and IL7R 
(3DI2 and 3UP1). All distance constraints utilized flat-bottomed harmonic potentials which 
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penalized models in which the Cα-Cα distance(s) for crosslinked residues fell outside of the 
ranges of 6 – 16 Å52 and 9 – 30 Å53 for the EDC and BS3 crosslinks, respectively.  
For each possible combination of 1 – 5 crosslink-derived constraints, 20 docking runs were 
performed, each yielding up to 2,500 models for a maximum of 50,000 models per constraint 
combination. For comparison purposes, 20 docking runs, each yielding 5,000 models (100,000 
total) were carried out without constraints. For each constraint combination as well as for the 
unconstrained docking exercise, the top-scoring single model based on total score were 
identified. In addition, the top-scoring set of 100 models ranked by total score metric was 
clustered with the Rosetta cluster program using a 2.0 Å cluster radius. Analysis of clusters was 
performed with in-house shell and Python scripts including a Python/OEChem script that 
determined the Cα atom-based r.m.s.d. for each clustered model relative to the X-ray crystal 
structure of the IL-7/IL-7R reference complex (PDB ID: 3DI2). Representative models were 
superimposed with the X-ray crystal structure of the IL-7/IL-7R complex for difference analysis, 
and high confidence models were defined as those for which the mean Cα atom r.m.s.d. was less 
than 2.0 Å.  
4.4 Results and Discussion 
4.4.1 Hydrogen-Deuterium Exchange 
We conducted HDX on the unbound IL-7 and the bound-state in presence of IL-7Rα and 
collected kinetic plots with 94% sequence coverage and 48 unique peptides (Figure 4.1A for 
representative HDX kinetic plots and Figure 4.2 for the rest). Regions 17-24 (a), 58-66 (c) and 
81-91 (e) of IL-7 show less deuterium uptake across the incubation time up to 2 h, indicating 
their involvement in the binding interaction. On the other hand, region 35-42 (b) takes up more 
deuterium, showing exposure when bound to IL-7Rα. Another region, represented by peptide 71-
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76 (d), is an example not affected by binding, serving as a negative control. Statistical analysis of 
the cumulative deuterium uptake differences further supports these observations sometimes up to 
near residue-level (Figure 4.1B). We consider the differences as significant when they are greater 
than three times the propagated error, giving 99.7% confidence. We mapped the cumulative 
HDX differences on the IL-7 structure (Figure 4.1C) to show that the most protected regions lie 
on helix A (Region a) and helix C (Region e). The C-terminus of helix B (Region c) also shows 
moderate protection, whereas the loop region (Region b) between helix A and B becomes more 
flexible upon binding.  
 
Figure 4.1 Analyzed HDX kinetics of IL-7. (A) Representative HDX kinetics of unbound IL-7 
(purple) and of bound with IL-7Rα (red). (B) Statistical analysis of cumulative HDX difference 
for each residue. Residues are considered being affected upon binding with IL-7Rα when the 
difference is greater than three times the propagated error (shaded in faint yellow) of all time 
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To map the binding interface of IL-7Rα, we compared HDX kinetics of its bound and unbound 
states (Figure 4.3A and Figure 4.4) and obtained 80% sequence coverage and 45 unique 
peptides. The N-terminal peptide (Region a) shows identical uptake kinetics between the two 
states. All other peptides, however, present various extents of protection in the HDX profiles, as 
is clearly demonstrated in the statistical analysis of cumulative deuterium uptake difference 
(Figure 4.3B). The most protected residues, colored black in the IL-7Rα structure (Figure 4.3C, 
region c), comprise the elbow region on domain 1 (D1), indicating high probability to be the 
binding interface. Other regions with pronounced protection are on the other elbow region 
(Region e) and on one beta-strand (Region d) of domain 2 (D2). The widespread protection 
indicates that IL-7Rα exhibits a more structured and compact conformation upon binding; 
however, there is no differential evidence for being the binding interface or undergoing remote 
conformational changes with the stand-alone HDX. To increase the resolution, we applied 




Figure 4.3 Analyzed HDX kinetics of IL-7Rα. (A) Representative HDX kinetics for unbound 
IL-7Rα (green) and IL-7/IL-7Rα (red). (B) Statistical analysis of cumulative HDX difference 
upon each residue. Residues are considered affected upon binding with IL-7 when the difference 
is greater than three times of the propagated error (shaded in yellow) of all time points. (C) The 












4.4.2 Crosslinking of IL-7/IL-7Rα Complex 
To address the interacting regions in the IL-7/ IL-7Rα complex, we chose isotope-encoded BS3-
h12/d12 (11 Å), BS2G-h4/d4 (8 Å) and EDC/NHS (“zero-length crosslinker”) as the crosslinking 
reagents. Their spacer lengths cover a range of distance restraints, and their combined use allows 
interrogation of not only lysine (K) and the N-terminal -NH2 groups but also glutamic (D) and 
aspartic acids (E), affording broad coverage. We incubated IL-7Rα and IL-7 at a 1:1 molar ratio 
to allow complex formation and then mixed them with the cross-linkers at various excess 
concentrations in separate experiments. We monitored the yields with gel electrophoresis (Figure 
4.5). The cross-linked complexes present clearly at approximately 64 kDa, and the yields are 
estimated according to the intensities of the bands. We found that 100-fold excess BS3 and BS2G 
(1 mM) gives more abundant cross-linked IL-7/ IL-7Rα than does an excess of 25 (0.25 mM) 
and 50-fold (0.5 mM). For EDC/NHS, use of 10 mM and 20 mM of reagent results in product 
bands of nearly equal intensity. We submitted the crosslinked IL-7/ IL-7Rα from individual trials 
to in-solution digestion followed by LC-MS/MS analysis, in which the “light” and “heavy” 
isotope encoding aids the identification of cross-links. We manually validated the isotope-
encoded doublets and the product ions formed in MS/MS from raw files, establishing that the 




Figure 4.5 Gel electrophoresis of IL-7/IL-7Rα. (A) BS3 and BS2G crosslinking of IL-7 (17 kDa) 
and IL-7Rα (45-50 kDa) are performed at 0.25 mM, 0.5 mM and 1 mM. The crosslinked IL-7/ 
IL-7Rα band (64 kDa) indicates concentration-dependent production. The first two 
electrophoresis lanes are shown as control runs. (B) EDC crosslinking is performed at 5 mM, 10 
mM and 20 mM. Different species are identified on the right. 
In total, we identified 16 intermolecular cross-links. Six of them contain one cross-linked site on 
a long and flexible loop between helix C and D of IL-7, suggesting the flexibility of the loop 
region but providing no evidence of the binding interface. This loop can be ruled out as a binding 
interface, even in the absence of an X-ray structure, because it does not show protection in HDX 
upon binding.  Of the remaining 10 inter cross-links (Table 4.1, corresponding cross-links are 
shown in Figure 4.6-4.15), those on IL-7 are K11 on helix A (cross-link 1 and 2), D75 on helix C 
(cross-link 3), K69 on the C-terminus of helix B (cross-link 4), further supporting the previously 
assigned protected regions in the HDX kinetics study. In addition, we observed several cross-
links on a series of residues on the N-terminus (crosslink 6 to 10) and one on helix D (cross-link 





Table 4.1 Identified inter cross-links with BS3, BS2G and EDC crosslinking.  
 
Il-7 Il-7Rα Cross-Linker 
Reported Cross-Linkable 
Cα- Cα Distance, Å 
Measured Cα- Cα 
Distance in the 
Generated Model, Å 
1 K11 K84 BS3 9-3053 14.3 
2 K11 K141 BS3 9-3053 13.9 
3 D75 K77 EDC 6-1652 9.8 
4 K69 K78 BS3 9-3053 17.2 
5 K152 K141 BS3 9-3053 24.2 
6 K8 K84 BS2G / BS3 6-26/9-3053 12.3a 
7 N-term K84 BS2G / BS3 6-26/9-3053 - 
8 D2 K84 EDC 6-1652 - 
9 D4 K84 EDC 6-1652 - 
10 E6 K84 EDC 6-1652 - 
a Cross-linked distance is measured at the Cα of D9 instead of K8 in crystal structure (PDB: 
3DI2) because the N-terminal region from M1-K8 is missing in the X-ray structure.  
 
Figure 4.6 Mass spectra of cross-link 1. Extracted precursor mass spectra of cross-link 1 in the 
inlet, showing the isotopic peaks with equal intensity and shifted by 4 m/z unit when the charge 
state is +3. The product-ion spectrum of the heavy form of crosslinked peptide generated by 
“higher energy collisional dissociation” (HCD). The assigned fragment ions are in purple for IL-
7 and green for IL-7Rα.  
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Figure 4.7 Mass spectra of cross-link 2. Extracted precursor mass spectra of cross-link 2 in the 
inlet, showing the isotopic peaks with equal intensity and shifted by 6 m/z unit when the charge 
state is +2. The product-ion spectrum of the light form of crosslinked peptide generated by 
“higher energy collisional dissociation” (HCD). The assigned fragment ions are in purple for IL-




Figure 4.8 Mass spectra of cross-link 3. The product-ion spectrum of the crosslinked peptide 
(cross-link 3) generated by “higher energy collisional dissociation” (HCD). The assigned 







Figure 4.9. Mass spectra of cross-link 4. Extracted precursor mass spectra of cross-link 4 in the 
inlet, showing the isotopic peaks with equal intensity and shifted by 4 m/z unit when the charge 
state is +3. The product-ion spectrum of the light form of crosslinked peptide generated by 
“higher energy collisional dissociation” (HCD). The assigned fragment ions are in purple for IL-





Figure 4.10 Mass spectra of cross-link 5. Extracted precursor mass spectra of cross-link 5 in the 
inlet, showing the isotopic peaks with equal intensity and shifted by 4 m/z unit when the charge 
state is +3. The product-ion spectrum of the light form of crosslinked peptide generated by 
“higher energy collisional dissociation” (HCD). The assigned fragment ions are in purple for IL-





Figure 4.11 Mass spectra of cross-link 6. Extracted precursor mass spectra of cross-link 6 in the 
inlet, showing the isotopic peaks with equal intensity and shifted by 3 m/z unit when the charge 
state is +4. The product-ion spectrum of the light form of crosslinked peptide generated by 
“higher energy collisional dissociation” (HCD). The assigned fragment ions are in purple for IL-





Figure 4.12 Mass spectra of cross-link 7. Extracted precursor mass spectra of cross-link 7 in the 
inlet, showing the isotopic peaks with equal intensity and shifted by 4 m/z unit when the charge 
state is +3. The product-ion spectrum of the light form of crosslinked peptide generated by 
“higher energy collisional dissociation” (HCD). The assigned fragment ions are in purple for IL-




Figure 4.13 Mass spectra of cross-link 8. The product-ion spectrum of the crosslinked peptide 
(cross-link 8) generated by “higher energy collisional dissociation” (HCD). The assigned 





Figure 4.14 Mass spectra of cross-link 9. The product-ion spectrum of the crosslinked peptide 
(cross-link 9) generated by “higher energy collisional dissociation” (HCD). The assigned 





Figure 4.15 Mass spectra of cross-link 10. The product-ion spectrum of the crosslinked peptide 
(cross-link 10) generated by “higher energy collisional dissociation” (HCD). The assigned 
fragment ions are in purple for IL-7 and green for IL-7Rα.  
For the IL-7Rα, there are four cross-linked residues; three of them, K77, K78 (cross-link 3 and 4) 
and K84 (cross-link 1 and cross-link 6 to 10) are on the elbow region of D1, and the fourth, 
K141 (cross-link 2 and 5) is located on the elbow loop of D2, showing discriminating evidence 
that these two elbow regions constitute the binding interface of IL-7Rα rather than undergoing 
remote conformational changes. To delineate the interacting regions of the binding complex, we 
turned to protein-protein docking based on crosslinking distance restraints to elucidate the 
quaternary structure.   
4.4.3 Restraint-based Protein-Protein Docking 
Protein-protein docking calculations were performed with the RosettaDock program to discern 
the likely structure of the IL-7/IL-7Rα complex in aqueous solution. Five representative 
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intermolecular cross-links (i.e., crosslinks 1-5 in Table 4.1) were selected to define distance 
restraints. The other five cross-links involve N-terminal residues of IL-7 that are not resolved in 
the input X-ray crystal structure and, thus, are not included as docking restraints. Initial protein-
protein docking experiments with RosettaDock utilized all five crosslink-derived restraints 
simultaneously. Clustering of the top-scoring 100 IL-7/IL-7Rα complex models (RosettaDock 
total score) was performed with the Rosetta cluster program employing a 2.0 Å cluster radius. 
The largest cluster contained 53 similar models. We chose one representative model (Figure 
4.16, IL-7 in purple and IL-7Rα in green) and overlaid it on to the X-ray crystal structure (Figure 
4.16, black). The r.m.s.d. difference across all alpha carbons is 1.7 Å which is less than 2.0 Å 
cutoff used to define a high-confidence model.  
 
Figure 4.16 X-ray crystal structure of the IL-7/IL-7Rα (black, PDB: 3DI2) overlaid with 
generated docking models (green for IL-7Rα and purple for IL-7) using five intermolecular 
cross-links (1-5) as restraints. Cross-linked residues are in red, and dashed lines depict the 
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corresponding crosslinked spans. The adjoining number corresponds to cross-links shown in 
Table 4.1. 
We further mapped cross-links 1-6 onto the generated model (Figure 4.16). Although the N-
terminal region from M1 to K8 in IL-7 is not resolved, cross-link 6 is located more closely than 
cross-links 7-10 to the resolved residue D9, allowing its Cα-Cα distance to be estimated and 
taken for mapping. Cross-links 7-10, therefore, are not mapped in the complex model. All of the 
measured Euclidean Cα- Cα distances are within the reported range52-53 for each specific cross-
linker (Table 4.1). The excellent accord between the model and the X-ray crystal structure 
demonstrates the validity of solution-based data and the feasibility of using an integrative 
approach to obtain an accurate structure. In contrast, clustering of the top-scoring 100 models 
from an unrestrained docking exercise where more extensive sampling was performed (100K 
models) resulted in identification of only four two-membered clusters, none of which contained 
models that recapitulated the X-ray structure of the complex.  
4.4.4 Binding Interface for IL-7 and IL-7Rα 
On D1 of IL-7Rα, the elbow region (Figure 4.3-c) is heavily protected upon binding and 
considered to interact primarily with helix C of the IL7.  Not only the adjacent positions of these 
two domains, from directly viewing the docking model, but also a short EDC cross-link 3 
support their proximity. The observation is consistent with the contacting residues resolved from 
the crystal structure39, where K77 on the D1 elbow region of IL-7Rα forms H-bonds with D75 
and K82 on helix C of IL-7. Furthermore, HDX kinetics reveals another participating region on 
the C-terminus of helix B, evidenced by the low deuterium uptake (Figure 4.1A-c) and cross-link 
4. In addition, cross-link 6-10 suggest another contact region with the D1 elbow, the N-terminal 
region of helix A; this region, however, shows no protection in the HDX kinetics (Figure 4.1B), 
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decreasing the likelihood of being the binding interface. Besides the direct binding domains, 
adjacent and proximal regions can also allow crosslinking formation, which delivers topological 
information of the IL-7/IL7Rα complex. This observation shows the limitation of using stand-
alone XL-MS and underscores the necessity of incorporating other complementary approaches to 
achieve an impartial determination of a protein-protein interface. The other elbow region (Figure 
4.3-e) on D2 of IL-7Rα is bridged to helix A of IL-7 by cross-link 2, indicating close location of 
those regions in the generated model. The cross-linked residue, K11, is the nearest linkable 
residue to Q23, which contributes to H-bond formation with the paired residue K138 in D239. 
The C-terminus of helix D adjoins the D2 elbow loop, as represented by cross-link 5. The less 
than 10% cumulative deuterium uptake difference in region 138-152 (Figure 4.1B) and distant 
location in the docking model, however, suggest involvement but not prominent interaction. The 
integrated platform of using multiple cross-linkers and of incorporating protein-protein docking 
significantly increases the certainty and defines better the directly contacting regions.  
4.4.5 The Number of Intermolecular Cross-links Needed for a High-
Confidence Model 
Excellent results were obtained in the protein-protein docking exercise that utilized five 
crosslink-derived restraints. However, in the context of the integrated approach, it is possible that 
accurate models might be obtained with fewer restraints. To examine this possibility, we 
conducted docking runs with all possible combinations of using 1 to 5 cross-links as distance 
restraints. For each restraint combination, we identified the top-scoring 100 IL-7/IL-7Rα docking 
models with RosettaDock total score and clustered them with the Rosetta cluster program by 
using the aforementioned criteria (Cα atom r.m.s.d. ≤ 2.0). For an unknown system, the clusters 
with the largest size are likely to be the most promising ones to choose. Thus, we summarized 
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and evaluated all the largest clusters for each of the combinations (Figure 4.17). When using a 
restraint combination, multiple clusters of equal size are possible (e.g., for cross-link 1 and the 
combination of cross-links 4 and 5). Docking with larger number of restraints generally leads to 
larger cluster sizes; however, the size also depends on the cross-links chosen. We found that 
shorter cross-links are more demanding and lead to larger clusters. Supporting this contention is 
that the largest clusters in each category (e.g., one restraint, two restraints) all contain cross-link 
3, the EDC cross-link. This observation further emphasizes the importance of employing a 
multiple-cross-linker strategy to provide both tight requirements for crosslinking and, at the same 
time, relatively loose restraints that allow many cross-links to form, thus aiding the downstream 
analysis.  
 
Figure 4.17 Cluster sizes for largest clusters of IL-7/IL-7Rα models generated with each 
possible combination of 1-5 crosslink-derived restraints from protein-protein docking. Several 
clusters with nearly equal members are formed for restraint combinations of cross-link 1 and 
combinations of cross-links 4 and 5. 
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Table 4.2 Summary of representative models from the largest clusters by using any two cross-
links as docking restraints. The solvent accessible area (SASA) of two most protected regions in 
IL-7, as indicated by HDX kinetics, are calculated for each docking model and for the unbound-
state IL-7 in Pymol. 
Protein-protein docking with 10 different combinations of 5 crosslink-derived restraints taken 
two at a time yielded 11 largest clusters in total (Figure 4.17 and Table 4.2). Based on the 
structural similarity, we grouped and overlaid them into three different types (Figure 4.18). Our 
approach utilizes HDX results at this stage to evaluate the accuracy of the models. The 
omnipresent protection of IL-7Rα upon binding make IL-7Rα a poor choice to adjudicate the 
models. Instead, we chose only IL-7 HDX kinetics for the evaluation and mapped the residue-
level cumulative deuterium uptake difference onto its structure as shown before (Figure 4.1). To 
place the comparison on a quantitative basis, we calculated the solvent accessible area (SASA) 
of the two most protected regions, 19VSIDQL24 and 83VSEGTTIL90, as indicated by HDX, for 
each generated model (Table 4.2). For the type 1 models (Figure 4.18A), which are the most 
populated models given by seven different combinations (Table 4.2), the averaged SASA is 143 
± 12 Å and 212 ± 6 Å for 19VSIDQL24 and 83VSEGTTIL90, respectively. The values are 
significantly smaller than 230 Å and 319 Å in the unbound IL-7, suggesting there would be less 

































1_3 26 Type 1 133 220 Y 1.7 
1_4 22 Type 2 230 247 N 11.0 
1_5 11 Type 1 141 211 Y 1.4 
2_3 25 Type 1 158 213 Y 1.9 
2_4 10 Type 2  230 269 N 10.9 
2_5 12 Type 1 137 209 Y 1.5 
3_4 15 Type 1 142 214 Y 1.7 
3_5 62 Type 1 160 201 Y 1.7 
4_5 
4_5.1 13 Type 1 127 213 Y 1.3 




Figure 4.18 Different IL-7/IL-7Rα model-types, including type 1 (A), type 2 (B) and type 3 (C), 
generated from protein-protein docking with different combinations of two crosslink-derived 
restraints. IL-7 is mapped with the cumulative HDX uptake difference whereas IL-7Rα is 
colored in green. Similar models in each type are overlaid. (D) Type 3 IL-7/IL-7Rα model 
generated using only cross-link 1. 
For the type 2 models (Figure 4.18B), however, the two regions are outside the contacting 
interface and highly exposed, evidenced explicitly by a SASA for the region 19VSIDQL24 of 230 
± 1 Å that is identical to the SASA of the unbound IL-7. This identity indicates no binding-
induced protection for this region, in contradistinction to the HDX results. This inconsistency is 
further shown in other regions, for example the loops that connect different helices. Although 
type 2 models suggest the loops are the binding interface, HDX reports they either become more 
exposed upon binding or show no differences between two states (Figure 4.1B). The conflicting 
conclusions from HDX and docking forcefully decrease the likelihood of type 2 models to be 
correct. From similar reasoning, the type 3 model (Figure 4.18C) is also inconsistent with the 
HDX kinetics. Although the SASA of 83VSEGTTIL90 is 268 Å, smaller than that of unbound IL-
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7, the SASA of the other most protected region, 19VSIDQL24, is the same as that of unbound, 
indicating no involvement in the IL-7/IL-7Rα interaction. Instead, the suggested binding 
interface is consisted of a mini-helix and a flexible loop, which shows more deuterium uptake 
(Figure 4.1A-b) in HDX upon binding. Guidance from the HDX data allows us to reasonably 
rule out dubious docking models.  
A subsequent evaluation of the remaining models, i.e. type 1 models, after HDX adjudication 
and comparison with the published crystal structure reveals only subtle structural differences 
(Table 4.2), all smaller than 2 Å r.m.s.d for all alpha carbons. These latter models meet the 
criteria promoted in this study to define a high-confidence model. Using this integrated platform, 
we can conclude that docking restraints based on two intermolecular cross-links are adequate to 
identify an accurate quaternary model for this binding complex.  
Using three or four inter cross-links as restraints leads to better populated clusters and well-
defined IL-7/IL-7Rα models. Only two types of models (Figure 4.19) are generated and the 
second type can be excluded by considering the HDX results in the decision, where not the 
SASA values of both two peptides show differences between the bound and unbound IL-7 (Table 
4.3). The remaining models are all considered as high-confidence models upon comparison to 
the X-ray structure. Although using more than two cross-links also gives an accurate model, with 
no surprise, the successful exercise provides confidence for utilizing integrated methods to 




Figure 4.19 Different IL-7/IL-7Rα model-types, including type 1 (A) and type 2 (B), generated 
from three and four cross-links but with different combinations. IL-7 is mapped with the 
cumulative HDX uptake difference whereas IL-7Rα is colored in green. Similar models in each 
type are overlaid. 
Table 4.3 Summary of representative models from the largest clusters using three and four cross-
links as docking constraints. The solvent accessible area (SASA) of two most protected regions 































1_2_4 26 Type 2 230 252 N 11.0 
1_2_5 9 Type 1 128 215 Y 1.7 
1_3_4 28 Type 1 148 199 Y 1.5 
1_3_5 62 Type 1 138 195 Y 1.5 
1_4_5 27 Type 2 230 248 N 11.0 
2_3_4 35 Type 1 127 225 Y 1.5 
2_3_5 56 Type 1 141 206 Y 1.7 
2_4_5 22 Type 1 141 204 Y 1.5 
3_4_5 45 Type 1 142 213 Y 1.7 
1_2_3_4 25 Type 1 138 208 Y 1.7 
1_2_3_5 59 Type 1 137 216 Y 1.7 
1_2_4_5 18 Type 2 230 248 N 11.0 
1_3_4_5 58 Type 1 130 213 Y 1.6 
2_3_4_5 39 Type 1 145 207 Y 1.7 
When using only one cross-link as the docking restraint, however, seven different model-types 
are generated (Figure 4.18 for type 3 and Figure 4.20 for other types). Although some of these 
can survive HDX adjudication, they still deliver erroneous structures. Type 3 model (Figure 
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4.18) is an example, showing the two most protected regions interacting with the IL-7Rα. The 
SASA value for 19VSIDQL24 and 83VSEGTTIL90 are 65 Å and 182.3 Å, respectively, all smaller 
than that of the unbound IL-7, suggesting consistent protection, as observed from HDX kinetics. 
However, due to the mis-orientation of IL-7Rα, the r.m.s.d. difference in comparison with the 
crystal structure is 14.8 Å (Table 4.4), far exceeding the 2 Å threshold for a good model. A 
similar situation also applies to type 5 and type 7 models (Figure 4.20 and Table 4.4). Serving as 
a comparison control, one cross-link is insufficient to assign an accurate quaternary structure; 
thus, the minimal number of cross-links to fulfill this goal is two.  
 
Figure 4.20 Different IL-7/IL-7Rα model-types, including type 1 (A), type 2 (B), type 4 (C), 
type 5 (D), type 6 (E), type 7 (F), generated using only one cross-link. IL-7 is mapped with the 
cumulative HDX uptake difference whereas IL-7Rα is colored in green. Similar models in each 
type are overlaid. 
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Table 4.4 Summary of representative models from the largest clusters using individual cross-link 
as docking constraint. The solvent accessible area (SASA) of two most protected regions in IL-7 


































1.2 4 Type 2 230 335 N 15.1 
1.3 4 Type 3 65.0 182 Y 14.8 
1.4 4 Type 4 230 305 N 14.0 
2 5 Type 5 230 143 Y 15.1 
3 18 Type 1 138 207 Y 1.7 
4 4 Type 6 230 222 N 14.0 
5 7 Type 7 169 92 Y 11.4 
4.5 Conclusion 
This work highlights the effectiveness of the integrated approach to deliver quaternary structural 
information. Although the generality of the number “two cross-links” may vary from system to 
system, the prospect of generating a high-confidence model based on a few cross-links is clearly 
demonstrated. More crosslinks-derived restraints increase the likelihood of generating accurate 
models, but only modestly, and extensive efforts to identify large numbers of cross-links may not 
be justified for some protein-protein complexes. 
The study also demonstrates successful utilization of HDX results in combination with XL-
enabled docking studies to identify the IL-7/IL-7Rα binding interface and to predict the 
quaternary structure of the complex in solution. Use of multiple cross-linkers spanning diverse 
distances and targeting different amino acids increases the chances of identifying inter-protein 
contacting regions and the spatial-resolution; restraints derived from shorter crosslinking 
reagents more effectively focus the docking results towards native-like models. The excellent 
results achieved for the IL-7/IL-7R system may be due in part to the rich concentration of 
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lysine residues along the binding interface, but for interfaces that are not lysine-rich, employing 
non-selective crosslinkers, (e.g., sulfo-NHS-SDA), can overcome that limitation.  
Implementation of several complementary methods significantly enriches the structural 
information from tertiary to quaternary, compared to any stand-alone method. The delivery of a 
high-confidence model with only two experimental cross-links as restraints demonstrate the 
capability of an integrated platform. It can not only categorize changes arising from either 
binding-induced protection or remote structural changes but also define the binding interface 
more precisely with modeling. For many other protein complexes, which require considerable 
effort to crystalize or don’t crystallize at all, the approach is an intriguing alternative to obtain 
structural information. That information applies to the proteins in solution and can fill in regions 
that do not diffract well. The established approach will certainly aid the design of protein 
therapeutics. 
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Chapter 5: Epitope and Paratope Mapping of PD-
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* This chapter is based on the following publication: Zhang, M. M.; Huang, R. Y-C.; Beno, B. 
R.; Deyanova, E. G.; Li, J.; Chen, G.; Gross, M. L. Epitope and Paratope Mapping of PD-
1/Nivolumab by Mass Spectrometry-based Hydrogen/Deuterium Exchange, Crosslinking, and 




Programmed cell death-1 (PD-1), an antigen co-receptor on cell surfaces, is one of the 
conspicuous immune checkpoints. Nivolumab, a monoclonal antibody therapeutic approved by 
FDA, binds to PD-1 and efficiently blocks its pathways. In this study, an integrated approach has 
been developed to map binding epitope/paratope of PD-1/Nivolumb, including hydrogen 
deuterium exchange mass spectrometry (HDX-MS) followed by electron-transfer dissociation 
(ETD), chemical crosslinking and molecular docking. HDX-ETD offers binding sites 
characterization with amino acid resolution. Chemical crosslinking reveals complementary 
information on one additional epitope (i.e., the BC-loop) and a potential paratope at the N-
terminus of the heavy chain. Furthermore, crosslinking identifies another loop region (i.e., the 
C’D-loop) that is subject to remote conformational change. The distance restraints derived from 
the cross-links enable building high-confidence models of PD-1/Nivolumab, evaluated with 
respect to a resolved crystal structure. This integrated strategy provides an opportunity for 
comprehensive characterization of other antigen/antibody interactions that would assist in 
understanding binding mechanisms and designing antibody therapeutics. 
5.2 Introduction  
Antibodies are key biosensors in the immune system that can neutralize antigens and evoke other 
biomolecules that fight pathogens.1 The binding between epitopes and paratopes is exquisitely 
specific and of high affinity, contributing to numerous applications in biological research, 
diagnostics, and therapy.2 Comprehensive description of the epitopes/paratopes, ideally to the 
residue level, is crucial to understand the binding mechanism and to design future therapeutic 
agents. Hydrogen deuterium exchange (HDX) coupled with mass spectrometry (MS), an 
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approach that reflects the local solvent accessible surface area (SASA) and H-bond network of 
the protein backbone, is a valuable tool for probing protein interfaces.3-9 Its advantages are the 
near-native conditions of the experiment, low sample amount and high throughput compared to 
X-ray crystallography. A major limitation, however, can be the coarse spatial resolution limited 
by  the length of proteolytic peptides generated in the HDX experiment.10 Besides proteolyzing 
the protein to smaller fragment peptides, another solution to increase the spatial resolution is 
electron transfer dissociation (ETD), a fragmentation technique that can locate deuterium on one 
or a few residues. It utilizes a transferred electron from a radical anion to fragment peptides or 
protein with minimal scrambling of the amide H and D, in contrast to collision-induced 
fragmentation that uses many low-energy collisions to induce fragmentation.11-14 Another 
potential disadvantage of HDX-MS is the inability to distinguish between the direct binding 
interaction and remote conformational or allosteric effects. A combination of other 
complementary methods may overcome this limitation.  
Mass spectrometry-based chemical crosslinking (XL-MS) has developed rapidly owing to the 
increased availability of  diverse cross-linkers, advanced analysis software, and improvements in 
sample handling.15-17 Observed cross-links deliver information about not only the connectivity of 
adjacent protein subunits but also the distance ranges between specific amino acid residues as 
defined by the spacing between functional groups in chosen crosslinking reagents. These features 
contribute to a wide range of successful applications, including structural elucidation of single 
proteins18, topological portrayal of large macromolecular assemblies 19-20, and interaction maps 
of an entire proteome 20-21. Mapping epitopes/paratopes by using XL-MS, however, is an 
underutilized opportunity.22 In this study, we incorporated XL-MS together with HDX and 
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HDX-ETD to illustrate an analytical approach for epitope/paratope mapping of an important 
antigen/antibody system.  
Programmed cell death-1 (PD-1)23, an immune checkpoint, is an antigen-independent co-
receptor, located on cell surfaces and expressed predominantly by T-cells.24 The critical role of 
PD-1 is to bind with specific ligands, PD-1 ligand 1 (PD-L1)25 and PD-1 ligand 2 (PD-L2)26, to 
maintain immune tolerance by suppressing self-reactive T-cells27 and preventing pathogenic 
autoimmunity. The signaling, however, can be utilized by tumor cells to escape immune 
surveillance.28-29 Therefore, blockage of the PD-1 pathway has been an appealing target in recent 
development of immuno-therapeutics.30-32 Nivolumab , one of two monoclonal antibodies 
(mAbs) on the market33, is designed to bind with PD-1, demonstrating  immune restoration in 
multiple tumor conditions34-36 with impressive clinical efficacy.  
Here, we applied HDX-MS to the PD-1/Nivolumab complex to obtain regional binding 
information, which was further refined by HDX-ETD to specify more closely the critical binding 
residues. The suggested epitope and paratope regions were subsequently evaluated by XL-MS, 
revealing complementary binding interfaces, and differentiating remote conformational changes. 
Utilizing the distance restraints derived from various cross-linkers, we conducted molecular 
docking to generate high-confidence 3D models and evaluated the strengths and limitations of 
this approach. A previously resolved X-ray crystal structure of PD-1/Nivolumab Fab 37-38 was 
employed for final comparison purposes. Besides the successful application in the binding 
interface determination with IL-7 and IL-7Rα (Chapter 5), the integration of several MS-based 
approaches also enables precise and detailed characterization of epitopes/paratopes of an 





5.3.1 Hydrogen-Deuterium Exchange Mass Spectrometry 
PD1 (25 M) and Nivolumab (25 M), dissolved in non-deuterated PBS buffer (Phosphate 
Buffered Saline, pH 7.4), were digested individually with an immobilized Enzymate pepsin 
column, 300 Å, 5 µm, 2.1 mm X 30 mm (Waters Corp., Milford, MA, USA) under different 
conditions including PD1 alone, Nivo Fab alone, and bound PD1 and Nivo Fab at a molar ratio 
of 1:2, for selected peptic peptides. Prior to the HDX experiments, PD1 (25 M) and the Nivo 
Fab (50 M) were incubated for 1 h to allow complex formation. HDX was conducted on an 
HDX PAL robot (LEAP Technologies, Carrboro, NC), in which 5 L of protein was diluted into 
55 L D2O buffer (10 mM phosphate buffer, D2O, pD 7.0) to initiate HDX. Different aliquots 
were submitted to HDX for several times: 0.33, 1.0, 10, and 240 min. The reaction mixture was 
then quenched by adding quenching buffer (4 M GdnCl and 0.4 M TCEP, pH 2.5, 1:1, v/v), and 
50 µL of quenched sample was injected into a Waters nanoACQUITY UPLC HDX ManagerTM 
system. The deuterated mixture was then digested online by using the same pepsin column at 20 
C for 3 min, and the resultant peptides were desalted with an ACQUITY UPLC BEH C18 
VanGuard column (130 Å, 1.7 m, 2.1 mm  5 mm) with 0.1% formic acid in water at 100 
L/min for 3 min. The eluted peptides were further separated on a trap column (ACQUITY 
UPLC BEH C18, 130 Å, 1.7 m, 1.0 mm  50 mm), under a 7.5 min gradient: 8-85% 
acetonitrile in water with 0.1% formic acid at 65 L/min. Peptides were introduced to a Waters 
Synapt G2si Q-TOF (Waters, MA) mass spectrometer for mass analysis. The instrument settings 
were capillary 3.5 kV; sampling cone 35 V; source temperature 80 C; desolvation temperature 
180 C; and m/z range 260-2000.  
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In the HDX-ETD experiments, 1,3-dicyanobenzene was utilized as the electron carrier for gas-
phase fragmentation of selected peptic peptide by using an isolation window of 6 (± 3 Da). The 
corresponding instrument settings were sampling cone: 20 V; isolation window: ± 3 Da. 
Experiments were all performed as biological triplicates. 
5.3.2 HDX Data Analysis 
Peptic peptides were identified through a combination of exact mass analysis and MSE by using 
ProteinLynx Global Server 3.0.2 (Waters Corp., Milford, MA, USA). Both peptide-level and 
residue-level (ETD experiments) deuterium uptakes were calculated by using Waters DynamX 
3.0TM software. Deuterium uptake differences were calculated from the centroid of the isotopic 
pattern of the deuterated and non-deuterated peptides ions.  
5.3.3 Chemical Crosslinking 
PD1 (15 M, Bristol-Myers Squibb, NY, NY) and 30 M Nivolumab Fab (Bristol-Myers 
Squibb, NY, NY) were incubated at room temperature for 40 min prior to initiating the 
crosslinking reactions. For a buffer, 10 mM PBS (7 mM KCl, 137 mM NaCl, pH = 7.4) was used 
for NHS-ester cross-linkers, and 50 mM MES buffer (15 mM KCl, pH = 6.5) for EDC 
crosslinking. For the BS3-h12/d12 (bis(sulfosuccinimidyl) suberate) (Creative Molecules, Canada) 
and BS2G-d0/d4 (bis(sulfosuccinimidyl) 2,2,4,4-glutarate-d0/d4) (Thermo Fisher Scientific, 
Carlsbad, CA) crosslinking experiments, fresh BS3-h12/d12 or BS
2G-d0/d4 solution were added to 
the protein mixture to a concentration of 0.75 mM, 1.5 mM and 3 mM, respectively. The solution 
was incubated at 25 °C with spinning at 500 rpm for 45 min. Tris-HCl (1 L of 1 M, pH = 7.4) 
was used to quench the crosslinking reaction after a 15-min incubation. For the EDC (Thermo 
Fisher Scientific, Carlsbad, CA) crosslinking, EDC and sulfo-NHS (N-hydroxysulfosuccinimide 
sodium salt, Millipore Sigma, St. Louis, MO) were dissolved at a 1:1 molar ratio in 200 mM 
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MES buffer just before mixing with the protein solution. The reaction was run at 25 °C for 45 
min. The EDC/sulfo-NHS concentrations were 5, 10, and 30 mM for different trials. Tris-HCl 
was added to a final concentration of 200 mM and incubated for 15 min to terminate the 
crosslinking chemistry.  
5.3.4 Gel Electrophoresis 
Bis-tris-Precast gels (4-12% SurePAGE) and MES running buffer were purchased from 
GenScript (Piscataway, NJ). Colloidal Blue Staining kit and the protein marker were from 
Thermo Fisher Scientific (Carlsbad, CA). For each gel band, approximately 100-200 pmol of 
each protein was obtained and loaded. The operating voltage was 200 V for 35 mins.     
5.3.5 Enzymatic in-solution Digestion 
A Zeba column (Thermo Fisher Scientific, Carlsbad, CA) was used to remove access 
crosslinking reagents. After desalting, a final concentration of 0.25% (w/v) RapiGest (Waters, 
Milford, MA) was constituted in the reaction mixture and incubated at 80 °C for 30 min for 
denaturation. The reduction and alkylation of disulfide bonds were conducted with 7.5 mM DTT 
at 55 °C for 30 min and 14 mM IAM (Millipore Sigma, St. Louis, MO) in the dark for 30 min. 
Trypsin (Promega, Madison, WI) digestion (10:1), together with PNGase F (glycerol-free) 
(BioLabs, Ipswich, MA), was performed at 37 °C for 2h, followed by additional chymotrypsin 
(Promega, Madison, WI) digestion for 4 h to get the best coverage. The peptide mixture so 
generated was treated with C18 NuTip, the solvent evaporated, and the protein reconstituted in 
0.1% formic acid after vacuum.  
5.3.6 LC-MS/MS Analysis 
The digested peptides were desalted with a C18 reversed-phase column (Acclaim PepMap C18, 
100 µm x 2 cm, 5 µm, 100 Å; Thermo Fisher Scientific, Carlsbad, CA) for 10 mins at 4 L/min. 
157 
 
The resulting peptides were separated on a custom-packed C18 column (Magic Beads, 100 µm x 
180 mm, 5 µm, 120 Å; Michrom Bioresources, Auburn, CA) mounted on the Ultimate 3000 
Rapid Separation system (Dionex). The HPLC solvent consists of phase A (0.1% formic acid in 
water) and phase B (0.1% formic acid in 80% acetonitrile). The flowrate was operated at 400 
nL/min with a 120-min gradient (2.5% B to 12% B in 30 min, increased to 60% B for 65 min, 
ramped to 85% B in 5 min, kept at 85% B for 5 min, returned to 2.5% B in 5 min, and 
equilibrated at 2.5% B for 10 min). A Thermo Q Exactive Plus orbitrap mass spectrometer was 
used for LC/MS/MS analysis of the digested, cross-linked sample. For isotopic-encoded 
crosslinking runs, the data-independent mode was set for per charge state with the associated 
mass tag.  
5.3.7 Identification of Cross-links 
LC-MS/MS files were submitted to pLink 39-40 (ver. 2.3.1, Institute of Computing Technology, 
Chinese Academy of Sciences, Beijing, China) for cross-link identification. Search parameters 
were: enzyme: trypsin/chymotrypsin; missed cleavage: 3; precursor tolerance: 10 ppm; fragment 
tolerance: 30 ppm; variable modification: oxidation of M, deamidation of N, Q and the N-
terminus; fixed modification: carbamidomethyl of C; minimal peptide length: 6 aa; maximal 
peptide length: 60 aa; minimal peptide MW: 600 Da; maximal peptide mass: 6000 Da. The false 
discovery rate was 5% with 10 ppm MS1 filter tolerance. Isotopic doublets in the mass spectrum 
was searched and confirmed in the raw file. MS/MS peak assignments were further validated 
manually on the basis of the product ion mass list.  
5.3.8 Molecular Docking with Cross-link Derived Restraints 
The Rosetta (v. 3.8) 41-43 docking_protocol (RosettaDock) program 44-45 running on multi-
processor Linux servers was used for the protein-protein docking. Protein models for PD1 and 
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Nivolumab Fab were obtained from the X-ray structure of the PD1/Nivolumab Fab complex 
(PDB ID: 5WT9) 37. Coordinates for the Nivolumab Fab chains H and L and PD1 were extracted 
from the PDB file of the complex, written out as two separate PDB formatted files (Nivolumab 
Fab and PD1) and then prepared for docking in a two-stage process.  First, residue atoms that 
were not present in the PDB files and hydrogen atoms were added, and non-protein residues 
were removed with the Rosetta score_jd2 program. Subsequently, energy minimization of the 
structures output by score_jd2 within the context of the Rosetta energy model was performed 
with the Rosetta relax program.  Sets of 10 models were generated for each structure by using the 
“constrain_relax_to_start_coords” and “coord_constrain_sidechains” options to limit structural 
changes, and the model of each protein with the lowest Rosetta total energy score was selected 
for protein-protein docking. 
The processed PD1 and Nivolumab Fab models were imported into Maestro, 46 and the PD1 
model was manually displaced and rotated arbitrarily relative to the Nivolumab Fab. Both 
protein models were merged into a single, three-chain model that was exported to a PDB format 
file for the protein-protein docking computations. 
Docking exercises were performed with the RosettaDock program using eight distance restraints 
derived from the PD1/Nivolumab Fab chemical cross-links listed in Table 1. The distance 
restraints were implemented as flat-bottomed harmonic potentials that penalized models where 
the Cα-Cα distance(s) for crosslinked residues fell outside of the ranges of 6 – 16 Å47 and 9 – 30 
Å48 for the EDC  and BS2G or BS3 crosslinks, respectively. For the restrained docking study, 250 
runs were performed, each yielding up to 400 models for a maximum of 100,000 models. For 
comparison purposes, 250 docking runs, each yielding 400 models (100,000 total) were also 
carried out without restraints. Following completion of the docking calculations, the 100 models 
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from the restrained docking exercise with the most favorable values of the RosettaDock 
total_score were identified and used to generate Figure 6. The best scoring 100 models from the 
non-restrained docking exercise were also identified and compared to the X-ray structure of the 
PD1/Nivolumab Fab complex. A Python/OEChem49 script was used to determine the Cα atom-
based r.m.s.d. for PD1 in each clustered model relative to the X-ray crystal structure of the 
PD1/Nivolumab Fab complex (PDB ID: 5WT9) and to analyze models of PD1 docked to 
Nivolumab Fab. 
5.4 Results and Discussion 
5.4.1 Epitope and Paratope Mapping by HDX  
To map the epitope on PD-1, we performed HDX experiments with unbound PD-1 and PD-1 
bound to the antigen-binding fragment of Nivolumab (Nivo Fab) at a molar ratio of 1:2. 
Deuterium uptake was monitored at 0.33, 1.0, 10, and 240 min on 19 unique peptides, covering 
85% of PD-1 sequence. Information on 15% of the sequence was lost likely because the antigen 
contains complex N-linked glycans at those sites that hamper peptide chromatography and 
identification. Accumulative deuterium uptake differences across the four time points were 
calculated (Figure 5.1A), revealing three regions that undergo protection: 
25LDSPDRPWNPPTFSPALL42, 80AAFPEDRSQPGQDCRF95 and 125AISLAPKAQIKESL138. 
Specifically, regions 125AISLAPKAQIKESL138, located on the FG-loop of the PD-1 structure 
(Figure 5.1B), and 25LDSPDRPWNPPTFSPALL42, part of the N-loop (Figure 5.1B), exhibit the 
most significant decrease in HDX upon binding to Nivo Fab with protection corresponding to 
decreases of 7 and 4 Da, respectively. Region 80AAFPEDRSQPGQDCRF95 containing the C’D-
loop (Figure 5.1B) showed less protection corresponding to a decrease of approximately 2 Da. 
The deuterium uptake differences were similar across all time periods for the three regions 
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(Figure 5.1C), suggesting stable solvent protection, strong bonding, and associated small off 
rates in the equilibrium.  
 
Figure 5.1 Epitope regions on PD-1 indicated by HDX. (A) Differential HDX kinetics plots of 
PD-1 and PD-1/Nivolumab Fab complex. (B) Epitope regions mapped onto the PD-1 crystal 
structure (PDB: 3RRQ). (C) HDX kinetics of three peptides corresponding to the epitope regions 
in PD-1. Unbound PD-1 is colored in black and bound PD-1/Nivolumab Fab is colored in 
burgundy. The green shaded region is the propagated error across all time points. HDX kinetics 




Figure 5.2 HDX kinetic plots of other peptides in PD-1. Unbound PD-1 is colored in blue and 
bound PD-1/Nivo Fab is colored in green. 
We also performed HDX experiments with PD-1 and full-length Nivolumab (Nivo mAb) for 
comparison (Figure 5.3). One of the peptides, 132KAQIKESLRA ELRVTE147, was not found in 
PD-1-Nivo mAb complexes, possibly due to the larger number of peptides when using the full 
Nivo mAb. The larger number of peptides from full-length mAb hampers the acquisition and 
identification of PD-1 peptides in the fast chromatography used in HDX. The other peptide 
regions, on the other hand, showed consistent and similar trends regarding the deuterium uptake 
differences for bound and unbound states, indicating comparable binding behaviors between the 




Figure 5.3 Differential HDX kinetics plots of PD-1 and PD-1/Nivo mAb complex. 
To map the paratope on Nivolumab, we conducted a series of similar HDX experiments. Non-
bound and bound Nivo Fab (PD-1: Nivo Fab at a molar ratio of 2:1) were exchanged with 
deuterated buffer from 0.33 min to 4 h. The accumulative deuterium uptake differences between 
the two states confirm the involvement of the CDR regions in PD-1 binding (Figure 5.4). Peptide 
regions covering CDR-H2 on the heavy chain (Figure 5.4A) and CDR-L3 on the light chain 
(Figure 5.4B) showed the greatest protection, corresponding to more than 8 Da and a constant 
difference of HDX as a function of time (Figure 5.4C). Peptides covering CDR-H1, CDR-H3 
and CDR-L2 showed smaller changes in HDX upon binding (~ 6 Da for the first and ~ 3 Da for 
the latter two). The HDX of peptides covering 33SSYLAWYQQKPGQA46 exhibited only 1 Da 
deuterium uptake difference across all HDX time points, and the difference mainly occurred at 
the longer HDX time (Figure 5.4C). Given that this region only partially overlaps with CDR-L1, 
27RASQSVSSYLA37, few amino acids in this region are involved in PD-1 binding, resulting in 
small differences in HDX. The HDX paratope of Nivolumab, in general, is in accord with what 




Figure 5.4 Paratope regions on Nivo Fab as determined by HDX. Differential HDX kinetics 
plots of Nivo Fab vs. PD-1/Nivo Fab complex for (A) heavy chain and (B) light chain, 
respectively. (C) HDX kinetics of the peptides in the corresponding paratope regions in Nivo Fab 
(unbound PD-1 is colored in black and bound PD-1/Nivo Fab is in burgundy. The green shaded 
region is the propagated error across all time points. HDX kinetics plots of the other peptides are 







Figure 5.5A HDX kinetic plots of the peptides on the heavy chain of Nivo Fab. Unbound state is 




Figure 5.5B HDX kinetic plots of the peptides on the light chain of Nivo Fab. Unbound state is 
colored in blue and bound PD-1/Nivo Fab is colored in green. 
167 
 
5.4.2 Epitope Refinement by HDX-ETD 
Epitope identification by HDX is limited by the size of peptic peptides and by overlapping 
peptides, providing only regional information. To increase the spatial resolution, we coupled 
ETD fragmentation with HDX-MS to refine further the protected regions. To set up the ETD 
measurements, we used a previously published procedure11 to measure the extent of H/D 
scrambling of a synthetic peptide, HHHHHHIIKIIK, under several conditions and selected those 
that show minimal scrambling. In addition, the bound-state PD-1 was achieved with Nivo Fab to 
produce fewer peptides, lower complexity in the separation step of HDX than that with full-
length Nivo mAb, and increased the signal-to-noise ratios for peptide peaks. The incubation time 
for deuterium labeling was controlled as 1 min, a time point that gives distinct differences in the 
peptide-level HDX.  
We submitted to ETD the three peptides (Figure 5.1C) that cover the epitope regions identified 
by the HDX kinetics. Not all the peptides could be successfully resolved owing to their nature 
(e.g., residue composition) and to incomplete fragmentation of the peptide at their available 
charge states. For example, the doubly charged peptide 25LDSPDRPWNPPTFSPALL42, part of 
the N-loop, suffers from multiple proline residues in the sequence, showing a limited number of 
product ions. The peptide 80AAFPEDRSQPGQDCRF95 containing the C’D loop has only a 
moderate difference in HDX between bound and unbound (~ 0.5 Da at 1 min), and that makes it 
difficult to measure differences in HDX given the large size of the peptide (16 residues) and the 
experimental error associated with HDX-ETD. On the other hand, a triply charged peptide 
125AISLAPKAQIKESL138, located on the FG-loop, successfully produced a series of C fragment 




Figure 5.6 Cumulative deuterium uptake plot for C-type ions of 125AISLAPKAQIKESL138 in 
PD-1 and PD-1/Nivo Fab complex by HDX-ETD. Deuterium uptake differences are calculated 
and labeled for each C-ion. The potential binding residues are indicated with arrows and colored 
in red. 
We plotted the cumulative deuterium uptake for all C-ions and calculated the deuterium uptake 
difference for each ion between the bound and unbound states of PD-1 (Figure 5.6: note that the 
deuterium uptake of each Cn-ion represents that occurring on the n + 1 residue). The absence of 
C1 and C2 ions is likely an undesirable consequence of the ionization condition optimization in 
which we balanced the intensity of the fragment ions and the extent of deuterium scrambling. 
The deuterium uptake measured on the C3 ion was reduced (~ 0.8 Da) upon complex formation. 
Given that deuterons on the first two residues are almost always lost owing to back exchange50 
and the C2 ion was not resolved in the experiment, protection of residue 
127S or 128L or both 
could account for the observed decrease in deuterium uptake on C3. Further increases in HDX 
protection were observed at C6, showing 1.6 Da reduction in the PD-1/Nivo Fab complex 
compared to the unbound PD-1; the considerable drop in deuterium uptake pinpoints the 
protected residue 131K, given the HDX-silent 130P and the similar deuterium uptake difference of 
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C4 comparing to that of C3. In addition, the C7 ion exhibits additional HDX protection, increasing 
from 1.6 at C6 to ~ 2.3 Da. The HDX for C9 shows an additional uptake in protection as at C7, 
suggesting protection on residues 134I and 132A, respectively, upon binding to the Nivo Fab. 
Other Cn fragments showed insignificant differences between the two states compared to the 
adjoining Cn-1 ions. In summary, HDX-ETD allows epitope refinement to 
127S and/or 128L, 131K, 
132A and 134I in the region 125AISLAPKAQIKESL138. 
Although HDX-ETD successfully reveals several epitope binding residues, it can be challenging 
to differentiate HDX protection induced by direct binding or by a remote conformational change 
induced by binding. Additional information that shows the interacting domains is desirable, and 
that prompts our subsequent investigation with complementing chemical crosslinking.  
5.4.3 Chemical Crosslinking of PD-1 and Nivolumab Fab  
To achieve better coverage and more comprehensive information of the epitope and paratope 
regions provided by HDX, we utilized several cross-linkers, including BS3-H12/D12 and BS
2G-
H4/D4, different in spacer lengths, and EDC/NHS targeting glutamic (D) and aspartic acids (E), 
complementary to the usual NHS-ester reactive residues (e.g., lysine (K), serine (S), tyrosine (Y) 
and the N-terminus). We tested several concentrations of cross-linkers with respect to those of 
the proteins and could monitor the success of crosslinking by the band of PD-1/Nivo Fab on an 
SDS PAGE gel (Figure 5.7). Individual cross-linked samples were digested in solution followed 
by LC-MS/MS analysis and crosslinking identification with pLink 39-40. In total, we identified 
eight distinct inter-molecular cross-links (Table 5.1; representative mass and product-ion 
(MS/MS) spectra are shown in Figure 5.8) located on different regions of PD-1 and the Nivo 




Figure 5.7 Gel electrophoresis of PD-1/Nivo Fab. PD-1 and Nivo Fab cross-linked with (A) BS3 
at the concentration of 0.75 mM (50:1), 1.5 mM (100:1) and 3 mM (200:1), cross-linked with (B) 
BS2G at 1.5 mM (100:1) and 3 mM (200:1) and cross-linked with EDC at 5 mM, 10 mM and 30 
mM. The first two electrophoresis lanes are control runs. Different species are identified on the 
lane correspondingly. 
Table 5.1. Summary of observed inter cross-links 
    PD-1 Nivo Fab Cross-linker Epitope Paratope 
1 S27 – K57(H) BS2G /BS3 
N-Loop 
CDR-H2 
2 D26 – K57(H) EDC 
3 S27 – Y35(L) BS3 CDR-L1 
4 S62– N-term (H) BS3 
BC-Loop N-terminus (H) 
5 E61 – N-term (H) EDC 
6 K135 – K57(H) BS3 
FG-Loop 
CDR-H2 
7 K135 – Y35(L) BS3 CDR-L1 




Figure 5.8 Representative mass spectra and product-ion spectra (XL-8) 
For PD-1, multiple cross-links were formed on the N-loop (cross-link 1-3) and the FG-loop 
(cross-link 6-8), two regions that also showed significant protection in the HDX kinetics, 
consistent with the assignment as epitope regions. XL-MS results not only complement those of 
HDX but also reveal an additional binding region on PD-1, the BC-loop, identified by cross-links 
4-5 by both BS3 and EDC chemistry. It is worth mentioning that, for EDC crosslinking, the 
Euclidean distance between the cross-linked atoms is only ~ 3 Å, the length of one amide bond. 
Thus, this XL reagent locates and defines the binding interfaces with higher spatial resolution 
than do other reagents.  Cross-link 5 emphasizes the vicinity of the BC-loop to the N-terminus of 
the heavy chain on Nivo Fab, indicating physical contacts between the epitope and paratope.   
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On the other hand, we observed no cross-links on the C’D-loop, and this could result from the 
lack of reactive residues or may indicate that it is not a binding interface. Although the sequence 
of C’D-loop contains several eligible residues for crosslinking (e.g., D and S), their side chains 
may orient in an unfavorable way for crosslinking. Because the C’D-loop region showed only 
low extent in the accumulative deuterium uptake in HDX upon binding with Nivo Fab, we 
suggest this is not a binding region that involves strong interactions. Binding-induced remote 
conformational changes more likely account for the reduced HDX upon binding.  
On the heavy chain of the Nivo Fab, we observed three cross-links involving 57K (i.e., cross-
links 1, 2 and 6) located in the CDR-H2 region identified from the HDX kinetics. This region, 
based on the supporting evidence from both HDX and XL-MS, is confidently assigned to be a 
paratope. A newly revealed paratope region is the N-terminus of the heavy chain, which affords 
multiple cross-links not only with the BC-loop of PD-1 but also with the FG-loop. On the light 
chain of Nivo Fab, we observed only one cross-linked residue, 35Y, on the CDR-L1 peptide. The 
identified cross-links (i.e., 3 and 7) support the CDR-L1 region as a binding interface with PD-1. 
For the four other CDR regions, we identified no cross-links, showing the limitations of using 
stand-alone XL-MS for mapping. Restricted numbers of reactive residues, considering both the 
intrinsic and low reactivity, side-chain orientation, and complexity of the cross-linked species 
diminish the possibility of using XL alone to characterize epitope/paratope interfaces. A more 
confident assignment than either approach alone is integrating HDX and XL-MS, which is 
validated by a comparison of our MS results and the resolved X-ray crystal structure in the next 
section. 
5.4.4 Epitopes/Paratopes and Comparison with X-ray Crystallography 
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We conducted HDX to map the epitope and paratope on the peptide-level of PD-1 with both 
Nivo Fab and full-length Nivolumab, showing consistent results and indicating comparable 
binding behavior. The residue-level analysis was therefore performed with PD-1/Nivo Fab using 
HDX-ETD and crosslinking MS.  
 
Figure 5.9 Summary of binding regions identified by HDX (blue) and XL-MS (red) for (A) the 
PD-1 and the Nivo Fab complex including (B) heavy chain and (C) light chain. Critical binding 
residues indicated by HDX-ETD are pinpointed with triangles. Epitope/paratopes assigned from 
the crystal structure (PDB: 5WT9) are underlined in grey. 
The results from HDX suggest three epitope regions on PD-1, namely the N-loop, the FG-loop 
and the C’D-loop, whereas XL-MS supported the former two and revealed an additional BC-loop 
(Figure 5.9). A lack of cross-links and a small HDX difference between bound and unbound 
make the C’D-loop less likely to be a binding interface but rather a region undergoing a remote 
conformational change induced by binding elsewhere. These conclusions agree well with the 
reported epitope regions in the crystal structure of PD-1/Nivo Fab (PDB: 5WT9)37-38, where the 
N-loop, BC-loop and FG-loop are identified as epitopes. The C’D loop, however, is not resolved 
and there are no observed physical contacts between the antigen and any paratope regions. The 
integrated information from HDX and XL-MS also provide insight on the epitopes/paratopes, in 
good accord with those indicated in the crystal structure. For example, a resolved H-bond 
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between 25L on the N-loop of PD-1 and 57K on the Fab heavy chain is consistent with two cross-
links (cross-link 1 and 2, Table 5.1) to nearby reactive residues, 26D and 27S. In addition, the 
stabilization between the N-loop and CDR-L1 is consistent with cross-link 3 and with H-bonding 
between 26D on PD-1 and 
35Y on the Fab light chain. HDX coupled with ETD fragmentation 
further reveal the binding residues in the FG-Loop, three of which, 128L, 131K and 132A, contact 
with the Nivo Fab through H-bonding and van der Waals interactions. Assignment of this 
epitope region is also supported by cross-link 7, resembling the H-bond between 131K on PD-1 
and 37A on the Fab light chain. Additionally, we observed that the FG-loop can cross-link with 
other domains through 135K; those cross-links include the CDR-H2 (cross-link 6) and the N-
terminus of the heavy Fab (cross-link 8). The N-terminus also cross-linked with 61E and 62S on 
the BC-loop of PD-1 (cross-links 4 and 5), suggesting a paratope region that is not seen in the 
solid-state structure.  
In addition, the crosslinking network for the epitopes/paratopes delivers topological information 
of the PD-1/Nivo Fab complex by providing defined distance ranges. This allows a description 
of the interaction regions and even of the overall architecture when the information is coupled 
with other approaches (e.g., protein-protein docking). The 3D-information of the binding 
complex can provide a foundation for even more accurate determinations of the 
epitope/paratope. 
5.4.5 Protein-Protein Docking of PD-1 and Nivolumab Fab  
We conducted a protein-protein docking study with the RosettaDock program44-45 by starting 
with the structures of PD-1 and the Nivo Fab extracted from the X-ray structure of the complex 
(PDB: 5WT9)37. Docking of apo Nivolumab and PD-1 was not feasible because many critical 
residues in apo-PD-1 are not resolved. For each docking run, we separated the two proteins with 
175 
 
the same intial configuration, followed by rotation to arbitrary extents (details in Methods). In 
Chapter 451, we demonstrated that incorporation of multiple cross-link-derived restraints in the 
protein-protein docking computations can effectively yield high-quality models; thus, the 
restraints based on all eight of the identified cross-links (Table 5.1) were utilized here. We 
generated 250 RosettaDock docking runs, each of which gave up to 400 PD-1/Nivo Fab models. 
The 20 best-scoring models based on the RosettaDock “total_score” metric revealed a tight 
cluster of models, all of which closely recapitulated the X-ray structure of the PD-1/Nivo Fab 
complex (Figure 5.10A). For these 20 models, the root-mean-square deviation (r.m.s.d.) of all Cα 
atoms for PD-1 in the models relative to PD-1 in the X-ray structure ranged from 0.4 – 1.8 Å 
with a mean of 1.0 ± 0.4 Å, which is less than 2 Å, a threshold that often is used to define a high-
confidence model. The successful generation of the complex architecture showing the 
protein/protein interface enables an in-depth view of the potential epitopes/paratopes. 
 
Figure 5.10 Docking models of PD-1/Nivo Fab complex. (A) Twenty best-scoring protein-
protein docking models of PD-1/Nivo Fab complex (PD-1 in cyan, the heavy chain of the Nivo 
Fab in dark pink, the light chain of the Nivo Fab in light pink), superimposed on the X-ray 
structure (red). (B) A representative model of PD-1/Nivo Fab complex with an enlarged view of 
the epitopes/paratopes (BC-loop in magenta, C’D-loop in black, N-terminus of Nivo Fab heavy 
chain in marine, CDR-H1 in purple). 
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We chose a representative model and enlarged the binding interface between PD-1 and Nivo Fab 
(Figure 5.10B). The BC-loop of PD-1 locates at similar proximity with CDR-H1 and the N-
terminal region of heavy Fab, indicating that the two regions may contribute simultaneously to 
the binding interaction. The conformation is consistent with the N-terminal region being a 
paratope. The X-ray structure suggested the BC-loop is in physical contacts with CDR-H1, 
whereas we identified cross-links on the N-terminus of the heavy chain, complementing the 
scheme and emphasizing the necessity of examing binding events using solution-based 
approaches. In addition, another questionable region, the C’D-loop on PD-1, is far from the 
binding interfaces, minimizing the likelihood of being an epitope. Moreover, unlike it is resolved 
in the unbound PD-1, the C’D-loop is missing in the bound PD-1 complex, giving supporting 
evidence of undergoing considerable remote conformational changes companied with different 
structural dynamics. The quaternary structure of the PD-1/Nivo Fab complex enables more 
confident assignment of the epitope/paratope regions. 
There are limitations, however, in generalizing the integrated method that includes XL-MS and 
molecular docking to other protein-binding systems. One obstacle we encountered in the docking 
study of the PD-1/Nivo Fab complex is the dissimilar structures of PD-1 in its unbound state 
(PDB: 3RRQ) and bound state (PDB:5WT9). Epitopes on PD-1 are mainly loops, some of which 
cannot be resolved in the X-ray structure owing to their high flexibility in absence of bonding to 
the Nivo Fab (e.g., the N-loop). Consequently, distance constraints derived from the residues 
within this region are of little use for downstream docking. More importantly, for loops that are 
resolved, the orientation may be significantly different than those in the bound state. The 
conformations of dynamic loop regions are susceptible to the presence of mutations and/or 
truncations and to crystallization conditions including and ionic strength of the medium; these 
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can lead to incorrect conformations for the solid-state structure. Given that the docking protocol 
does not readily accommodate changes in protein tertiary structure, biased initial structures could 
lead to erroneous 3D models of the binding complex. Incorporation of other computational 
methods (e.g., discrete molecular simulation) can better accommodate the structural changes. In 
fact, binding interfaces that mainly contain helices and beta-sheets, which possess relatively 
fixed high order structures, are preferable inputs for docking studies.  
5.5 Conclusion  
This study provides convincing evidence that epitope and paratope mapping by HDX, 
crosslinking, and docking can be effective. Although HDX-MS, as a stand-alone method, has 
shown fruitful applications in mapping binding interfaces, it can be circumscribed by the limited 
resolution and ambiguous assignment as epitope or remote conformational change. Using PD-
1/Nivo Fab as an example, we demonstrated that integrating HDX-ETD, XL-MS, and molecular 
docking gives a comprehensive description of epitopes/paratopes. Critical binding residues can 
be successfully identified from HDX-ETD and chemical crosslinking results, further delineating 
H-bonds and van der waals interactions along a protein/protein interface. In addition, XL-MS 
confirms epitopes/paratopes characterized by HDX-ETD and allows assignment of sites showing 
protection as remote conformational changes. The restrained distances afforded by XL-MS allow 
building high-confidence 3D models with molecular docking. The integrated platform magnifies 
the ability of each biophysical method, offering an alternative for other antigen/antibody systems 
that are difficult to crystallize for X-ray diffraction. It is noteworthy that docking exercises 
require careful consideration even with the availability of high-quality protein structures, which 
could be obtained by high-resolution techniques or computational methods. Whereas, even 
without molecular docking, the combination of HDX-ETD and XL-MS, the latter which is not 
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often used in epitope/paratope mapping experiments, gives insightful information to deepen our 
understanding of antigen-antibody binding and to assist the design of antibody therapeutics.  
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In cyanobacteria and red algae, the structural basis dictating efficient excitation energy transfer 
from the phycobilisome (PBS) antenna complex to the reaction centers (RCs) remains unclear. 
PBS has several peripheral rods and a central core that binds to the thylakoid membrane, 
allowing energy coupling with Photosystems II (PSII) and Photosystem I (PSI). Here, we 
integrated chemical cross-linking mass spectrometry with homology modeling analysis to 
propose a tri-cylindrical cyanobacterial PBS-core structure. Our model reveals a side view 
crossover configuration of the two basal cylinders, consolidating the essential roles of the 
anchoring domains comprised of the ApcE PB-loop and ApcD, which facilitate the energy 
transfer to PSII and PSI respectively. The uneven bottom surface of the PBS-core contrasts with 
the flat reducing side of PSII. The extra space between two basal cylinders of the PBS-core and 
PSII provides increased accessibility of regulatory elements, e.g., orange carotenoid protein, 
which are required for modulating photochemical activities.     
6.2 Introduction  
In natural photosynthesis, light-harvesting complexes capture and transmit solar energy to the 
reaction centers (RCs) where photochemistry takes place, leading to long-term energy storage 1-2. 
In cyanobacteria and red-algae,  phycobilisomes (PBSs) harvest the energy of a spectral range 
between 450 and 650 nm, which is different than that of Chl a (chlorophyll a) in the RCs: i.e., 
photosystem I (PSI) and photosystem II (PSII), and significantly increase the utilization of the 
solar energy spectrum 3. Phycobilisomes, with a molecular mass range of 5-20 MDa, are located 
on the cytoplasmic side (or the stromal side of the red algal chloroplasts) of RCs. PBSs are 
highly organized assemblies of brightly colored phycobiliproteins and colorless linker 
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polypeptides 4. Each phycobilisome consists of a central cylindrical core made of 
allophycocyanin, from which several outwardly oriented rods radiate. Light energy collected by 
phycobiliproteins in the peripheral rods is transferred to PSI and PSII, with the PBS-core 
allophycocyanin acting as a link between phycocyanin and the Chl a in RCs. The detailed 
structural orientation of the PBS and the RCs, however, remains to be determined, probably 
because of the structurally weak interactions of PBS and RCs, which could be advantageous for 
easy regulation of the excitation energy transfer under varying light conditions5-6. The PBS-core 
not only serves as a cornerstone for the rods to attach 7-8, but also acts as an anchoring module 
that dictates efficient energy flow from PBSs to RCs 9-13.  
The building blocks of the PBS-core are two homologous proteins, α- and β-phycocyanin 
subunits, which form a heterodimer, αβ, and further self-assemble into disc-like (αβ)3 trimers 
4. 
Several discs of allophycocyanin (ApcA/B) stack into a cylinder, varying in numbers in different 
organisms. The best-known PBS structure is described as hemidiscoidal PBS 7, 14. In this group, 
there are bi-cylinder type of PBS in  Synechococcus sp. PCC 6301 15 and penta-cylinder type in 
Mastigocladus laminosus as well 16. The core structure of Synechocystis sp. PCC 6803, however, 
is tri-cylindrical as determined in 1986 by electron microscopy (EM) 17, Later, advanced EM 
methodology yielded a high resolution structure at 13 Å using a genetically modified strain in 
Synechocystis 6803 (CK strain) 7 which contains an intact core complex but no PC rods. The EM 
structure reveals that this PBS-core consists of three stacked core cylinders: two on the bottom 
and one on the top. The 2D EM map further highlights a two-fold rotational symmetry of the 
triangular core, indicating that the two basal cylinders are arranged in an anti-parallel fashion. 
Although the overall architecture is resolved, a detailed molecular model showing the location of 
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each terminal energy emitter, ApcE, ApcD, and the tomography of the bottom surface of the 
PBS-core that directly interacts with the thylakoid membranes are not known.  
Recently, Zhang et al. significantly advanced the understanding of the PBS structure, 
specifically, in a red alga Griffithsia pacifica 18 by charactering a 16.8 MDa PBS (thus GpPBS) 
using cryo-EM at a resolution of 3.5 Å. GpPBS contains numerous protein subunits, linker 
proteins, and chromophores, revealing in great detail of the GpPBS architecture. GpPBS is 
morphologically categorized as a block-shaped type 18, likely an evolutionary derivative of  the 
core of hemidiscoidal PBS 18. The GpPBS core is characterized by two unique features: the lack 
of one trimeric ApcA/B disc at the distal end of ApcD in each basal cylinder (Fig. 6.1A) and thus 
a decreased copy number (by comparing to a four-APC-trimer cylinder) of ApcC 
(allophycocyanin C, formerly LC), a small polypeptide linker protein that stabilizes and caps the 
core cylinders 19. The top cylinder in GpPBS-core is featured by two APC trimers, instead of 
four, which are stacked back-to-back (or tail-to-tail).  Interestingly, part of the 2nd and 3rd linker 
domains of ApcE 18,  which is usually buried in the core of each cylinder 
3, are exposed and do 
not interact with the APC trimers. 
In this study, we build a 3D structure of cyanobacterial PBS-core (cPBS-core) starting with the 
available crystal structure of cyanobacterial allophycocyanin and the red algal PBS cryo-EM 
structure in combination with protein structure and function prediction software suites. The 
generated model represents a cyanobacterial tri-cylindrical core with two basal cylinders and one 
top cylinder, each of which contains four APC trimers. Other APC subunits, including ApcD, 
ApcE and ApcF, were all modelled to afford the core architecture. We also performed chemical 
cross-linking using three types of PBSs isolated from Synechocystis 6803, mapped the identified 
cross-links onto the proposed 3D model, a portrayal of the native cPBS-core, and calculated the 
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Euclidean Cα- Cα distances between each pair of the cross-linked residues. The proposed cPBS-
core was then justified and evaluated by the experimental distance restraints with respect to 
individual subunits. The described framework reveals a side view X-shape configuration of the 
two basal cylinders, which only allows the protrusion of the PB-loops on ApcE and ApcD 
interacting with the thylakoid membranes. The bottom surface of the PBS that touches the 
thylakoid membrane/RCs is not perfectly flat, in contrast to the flat surface of the reducing side 
of PSII. The increased accessibilities to the bottom surface of the PBS-core and the reducing side 
of PSII provide perspectives on the excitation energy regulation and reaction center 
photoprotection.  
6.3 Experimental 
6.3.1 Cyanobacteria Culture and PBS Purification  
The CK-PBS and CpcL-PBS mutant strains were generous gifts from Dr. Ghada Ajlani20-21. 
Cyanobacterial strains were grown in BG-11 medium at 30 C with 50 mol photo m-2. The 
growth media was supplemented with 20 mM TES (2-[(2-hydroxy-1,1-bis(hydroxymethyl) 
ethyl) amino] ethanesulfonic acid, N-[tris(hydroxymethyl)methyl]-2 aminoethanesulfonic acid)-
KOH (pH 7.5). The harvested cell cultures were resuspended in 0.8 M K-phosphate buffer and 
incubated with protease inhibitor cocktail (Thermo Fisher Scientific, Waltham, MA) and DNase 
(Sigma, St. Louis, MO). Cell lysates were obtained through three rounds of a French press at 4 
°C and pH 7.5. 2% Triton X-100 (Sigma, St. Louis, MO) was then added following by 30 min 
incubation at room temperature. The blue supernatant was loaded onto a sucrose gradient for 
overnight ultracentrifugation (370,000 × g). The purified PBS was then ready for cross-linking. 
6.3.2 Chemical Cross-linking and Proteolytic Digestion 
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CK-PBS, dissolved in 0.4 M K-phosphate buffer at 0.1 M, and the isotopic-coded BS3 cross-
linker mixture (BS3-H12/D12, Creative Molecule, Inc) were incubated together for 10 mins in the 
dark at 25 C, where the cross-linker was in 10-, 50-, 100-fold excess with respect to the PBS-
CK. Tris (1M) was added to give a final concentration of 50 mM to stop the cross-linking 
chemistry. For quenching and desalting purposes, Zeba spin columns (Thermo Fisher Scientific, 
Waltham, MA) were employed following the manufacture’s protocol. The cross-linked CK-PBS 
were then desalted and purified by acetone precipitation to prepare them for enzymatic digestion. 
The protein pellets were dissolved in 20 l, 8M urea for 30 min at room temperature for 
denaturation, followed by 30-min incubation with 2.5 mM TCEP (tris(2-
carboxyethyl)phosphine) at 37 C. Iodoacetamide was then added to the reaction sample at a 
final concentration of 5 mM for 30 min at 25 C in dark. The first-step digestion was achieved by 
Lys-C (0.05 g/l) for 2-h incubation at 37 C. Dilution to 1M urea with Tris buffer (100 mM) 
was needed for the subsequent trypsin digestion, which required overnight incubation at 37 C 
with a trypsin:protein ratio of 1:25. The digested mixture was quenched by 0.1% formic acid the 
next day. 
6.3.3 LC-MS/MS 
The peptide mixture was loaded onto a C18 trapping column 180 μm × 2 cm, C18 Symmetry, 5 
μm, 100 Å, Waters, MA) for desalting with phase A (water with 0.1% formic acid) of Dionex 
Ultimate HPLC (Thermo Fisher Scientific, Waltham, MA). Peptide samples were then eluted 
and separated on a reverse-phase C18 column (100 μm × 15 cm, C18 Symmetry, 5 μm, 100 Å, 
Waters, MA) with a 105-min gradient: increasing phase B (80% acetonitrile, 20% water, 0.1% 
formic acid) from 2% to 40% for the first 90 mins, from 40% to 95% for next 10 mins and 
equilibrated at phase A for another 5 mins. The flow was controlled at 250 nL/min and sprayed 
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through a Nanospray Flex source coupled with a Q Exactive Plus mass spectrometer (Thermo 
Scientific, Waltham, MA). The mass spectrometer was operated at the following settings: 1.8 kV 
spray voltage; positive-ion mode; MS1 acquisition at 70,000 resolving power at m/z 200; AGC 
target 3106; MS/MS acquisition at 17,500 resolving power at m/z 200; AGC target: 1105; 
maximal injection time of 100 ms. Data dependent acquisition and with “mass tag” were utilized. 
In the latter method, for charge states of 2 to 7, the delta mass differences were set as ±6.03762, 
±4.02508, ±3.01881, ±2.41505, ±2.01254, and ±1.72503 m/z, respectively. Singly charged 
species were excluded and each charge state was acquired independently.  
6.3.4 Cross-linked Peptides Identification 
MS and MS/MS data were imported into pLink software for identification. Searching parameters 
were: enzyme was trypsin (up to three missed cleavages) with 20 ppm of precursor tolerance and 
60 ppm of fragment tolerance. Variable modifications were: oxidation of M, deamidation of N, 
Q, and N terminus. The minimum number of peptide length is 6 with peptide mass of 600 Da and 
maximum number is 60 with peptide mass of 6000 Da. The false discovery rate was equal to or 
smaller than 5% at spectral level with a 10-ppm filter tolerance. Isotopic pairs were examined 
manually in raw files to confirm cross-link identification. The theoretical product-ion mass list 
was calculated in Protein Prospector. Manually validation of the fragments was further 
performed as a comparison to the pLink assignment.  
The cross-linking dataset was also submitted into ICC-Class for cross-linking identification. In 
the DXMSMSMatch program, the settings were: cross-linker was DSS with DX of 12.07532. 
The DX mass tolerance was 0.013 Da, retention time tolerance was 60 s. The filtered DX mass 
tolerance was 5 ppm and the filter DX time window was 60 s. The digestion sites were K and R, 
including cross-link sites. Missed digest sites was up to 4. Assigned cross-link sites are K and N-
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terminal primary amines. Precursor tolerance was 5 ppm and fragment tolerance were 30 ppm. 
Manually validation of the fragments was carried out as the same way mentioned above. 
6.3.5 Homology Modeling and Structural Construction 
Homology simulation was performed on I-TASSER server. Detailed information and adopted 
template are described in homology modeling section.  
6.4 Results  
6.4.1 Homology Modeling and Construction of a Tri-Cylindrical 




Figure 6.1 Model construction of a tri-cylindrical cyanobacterial PBS-core. (A) Symbolic 
illustration of disc extension based on GpPBS-core structure (PDBID: 5Y6P) and cyanobacterial 
structure. GpApcA (salmon), GpApcB (cyan), GpApcE (lime), cApcA (c for cyanobacteria, light 
pink), cApcB (dark blue). (B) Detailed cartoon representation of disc extension based on 
GpPBS-core structure (PDBID: 5Y6P) and cyanobacterial structure. (C) Extension of the B1 disc 
in GpPBS-core using cApcA-ApcB hexamer (PDBID: 4F0U). (D) Determination of the cApcE-
LD3 structure based on the evaluation of five predicted cApcE-LD3 models (dark green), given 
by I-TASSER, with respect to the GpApcE-LD3 (lime). Other APC domains, i.e. cApcE-LD1 
(dark green), cApcE-LD2 (dark green), αLCM (dark green), cApcC (red), cApcD (yellow) and 
cApcF (grey), are constructed similarly. (E) The final core model of cPBS. All structure figures 
were prepared using PyMOL.  
We adopted the high-resolution GpPBS-core structure from red algae Griffithsia pacifica 
(PDBID: 5Y6P) 18 as a building chassis. Although the overall appearance of GpPBS is a block 
type PBS, it essentially retains the classical two fold symmetry with its symmetrical axis oriented 
perpendicularly to the thylakoid membranes 18, and importantly, is also considered to be 
evolutionally derived from a core of hemidiscoidal PBS-core by eliminations of the exterior APC 
disc (APC trimer) of all three cylinders.  This hypothesis is consistent with a hemidiscoidal 
model proposed in earlier reports 7. We are interested in building a tri-cylindrical cyanobacterial 
hemidiscoidal PBS core with four stacked APC trimers per cylinder. 
The cryo-EM structure of the GpPBS-core revealed several features: each basal cylinder contains 
three  GpApcA/B trimers, namely disc A1-3 and Aʹ1-3, and the top cylinder contains only two 
trimers with tail-to-tail orientation (three ApcBs in one disc to three ApcBs in another disc), i.e., 
disc B1 and B2 (Fig. 6.1A and 6.1B, left, for simplified and detailed cartoon representation, 
respectively). Each disc contains 3 copies of ApcA and ApcB. This structure is in contrast to that 
of a model in Synechocystis 6803 7, 11, which indicates that each core cylinder contains four 
discs, arranged in a face-to-face (three ApcAs in one disc to three ApcAs in another disc), tail-to-
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tail, and face-to-face fashion. Using homology modeling, we swapped all the GpPBS-core APC 
discs by using cyanobacterial APC (cApc) discs. Each cylinder was also extended up to four 
discs. First of all, a hexameric cyanobacterial APC (PDBID: 4F0U) was generated and used as a 
building unit. This hexamer contains two discs arranged in face-to-face. To extend the top 
cylinder, a cyanobacterial APC hexamer was adopted to align with the disc B1. The alignment of 
the B1 disc results in the replacement of the red algal counterpart and in an extension of one 
cyanobacterial APC trimer, i.e., the B0 disc (Fig. 6.1A and 6.1B, middle, for simplified and 
detailed cartoon representation, respectively). Similarly, the top cylinder was extended with the 
alignment of B2 disc by another hexameric APC (two discs, face-to-face), leading to an addition 
of disc B3 to make a total of four-disc top cylinder. The replacement and extension for the two 
bottom cylinders were performed on A1 and Aʹ1 discs, giving additional APC trimers as disc A0 
and Aʹ0. The remaining red algae A2/A3 and Aʹ2/Aʹ3 hexamers were further swapped with 
cyanobacterial APC hexametric units, contributing to a cPBS-core architecture with four 
cyanobacterial discs on each of the three cylinders (Fig. 6.1A and 6.1B, right, for simplified and 
detailed cartoon representation, respectively). The selection of cyanobacterial crystal structure 
(PDBID: 4F0U) took into account of its high resolution structure and high protein sequence 
homology with those of Synechocystis 6803 22, which was used in our following chemical cross-
linking studies. Extension of A0/Aʹ0 not only fulfills the face-to-face geometry in adjacent discs 
(A1 and Aʹ1 respectively) but also enables the 2nd linker domain ApcE-LD2/ApcE-LD2ʹ being 
buried inside the cylinder, as the ApcE-LD1/ApcE-LD1ʹ is concealed within disc A3/A2 and 
Aʹ3/Aʹ2 in two basal cylinders respectively 18. We demonstrated in detail the swapping and 
elongation of the B1 disc (GpPBS-core) as an example (Fig. 6.1C). A value of less than 1 Å 
RMSD (root-mean-square deviation) was obtained (Table S6.1), indicative of high structural 
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similarities of red algal ApcA/B trimer and the cyanobacterial ApcA/B trimer assembly. The 
protein sequence identities between the cyanobacteria and red alga indeed strongly support this 
conclusion (Fig. S6.1). The remaining GpApcA/B trimers in each basal cylinder that contain 
ApcD and ApcE were also substituted by cApcA/B hexamer with consistent low RMSD, 
contributing to a complete framework of a cPBS core (Fig. 6.1E). For other PBS-core 
components, such as ApcC, ApcD, ApcE, and ApcF, we either used the available crystal 
structure (ApcE, PDBID: 4XXI; ApcD, PDBID: 4PO5) 23 or predicted their structures by using 
protein sequence from Synechocystis 6803 on the Zhang Server 24 and then defined their 
positions by using homology modeling. Their copy numbers were based on the characteristic 
features of a tri-cylindrical cyanobacterial PBS 7. 
ApcE, also termed as Core-Membrane Linker or LCM 
25, is a multifunctional protein containing 
both phycocyanin binding domain, known as PB domain (or αLCM), and several linker domains 
that are essential for connecting APC trimers and thus for assembly of APC discs into cylinders. 
The αLCM is located in disc A2 and Aʹ2 in the red algal structure 18. It was proposed that ApcE 
linker domain also serves to stitch all the discs and subsequently cylinders together to form the 
PBS-core 7. The large cApcE protein in tri-cylindrical PBS in Synechocystis 6803 contains four 
domains, namely, αLCM (PB domain/ α domain in LCM, M
1-V240), cApcE-LD1 (D247-V427), 
cApcE-LD2 (I431-D684) and cApcE-LD3 (K685-G896) (Fig. S6.2), which were treated individually 
for structure prediction and modeling. For example, when the cApcE-LD3 peptide sequence was 
submitted to I-TASSER server 24, the homology-modeling algorithm screened through the 
database and adopted the GpApcE (PDBID: 5Y6P) and another two protein structures (PDBID: 
2KY4, DOI: 10.2210/pdb2ky4/pdb; 3OHW, DOI: 10.2210/pdb3OHW/pdb) among others as 
references, giving top five high-scoring models (Fig. 6.1D, M1-M5, Table S6.1). These models 
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resemble the overall configuration and helical content which are consistent with protein sequence 
identity (Fig. S6.2). Each generated model was then aligned with both GpApcE-LD3 domains in 
the top cylinders, evaluated in terms of RMSD for all corresponding alpha carbons (Table S6.1). 
The model 1 (M1) and M4 of cApcE-LD3 give two smallest RMSD values, showing major 
differences at the region K685- E703. This region in cApcE-LD3-M1 sticks towards the basal 
cylinders, while that of cApcE-LD3-M1 curls back to the top cylinder. Given the fact that 
cApcE-LD3 bundles basal and top cylinders together as a linker domain, it is believed that the 
region K685- E703 is more towards the bottom cylinders; this hypothesis is also supported by a 
recently resolved PBS from prophyridium purpureum 26. Therefore, we chose cApcE-LD3-M1 
as the representative model. We use both an I-TASSER generated model and the X-ray crystal 
structure of αLCM (PDBID: 4XXI) 27 in our modeling, since the former model contains the PB-
loop that allows model building of the PBS-core-PSII 13.    
Other cApcE linker domains, i.e., cApcE-LD1 and cApcE-LD2,) which are composed similarly 
with a Pfam00427 (PDBID: 2KY4, 2L06, 3OHW, released by Northeast Structural Genomics 
Consortium of America), and the αLCM were performed for homology modeling in a comparable 
fashion. Five generated top-scoring models for each domain were evaluated individually by 
structural alignment in terms of calculated RMSD (Table S6.1). We chose the models with the 
smallest RMSD value to give the best likelihood of being the most reasonable configuration, 
namely model 4 for αLCM, model 4 for cApcE-LD1, and model 4 for cApcE-LD2. cApcE-LD1 
and cApcE-LD2 are in the cavity of the basal rod-like protrusions between the A2/A3 (or 
A2/A3) and A0/A1 (or Aʹ0/Aʹ1) cApcA/B discs, respectively, stabilizing two basal cylinders. 
Two copies of αLCM situate at the A2 and Aʹ2 of the basal cylinders with a large loop (PB-loop) 
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from T77 to G135, extending towards the thylakoid membrane and anchoring the whole cPBS 
assembly to reactive centers 2, 7, 28-29.  
GpApcD, an APC α-like subunit that is required for energy delivery from PBS to PSI30, was 
substituted by a resolved structure of ApcD at 1.75 Å from a previous study (PDBID: 4PO5) 23. 
The two GpApcD subunits are located at the A3 and Aʹ3 discs in the basal cylinders, 
respectively, both of which are well-aligned with the cApcD and affording RMSD differences 
that are smaller than 0.65 Å (Table S6.1).  
After swapping ApcE and ApcD in the structure, we next performed homology modeling of 
cApcC, which belongs to the CpcD superfamily and upholds a cylinder in shape 19. The structure 
was based on an X-ray crystallographic study of a trimeric ApcC from Fischerella sp. PCC 6703 
(PDBID: 1B33) 19. The SPICKER program, an algorithm to discern near-native models from a 
pool of decoyed protein structures 31, converged the simulation and identified only one large 
cluster, indicating the high quality of the generated models. The alignment of cApcC onto 
GpApcC shows little differences in the RMSD value (Table S6.1), indicative of a good model. 
The copy numbers of ApcC, however, in the characterized GpPBS structure are two per PBS, 
surprisingly low probably because there is one missing trimeric disc (APC trimer) on each basal 
cylinder and two discs (APC trimers) missing on the top cylinder where the ApcC subunit 
usually binds 19. It has been accepted that in cyanobacteria each core cylinder has two ApcC 
proteins located at both ends 19. We substituted the existing GpApcC with cApcC in the 
cApcA/B trimer (note that GpApcA/B trimer has been swapped by cApcA/B trimer). The 
complex of cApcC/cApcA/B was then regarded as an independent object and aligned onto the 
end of each core cylinder, resulting in A0, Aʹ0, B3 and B0 discs containing cApcC.  
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ApcF, an APC β-like unit, affects state transitions and energy transfer through interactions with 
αLCM 32. cApcF is modelled at the same trimeric disc where the αLCM is located (A2 and Aʹ2) with 
replacement of the GpApcF. Thus, cApcF interacts with αLCM, cApcE-LD1, and potentially with 
the nearby pigment, αLCM phycocyanobilin 18, 32, to allow energy transmission to PSII 33. Only 
one model was generated and its RMSD value is less than 1 Å, indicative of an excellent 
modeling (Table S6.1). By combining the protein sequence analysis of two ApcFs from GpPBS 
and Synechocystis 6803, we noticed some minor differences in detail (Fig. S6.3): an indel 
(insertion/deletion) around 139-142 between two structures. In cyanobacteria, this region is 
comprised of four amino acid residues less than GpApcF. This indel is in a fragment of an α-
helix (G-H) in cyanobacterial ApcF. For the red algal PBS (PDBID: 5Y6P), ApcF has an 
extension at the tip of the G-H helix hairpin 18.  ApcF is considered to be an important factor that 
fine tunes the spectroscopic properties of the PCB in αLCM. We hypothesize that the combination 
of an indel and a fragment of an α-helix extension, instead of affecting the spectroscopic 
properties of αLCM, could more likely help each basal cylinder build up its polarity so that only a 
trimer (A1/Aʹ1, α3β3) can bind with a back-to-back configuration. In terms of the assembly of 
trimer A2/Aʹ2, we propose that the linker domain (i.e., ApcE-LD1) plays an important role to 
recruit ApcF to build (A2/Aʹ2) trimers and to exclude the joining of a β unit. Further biochemical 
and spectroscopic research on this region by using genetically tractable cyanobacteria may shed 
light on its function.  
6.4.2 Chemical Cross-linking and Strategy 
Chemical cross-linking coupled with mass spectrometry (MS) provides information of proximal 
amino acid residues within proteins and protein complexes. It is particularly useful for protein 
complexes that are recalcitrant to conventional structural biology studies. Successful observation 
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of a red algal PBS structure at the atomic level using cryo-EM took advantage of a particularly 
stable PBS species that allows PBS sample preparation for cryo-EM analysis at low salt 
condition. The cyanobacterial PBS, however, is much less stable, and the structure at the atomic 
level remains unclear. Here, we used residue-level chemical cross-linking to provide structural 
restraints to justify and evaluate a protein complex model that we generated by using 
bioinformatics methods (Fig. 6.1E). 
 
Figure 6.2 Identified cross-links in different types of cPBS. The subunit interaction networks, 
prepared by Cytoscape 34, are shown for (A) wild type cPBS (WT-cPBS) and two mutants 
including (B) CK-cPBS and (C) CpcL-cPBS. Cartoon representation of each PBS type is shown 
in the inset of each panel (top left), where WT-cPBS consists of six rods and a tricylindrical core. 
CK-cPBS contains only a tricylindrical core and CpcL-cPBS contains only the rods. The 
numbers represent the location of the cross-linked residues in each subunit. ApcA (light pink), 
ApcB (dark blue), ApcC (red), ApcD (yellow), ApcE (dark green), and ApcF (grey).  
In this experiment, we used wild type PBS of cyanobacteria Synechocystis 6803 (WT-cPBS) and 
two mutant PBS for cross-linking analysis (Fig. 6.2 and Fig. S6.4). In WT-cPBS, we identified a 
total of 36 cross-links, in which 19 inter-subunit cross-links are within the PBS-core (Fig. 6.2A 
198 
 
and Table S6.2). We also found numerous loop-links and mono-links (data not shown) that 
provide limited structural information for subunit-subunit interactions. In contrast, when CK-
cPBS, a rod-less PBS 20, was cross-linked and submitted to MS interrogation, 38 unique cross-
links were identified (Fig. 6.2B, Table S6.3). Besides the 19 inter cross-links identified in the 
WT-cPBS sample, 19 more cross-links have been found in CK-cPBS. The differences in 
identified cross-links between WT-cPBS and CK-cPBS are probably due to the shielding effect 
in WT-cPBS by six outward radiating PC rods that have extensive contacting interfaces and large 
steric hindrance to limit the accessibility of cross-linkers to core components. A CpcL-cPBS 
mutant 21 containing only the rods was also used for a negative control. For the CpcL-cPBS 
mutant (Fig. 6.2C, Table S6.4), we identified 13 cross-links of rod-subunits and associated 
proteins, especially, ferredoxin-NADP+ oxidoreductase (FNRL) that has been successfully 
located in two types of PBSs in our recent research 28. The obtained cross-linking network allows 
distinct distance restraints for constructing and validating the cPBS-core model (Fig. 6.1E).  
6.4.3 Model Evaluation by Chemical Cross-links 
BS3-H12/D12 is one of the most widely used cross-linkers, possessing a spacer length of 11.4 Å. 
The use of an isotopically encoded cross-linker such as this increases the confidence and 
accuracy of cross-linked peptide identification, with advantages for studying large protein 
complexes compared to non-isotope encoded cross-linkers. Each end of the cross-linker can form 
a covalent bond with a primary amine (lysine side chain or protein N-terminus).  If two such 
functional groups are within reach of ~30 Å, the cross-linker tends to react with either/both and 
to yield a mono-link or a cross-link, which can be identified by LC-MS/MS, revealing structural 




Figure 6.3 The cPBS-core structure mapped with observed cross-links. (A) Side view (cylinder 
perpendicular to the observer) and (B) bottom view of the cPBS-core, which is further mapped 
with (C) cross-link cApcC-K52-cApcB-K113, and (D) cross-link cApcE-K331-cApcA-K6. 
cApcA (light pink), cApcB (dark blue), cApcC (red), cApcD (yellow), cApcE (dark green), 
cApcF (grey).  
In the cross-linked CK-cPBS sample, we successfully identified a total of 38 PBS-core subunit 
interactions (representative MS and product-ion (MS/MS) spectra of cross-linked peptides are 
shown in Fig. S6.5 and S6.6). We then mapped them individually to evaluate the PBS-core 
model. For better visualization, the core structure of cPBS is shown in the side view and bottom 
view, respectively (Fig. 6.3A and 6.3B). For example, the cross-link between cApcC-K52 and 
cApcB-K113 (Fig. 6.3C and Table 6.1) can be located at either end APC trimer of each cylinder 
( i.e., A0, A3, A0, A3, B0, B3). We note that cApcC-K52 is surrounded by three cApcB-K113 
in the APC trimer (with C3 rotational symmetry). This arrangement gives reasonable cross-linked 






Table 6.1 Summary of two representative cross-links, including the information of possible 
cross-linking sites located on different copies of cApcA/B discs and the measured Euclidean Cα-
Cα distances (< 30 Å) 
Inter-molecular 
Cross-links 
Cross-linked Subunit on cApcA/B 
Discs 
Cross-linked 
Distance, Cα-Cα, Å 
cApcC52-cApcB113 
A3(or A0/A’3/A’0/B3/B0)-β1 20.0 
A3(or A0/A’3/A’0/B3/B0)-β2 18.5 
A3(or A0/A’3/A’0/B3/B0)-β3 11.2 
cApcE331-cApcA6 
A3(or A0/A’3/A’0/B3/B0)-α1 19.4 
A2 (or A’2)-α3 12.7 
Another example cross-link is between cApcE-LD1 and cApcA, which is formed towards the 
central cavity of the basal cylinder. There are two possible cross-linked sites with cApcE-K331: 
one is A3-α1-cApcA-K6 and the other is A2-α3-cApcA-K6 (Fig. 6.3D). (Note the nomenclature 
(disc (A3 or A2), first (1 or 3) α subunit, lysine (6)). The estimated cross-linked distances fit well 
within the 30 Å threshold 36 (Table 6.1). Overall, 34 out of the 38 cross-links bridge pairs of 
amino acids whose Cα-Cα distances are less than 30  1.5 Å , 20 of which exhibit more than one 
possible cross-linked site owing to the redundancy of ApcA/B in each disc; the multiple chances 
of forming structurally relevant cross-links in those cases testifies the reliability of the 
constructed cPBS-core model.  
Two of the other four cross-links are associated with ApcE-685, a residue that locates on the 
loop region connecting ApcE-LD2 and ApcE-LD3. The cross-linked distances are slightly larger 
than 30  1.5 Å, which could result from the dynamic nature of the loop (Table S6.5). The other 
two cross-links showing extra-long cross-linked distances are both related to ApcE-K87 in the 
middle of a flexible loop on cApcE, i.e. cApcE87-cApcA27 in CK-cPBS and cApcE87-cApcB17 
in both of WT-cPBS and CK-cPBS (Fig. 6.2A, 6.2B). The cross-linked distance is around 50 Å 
for the former one and 43 Å for the latter (Table S6.5). The PB-loop, consisting of 58 amino 
acids with primarily basic residues, has been proposed as an anchoring arm attached to the 
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thylakoid membrane, possibly through electrostatic interaction 2, 37. Consequently, the PB-loop 
can be highly flexible in the absence of the membrane, resulting in the cross-links that cannot 
form if the PB-loop is anchored on the membrane/reaction centers. In the cryo-EM structure, the 
PB-loop is not observed 18, possibly owing to the flexible nature of this domain. It should be 
noted that without the binding partners of the PB-loop, i.e., the membrane/reaction centers, the 
structural prediction using any program seems uncertain 13. The cross-linking chemistry and 
cryo-EM structure may capture and reflect different protein conformers in terms of the loop 
orientation. To understand its precise location and functionality, various mutants under different 
chemical environments are needed for adequate cross-linking restraints, which will facilitate the 
downstream computational simulation. Overall, selection of CK-PBS represented a successful 
strategy to pinpoint the subunit interaction network. The cross-linked distances supported very 
well the cPBS-core structure proposed by computational prediction.  
6.5 Discussion 
The PBS-core in Synechocystis 6803 represents a classical tri-cylinder core with C2-symmetry 
7, 
two of which are basal cylinders that contain various APC units (with copy numbers), i.e. ApcA 
(32), ApcB (34), ApcD (2), ApcE (2), ApcF (2) and ApcC (6). ApcD, ApcE, ApcF, and ApcC 
are arranged in mirror positions in two basal cylinders. The symmetrical feature of cPBS 
correlates well with that of a dimeric PSII, the most active form in cyanobacteria, red algae and 
higher plants. Captured energy is funneled from the cPBS rod to the cPBS-core unidirectionally 
and then reaches the terminal energy emitters (TEE), ApcE and ApcD 38, where excitation 
energy is finally transmitted to Chla in PSII and PSI for photochemical reactions 12. The 
interface between the cPBS-core structure and RCs is of great interest in understanding the 
energy transmission mechanism and dynamic process under varying environmental conditions. 
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Traditionally, two basal cylinders have been described as antiparallel and evenly covering the 
thylakoid membrane surface/reaction centers. Previous research techniques indeed have never 
been able to elucidate the detailed tomography of two basal cylinders relative to the thylakoid 
membrane surface. Our proposed tri-cylindrical PBS-core model, however, reveals that the two 
basal cylinders do not adopt a perfect antiparallel configuration, rather, the two basal cylinders 
are arranged in an acute X-shape at an angle of ~ 24° relative to each other (Fig. 6.4A). We start 
with our previously proposed PBS-PSII model 13 constrained by the structural proteomic data 2  
and further propose that each basal cylinder is tilted 12° relative to the thylakoid membrane (Fig. 
6.4B and 6.4C).  Specifically, ApcD, from the discs A3/Aʹ3, and αLCM, from the discs A2/Aʹ2, 
comprise a protrusion that preferentially touches the surface of thylakoid membrane. The distal 
disc A0/Aʹ0 tilts away from the thylakoid membrane surface (Fig. 6.4A and 6.4C). This 
orientation leaves an open space between the thylakoid membranes and discs A1/Aʹ1 and A0/Aʹ0 
(Fig. 6.4B and 6.4C). The extra discs on both the top cylinder and two basal cylinders may 
reflect the functional connection difference between rods and PBS-core in the block-shaped PBS 
(Griffithsia pacifica) and the hemidiscoidal PBS (Synechocystis 6803). It seems that our 
cyanobacterial tricylindrical model has increased surface area for attachment of (six) rods, in 
contrast to that of Griffithsia, which has 14 rods attached to a smaller PBS-core, in a much more 
compact manner. It seems, though, that six rods on the PBS-core in cyanobacteria may have 
more flexibility relative to each other. This may partially explain why no high resolution cryo-




Figure 6.4 The cPBS-core structure reveals an acute X-shape of the two basal cylinders. (A) 
Cross-over (side view) of the two basal cylinders, front relative to another (back). Dashed lines 
show the general trend of the two sets of linker domains, adopting an acute 24° angle relative to 
each other. (B) Front basal cylinder (Aʹ0-Aʹ3) and (C) back basal cylinder (A0-A3) relative to 
PSII dimer. Dashed lines show the general trend of the cylinder with an acute 12° angle. (D) Side 
view of cPBS-PSII complex, showing two cavities between uneven PBS basal cylinder and PSII 
that allows OCPs to interact at the putative geometry. ApcE domain including αLCM, ApcE-LD1 
and ApcE-LD2 (dark green), ApcD (yellow), OCP (orange), PSII dimer (split-pea). 
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A previous study particularly indicated that ApcE-K87 tends to interact with CP47-K227 from 
PSII 2, and could possibly be one of the critical structural basis dictating excitation energy 
migration from PBS to the reaction centers, specifically, PSII. With regard to PSI, a chemical 
cross-link between the N-terminal of PSI and PBS-core has also been reported 2, namely, PsaA-
30K - ApcB-17K. Pigment protein complexes involved in light energy capture and chemical 
conversion are not evenly distributed in the thylakoid membranes 5-6, 39. In some of thylakoid 
membrane regions, PSII is enriched, whereas in other regions, PSI is aggregated in patches that 
allows biochemical isolation and characterization 5. The reducing side of PSII and PSI have their 
own characteristics; unlike the flat surface at the PSII reducing side, PsaC, PsaD, PsaE of the PSI 
reducing side comprise a protrusion collectively protecting the iron sulfur center.  
The acute X-shape configuration at the bottom of the PBS-core provides structural 
accommodations for other regulatory factors on either the PBS-core or the reducing side of PSII. 
Orange carotenoid protein (OCP), for example, is a critical photoprotective protein that 
dissipates excess light energy under stress conditions and disarms harmful reactive oxidative 
species arising from photosynthetic machinery. It is commonly held that the active form of OCP 
(OCPR) binds to core subunits in cPBS as the primary energy quenching sites 40. ApcE has been 
proposed to be a promising target for OCPR 41, given the unique shift of its bilin-binding pocket 
compared to that of the surrounding ApcA/B subunits, which are all conserved Cys81 bilin sites. 
The tilted angle of each basal cylinder provides sufficient room for the 34-kDa OCP to move in 
and bind and, perhaps more importantly, to accommodate the fluorescence recovery protein 
(FRP) 40, a 14 kDa protein that can accelerate the detachment of OCP from its binding sites 
followed by subsequent deactivation, and other essential regulators in the photoprotection 
process. In our model, the extra space between two face-to-face trimers A1/A0 (or Aʹ1/Aʹ0) and 
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the PSII reducing side can accommodate the entrance of OCP without any spatial conflicts (Fig. 
6.4D). 
 
Figure 6.5 cPBS containing bilins and energy transfer pathways. (A) Overview of cPBS-core 
containing bilins in a side view (cylinder perpendicular to the observer). (B) Enlarged Aʹ 
cylinder with bilins twisting in a clockwise fashion, shown in a side view (cylinder parallel to the 
observer) and (C) in a side view (cylinder perpendicular to the observer). (D) Overview of 
excitation energy transfer pathway in cPBS-core-PSII complex in a side view (cylinder parallel 
to the observer). (E) Enlarged interface between B0 and Aʹ cylinder. (F) Enlarged interface 
between Aʹ cylinder and the PSII. (G) Overview of GpPBS-core containing bilins and 
representative energy transfer pathway 18. Bilins in cPBS-core: ApcA (light pink), ApcB (dark 
blue), ApcE domains (dark green), ApcD (yellow) and ApcF (grey). Bilins in GpPBS-core: 
ApcA (salmon), ApcB (cyan), ApcD (light orange), ApcE domains (limon), ApcF (purple). The 
PSII dimer is colored in split-pea. 
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In our model, plausible excitation energy transfer routes can be predicted in cPBS-core and 
cPBS-core-PSII supercomplex as well. In the red algal structure, there are 48 bilins in the core 
structure (Fig. 6.5G) 18. In our structure, four extra trimers were modelled onto the red algal 
PBS-core (i.e., B0, B4, A0, and Aʹ0 (Fig. 6.1A)), giving a total of 72 bilins in a trycylindrical 
PBS-core (Fig. 6.5A). The model shows that if the four extra trimers are removed, the excitation-
energy-transfer distances between each bilin are comparable to those of red algal. The staggered 
trimer orientation between two cylinders was retained, similar to that of the red algal structure 
(Fig. 6.4A).  In each basal cylinder, we noticed, interestingly, that each trimer adopts a specific 
angle twist (clockwise) relative to the previous trimer (Fig. 6.5B and 6.5C), a feature that has not 
been noticed previously 18. Each twist angle may seem small (8° of Aʹ2 vs Aʹ3, 13° of Aʹ1 vs 
Aʹ2, and 8° of Aʹ0 vs Aʹ1); however, the twists accumulate to afford a close orientation of the B0 
chromophore (B0-α) to that of Aʹ0 (Aʹ0-α), rather than to the α chromophore on another basal 
cylinder A3 (Fig. 6.5D and 6.5E). The smallest distance between B0-α and Aʹ0‒α is estimated to 
be 21.8 Å, in contrast to that of B0-α and A3-α, which is 34.7 Å (Fig. 6.5E). Both distances can 
allow energy transfer to occur; the former, however, may be more efficient. The distance 
between bilins Aʹ2-βApcF and Aʹ2-αLCM is 14.6 Å (Fig. 6.5F), the shortest distance between bilin 
pairs in the core, consistent with the value in red algal PBS 18. The distance between bilin Aʹ2-
αLCM and Aʹ3-ApcD is 28.5 Å. (Note that we measured the conjugation bond system rather than 
molecule center distance (Fig. 6.5)).  
For our previously reported PBS-core-PSII complex, the energy transfer routes can also be 
predicted from our new model of bilin in PBS to chlorophyll a (Chla) in PSII. The shortest 
distance between the bilin of αLCM and a Chl a in CP47 is 38 Å. (Note that the PB-loop in ApcE 
was not resolved in previous studies, the real distance remains a subject for future research). The 
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distance between bilin of αLCM and ApcD is 28.5 Å. Interestingly, the distance of bilin of ApcD 
and Chl a in CP47 is in a comparable range as that of the αLCM bilin. It appears that, on one side 
of the cPBS-core, energy transfers from bilins on B0 to A’0 (B3 to A0) and then horizontally 
transfers to ApcE where it feeds into the Chl a in CP47. Given that PBS-core and PSII share the 
same C2 symmetry axis, there is another energy transfer route along B3 to A0, then to A2-αLCM 
and ends in Chl a in CP47, the mirror component in another PSII monomer. 
In summary, we constructed the first detailed cPBS-core structure of Cyanobacteria 
Synechocystis PCC6803 to reveal an acute X-shape of the two basal cylinders. Our study 
provides a structural basis for energy migration and its related regulation associated with the 
transient association between PBS and RCs. The proximate location of the pigment proteins in 
the functional complex is essential to promote efficient energy transfer and regulation.  
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Table S6.1 Alignment between different cPBS domains and the corresponding components in 
GpPBS. All predicted homology models are included. Three cylinders are evaluated 
independently based on the location of various subunits. The RMSD value is calculated among 
all Cα in the two corresponded structures given by PyMOL software. 
 
Alignment with corresponding components in 
GpPBS, RMSD of all Cα (Å) 
Cylinder A Cylinder Aʹ Cylinder B 
cApcA/B 0.622/0.613 0.787/0.569 0.616/0.745 
cApcC 0.621/0.621 0.582/0.582 0.621/0.582 
cApcD 0.645 0.644 - 
cApcEʹ  
(or αLCM) 
M1 0.379 0.380 - 
M2 0.384 0.386 - 
M3 0.460 0.454 - 
M4 0.309 0.312 - 
M5 0.469 0.471 - 
cApcE_LD1 
M1 0.345 0.359 - 
M2 0.696 0.69 - 
M3 1.0341 1.03 - 
M4 0.277 0.277 - 
M5 1.001 1.018 - 
cApcE_LD2 
M1 0.264 0.283 - 
M2 0.714 0.735 - 
M3 0.249 0.285 - 
M4 0.243 0.277 - 
M5 0.253 0.293 - 
cApcE_LD3 
M1 - - 0.222/ 0.232 
M2 - - 1.136/ 1.175 
M3 - - 1.166/ 1.199 
M4 - - 0.178/ 0.195 
M5 - - 1.304/ 1.322 









































































































































































































































































































































































































































































































































a cApcE87 related cross-links that exceed the 30 Å threshold of the BS3-H12/D12 cross-linker. 
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Table S6.4 Cross-links identified in CpcL-PBS.  
Cross-linked Sequence Cross-linked Protein Charge m/z Detected peptides in Raw File 
LGGKVASITPASLS(4)-
FDVFTR(1) 
cpcC1(281)-cpcB (1)/ 2 1177.1190 AB_X02_01.26941.26941.2.0.d
ta 























cpcD (1)-cpcA (2)/ 3 1279.9830 AB_X02_01.20401.20401.3.0.d
ta 





































Table S6.5 Summary of other intermolecular cross-links in CK-PBS, including the information 
of possible cross-linking sites located on different copies of cApcA/B discs and the measured 
Euclidean Cα-Cα distances. 
Intermolecular Cross-links 
Cross-linked Subunit on 
cApcA/B Discs 












α1-β1  8.3 
cApcA6-cApcB (N-Term) α1-β1 9.3 
cApcA27-cApcB(N-Term) α1-β1 20 
cApcA27-cApcB17 α1-β1 28.7 
cApcA27-cApcB28 α1-β1 14.1 
cApcA27-cApcB53 α1-β1 29.8 
cApcA52-cApcB17 α1-β1 17.3 
cApcA52-cApcB53 α2-β3 21.6 
cApcC45-cApcA6 A3/A0/A0/A3/B0/B3-α3 19.3 




















cApcE685-cApcA6 A1/Aʹ1-α1 30.5 
cApcE685-cApcA27 A0/Aʹ0-α2 b36.1 
cApcE685-cApcA52 
B2/B1- α3 25.8 
A1/Aʹ1-α1 13.2 










































a cApcE87 related cross-links that exceed the 30 Å threshold of the BS3-H12/D12 cross-linker.  








Figure S6.1 Sequence alignments (A) between cApcA (PDBID: 4F0U) and GpApcA (PDBID: 








Figure S6.3 Alignment of cApcF and GpApcF. (A) Alignment of the predicted cApcF-M1 (c for 
cyanobacteria, grey) onto the GpApcF (Gp or Griffithsia pacifica, black). Highlighted region 
(purple) is the indel of residue 139-142. The extension protrude is highlighted in orange. (B) The 











Figure S6.5 MS and MS/MS spectrum of a representative cross-link, ApcB (17)-ApcD (48). (a). 
The MS1 spectra of the light and heavy cross-linked peptide (BS3-H12/D12) which are sperated by 
m/z 3.019 (z=4). (b). MS/MS spectra of the cross-linked peptide (light). (c). MS/MS spectra of 






Figure S6.6 MS and MS/MS spectrum of a representative cross-link, i.e. ApcE (817)-ApcA (6). 
(a). The MS1 spectra of the light and heavy cross-linked peptide (BS3-H12/D12) which are 
sperated by m/z 3.019 (z=4). (b). MS/MS spectra of the cross-linked peptide (light). (c). MS/MS 































Mass spectrometry (MS)-based approaches have grown rapidly in the past 30 years, becoming an 
asset to characterize protein higher-order structures (HOS). Comparing to traditional biophysical 
methods, MS-based protein HOS analysis provides middle-to-high spatial resolution with high 
throughput and low amount of required sample. MS-based footprinting is one of these 
approaches, aiming to map solvent accessible surface area (SASA) of protein at different 
conditions. The focus of research described in this thesis is to develop and apply one or several 
MS-footprinting approaches to answer specific biological questions. In general, MS-based 
footprinting includes reversible footprinting (hydrogen-deuterium exchange (HDX)) and 
irreversible footprinting which can be conducted by radical reagents and other targeted labeling 
reagents. In this thesis, chapter 1 reviews MS-based footprinting in detail and discusses the 
difference between its subcategories. The following chapters focus on the development and 
application of these MS-footprinting approaches. 
7.1 Elaboration of FPOP Platform 
In 2005, the Gross lab developed fast photochemical oxidation of protein (FPOP) that can 
generate hydroxyl radicals on a flow system and label protein according to their SASA at the 
microsecond timescale. In the past decade, FPOP has been adopted in both academic and 
pharmaceutical labs to study protein conformational changes, protein-protein or protein-ligand 
interactions, protein aggregation and protein dynamics. For broader applications, elaboration of 
the FPOP platform is a primary interest in our lab. Chapter 2 describes one way of elaborating 
FPOP; that is, the development of a new radical labeling reagent, the carbonate radical anion. We 
generated the carbonate radical anion from hydrogen peroxide in the presence of bicarbonate 
buffer and investigated its reaction specificity. With selectivity towards methionine and aromatic 
residues, carbonate radical anion complements other radical reagents in the footprinting 
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“toolbox”. The targeted chemistry of the carbonate radical allows easier data process for protein 
systems that are rich in those reactive residues. The major limitation of this footprinting 
approach, however, is the basic pH condition during radical generation; the high pH can 
potentially limit its applications for pH-sensitive proteins. For future research, radical reagents 
that can be generated in biological-friendly conditions are to be developed. The ideal condition 
should constitute of neutral pH, require minimal number of chemicals, and contain inert 
precursors to avoid pre-labeling modification.  In addition, these radicals are preferred to yield 
bio-orthogonal mass adducts in proteins, in which way that the readout can be distinguished from 
the mass of PTMs or of degradation products during MS analysis. Furthermore, novel 
footprinting reagents that target relatively less reactive residues (e.g., alanine and glycine) are 
also desirable; perspective from organic chemistry regarding C-H bonds activation may provide 
useful guidance to address this issue. There are also technical concerns of developing a new 
reagent including the evaluation of its compatibility to different protein systems. In addition, the 
optimum dosage of the reagent needs a systematic discussion. To investigate residue preferences 
under different conditions, a series of small peptides that only differ in one amino acid are good 
model systems, allowing a better methodical comparison. 
In chapter 3, we discussed the expansion of FPOP platform from another aspect, which is the 
integration of two lasers to follow protein unfolding. We designed and established a two-laser 
platform to allow a pH jump induced by the first laser followed by the radical footprinting 
triggered by the second one. With a time-delay between the two lasers, we aimed to characterize 
the protein conformations occurring during unfolding. We evaluated different photoacids and 
radical reagents for this purpose, setting foundations for future research. In future studies, more 
photoacids and radical reagents need to be screened to avoid complicated chemistries upon laser 
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irradiation. Photoacids without nitroso-group (e.g., benzyl ester) can be a good start. Iodine 
radical footprinting and trifluoromethyl radical footprinting are both worth a try. With the 
development of more radical footprinters, there are better chances for more candidate reagents to 
be accommodated on the two-laser platform. The established platform would considerably 
benefit the study of the gating mechanisms of ion channel proteins, such as potassium ion 
channel proteins, transient receptor potential channel protein, and the M2 protein, which is a 
proton transport channel of influenza virus A that is sensitive to pH changes. Structural dynamics 
of the targeted protein with respect to different lipid environments and substrate binding can 
further be investigated.  
7.2 Integration of HDX-MS, XL-MS with Computational 
Methods 
HDX-MS and irreversible footprinting provide complementary information in terms of 
elucidating protein HOS. HDX-MS delineates SASA and dynamics of the backbone amides, 
whereas the irreversible footprinting (e.g., FPOP and chemical cross-linking (XL)) informs on 
reactive amino acid side chains. Integration of the two methods provides more precise and 
comprehensive description of protein HOS compared to employing either one.  
In Chapters 4 and 5, we showed two examples of adopting this combined approach, specifically 
with HDX-MS and XL-MS. The implementation of XL-MS successfully differentiates the 
regions undergoing remote conformational changes from those being protected in the binding 
events; two scenarios that cannot be distinguished by stand-alone HDX. We further incorporated 
molecular docking in the protein HOS interpretation, guided by the restraints derived from the 
cross-links, and acquired quaternary structural information of the binding complex.  
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Although the integrated platform shows great potential in protein HOS analysis, there are 
limitations that deserve future attention to overcome. Firstly, molecular docking heavily relies on 
accurate protein structures to start with. The involved proteins retain their structural rigidity 
throughout the docking process. This feature largely limits its applications to proteins that have 
significant numbers of flexible domains. In the future, other computational methods (e.g., 
discrete molecular simulation) that can better accommodate the structural changes are desirable. 
In addition, current HDX adjudication is conducted only qualitatively. We envision that the 
quantized HDX readout can advance the elucidation of protein HOS and ultimately contribute to 
protein structure prediction in the absence of differential experiments. Furthermore, the 
integrated MS-based approaches in combination with other biochemical techniques would better 
advance the characterization platform. For example, peptides representing the suggested binding 
regions from MS analysis can be synthesized and incorporated in binding assays (e.g., 
fluorescence polarization assay (FPA), competition FPA, isothermal titration calorimetry, and 
surface plasma resonance) to ascertain their binding interactions with the targeted protein and to 
obtain even their binding affinities. In addition, mutagenesis (e.g., alanine shaving) of the 
potential binding interfaces and the associated analysis of the binding kinetics with mutants are 
beneficial complements to locate further the critical binding residues that are favored 
energetically. Subsequent bio-functional assessments such as minigenome assays to study high 
pathogenic virus using protein or peptide mutants will also provide constructive evidence for a 
comprehensive analysis of the binding events.  
Besides the interleukin complexes and antibody/antigen complexes such as PD-1/Nivolumab, 
other antibody therapeutics can also be accommodated on this integrated platform. One example 
of many is the study of bispecific and trispecific antibody systems that contain numerous 
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designed paratopes and complex targeting antigens. The MS-based footprinting approaches on 
the integrated platform can not only identify their epitope/paratope regions but can also specify 
the interacting antigens for each paratope based on the cross-linking results, therefore promoting 
the mechanistic interpretation of the antibody function and potentially their discovery and 
development. 
Chapter 6 describes a collaboration wherein we used irreversible footprinting and computational 
methods, the combination of XL-MS and homology modeling. The latter helps to predict the 
structure of a phycobilisome complex, which is further modified and validated by the obtained 
cross-links. For future study, other proteins or protein complexes are good opportunities to 
expand its applications. From a technical point of view, method development in sample 
preparation is preferred, especially for large protein complexes. Chromatographic separation 
such as size exclusion chromatography and strong cation exchange chromatography are worth 
considering. These enrichment methods can distinguish the cross-linked peptides with higher 
charge states from the linear peptides, sustainably increasing the identification efficiency in the 
MS analysis. Other separation techniques such as asymmetrical flow field-flow fractionation 
(AF4) can also be a good candidate, which enables an on-line separation of macromolecules 
prior to cross-linking, minimizes the heterogeneity of the targeted protein complex when 
executing the cross-linking reaction, and facilitates subsequent MS analysis. In addition to 
photosynthetic complexes, other protein systems such as the Mediator complex, a transcriptional 
coactivator, and the anaphase-promoting complex (APC), which regulates chromosome 
segregation and anaphase progression, can also be analyzed in such fashion. All in all, marriage 
of footprinting and computational efforts provides a powerful approach to study large protein 
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complexes, whose structures are usually hard to obtain from conventional high-resolution 
structural biology methods including X-ray crystallography and NMR. 
 
